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ABSTRACT
Peptide identification is at the core of bottom-up proteomics measurements. However, even with
state-of the-art mass spectrometric instrumentation, peptide level information is still lost or missing
in these types of experiments. Reasons behind missing peptide identifications in bottom-up
proteomics include variable peptide ionization efficiencies, ion suppression effects, as well as the
occurrence of chimeric spectra that can lower the efficacy of database search strategies. Peptides
derived from naturally abundant proteins in a biological system also have better chances of being
identified in comparison to the ones produced from less abundant proteins, at least in regular
discovery-based proteomics experiments. This dissertation focused on the recovery of the
“missing or hidden proteome” information in complex biological matrices by approaching this
challenge under a peptide-centric view and implementing different liquid chromatography tandem
mass spectrometry (LC-MS/MS) experimental workflows. In particular, the projects presented
here covered: (1) The feasibility of applying a liquid chromatography-multiple reaction monitoring
MS methodology for the targeted identification of peptides serving as surrogates of protein
biomarkers in environmental matrices with unknown microbial diversities; (2) the evaluation of
selecting unique tryptic peptides in-silico that can distinguish groups of proteins, instead of
individual proteins, for targeted proteomics workflows; (3) maximizing peptide identification in
spectral data collected from different LC-MS/MS setups by applying a multi-peptide-spectrummatch algorithm, and (4) showing that LC-MS/MS combined with de novo assisted-database
searches is a feasible strategy for the comprehensive identification of peptides derived from native
proteolytic mechanisms in biological systems.
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CHAPTER 1
Introduction to mass spectrometry-based proteomics and overview of
research topics covered in this dissertation
1.1 The advent of MS-based proteomics in the biological sciences.

1.1.1 Functional genomics and the wholistic view of biology.
The development of large-scale DNA sequencing technologies of the 90’s provided an
unprecedented molecular understanding of biological systems at an incredible pace.1 In 1995 the
complete cellular genome of the bacterium Haemophilus influenzae was obtained,2 and in a span
of 8 years, the first draft of the human genome was essentially finished.3 Even model organisms
such as Saccharomyces cerevisae turned out to be more complex than initially thought i.e., from
the 2000 genes previously characterized with traditional biochemical experiments to over 6000
found by genomics analyses.4,

5

By expanding the scope of biological investigations, gene

sequencing quickly introduced an era of discovery-driven research, in which the components of
the system under investigation are collected irrespective of any hypothesis of how they might
work.5, 6
As time kept passing by, however, the amount of information provided by genome
sequencing with its fast discovering rates, surpassed the time it took to functionally characterize
new genes, and databases quickly started to fill with sequences lacking functional annotations.
Thus, cell and molecular biology research needed of new experimental approaches that could
keep up with the enormous and rapid amounts of information provided by genomics, while at the
same time providing of creative ways of how to handle, analyze, store and share biological data.
The responses that came out of these efforts led to the generation of several new “omics”
research fields, mainly transcriptomics and proteomics.5-7
Transcriptomics studies have been considered as a starting point to survey gene
expression as the most direct product of a gene is an RNA transcript. The comprehensive
interrogation of the identity and quantity for the complete set of transcripts in a cell directly reflects
the activation of functional elements in the genome in a certain developmental state or
physiological condition. Even when the genome is static in nature,8 the activity of genes is
dynamic, and in every organism, subsets of genes get transcribed for subsequent functional roles.
Amongst the two most employed approaches available for transcriptomics profiling, are
hybridization (e.g. microarray) and sequencing (e.g. RNA-seq), the former being high-throughput
1

and of generally low-cost making it widely popular in studies of various biological systems.9, 10
However, next-generation sequencing has made it feasible to achieve deeper sequencing of the
transcriptome with high resolution and dynamic range, alongside independence from existing
genome information, and clear determination of transcription boundaries. 11
Proteomics developments started in the late 20th century with the introduction of matrixassisted laser desorption/ionizations (MALDI) and electrospray ionization (ESI) by Koichi Tanaka
and John B. Fenn, respectively.12, 13 These two “soft” ionization techniques were the main drivers
that allowed the use of mass spectrometry (MS) to analyze proteins and then peptides due to
their ability of ionizing large and labile molecules. Importantly, the introduction of ESI enabled the
interfacing of liquid chromatography (LC) to MS for protein and peptide characterization. The most
notable feat was that by the group of Donald Hunt at the University of Virginia, in which using LCMS, 19 major-histocompatibility-complex (MHC) class I-bound peptides were partially sequenced
by the combined use of LC-MS,14 an achievement that over the years would lead to a decrease
in the use of Edman degradations,15 which are based on the stepwise reaction of the N-terminal
amino acids in a protein or peptide (up to 50 amino acids long) with phenylisothiocyanate and
cyclic cleavage of the labeled amino acids without disrupting other peptide bonds.
With the ability to detect and sequence femtomolar amounts of peptides via LC-MS/MS,
the challenge was now to assemble them back to their original proteins. This task was achieved
by some research groups around the world16, 17 which introduced the use of MS/MS spectra-toprotein search algorithms, a bioinformatics success that until now remains at the core of bottomup proteomics approaches. Continual improvements in protein extraction and enzymatic
digestions, peptide separations via LC instrumentation and mass spectrometers providing higher
scan speeds, mass resolution and accuracy; the field of proteomics has opened an era of
comprehensive characterization for protein sequence identification and quantification in which
each protein is not studied individually but under the context of interconnected systems.
Successful applications of LC-MS for proteomics analysis have provided protein-level functional
view for metabolic activities in various biological systems, from single bacteria isolates, higher
order eukaryotes, to complex microbial communities.18-20

1.1.2 Proteomics gives meaning to genomics and transcriptomics information.
Two polymeric strands of complementary deoxyribonucleotides form the DNA double
helix. The genetic information carried by the linear sequence of deoxyribonucleotide subunits is
further transferred to an intermediary RNA molecule that is then translated to a protein consisting
2

of a sequence of amino acids. This flow of genetic information from DNA to proteins
(DNA→RNA→Protein) is the well-known central dogma of biology.5, 21 However, with the advent
of OMICS technologies, we have now realized that there are exceptions to the dogma. More
complex organisms are known to possess smaller numbers of genes, yet they express twice or
thrice more proteins than less complex organisms. For example, in higher eukaryotes more than
50% of genes code for more than one protein, whereas in yeast and filamentous fungi, ~90% of
genes encode one protein per gene.8
Even when the genome content in an organism does not change, its products do. The
differential expression of genes is required to form distinct transcripts and proteins that control
distinct functions. Thus, in comparison to the genome, the transcriptome and proteome are
considered dynamic entities, because they can differ from cell to cell and even within the same
cell type, at different stages of activity or development.22,

23

The dynamic nature of the

transcriptome and proteome provides valuable information when studying functional relationships
between genes.24
Although mRNA quantification has been used as a proxy for measuring changes of protein
abundance and has informed about many cellular responses, proteins provide a closer look to
the functional activities of cells.25, 26 In contrast to mRNA, proteins are the effectors and regulators
of essentially all cellular processes in an organism.27 Across species, proteins constitute about
50% of the dry mass of a cell and reach a remarkable total concentration of 2–4 million proteins
per cubic micrometer or 100–300 mg per ml.26 The extensive proteome network of the cell adapts
dynamically to genetic perturbations and thereby defines the functional state and determines the
phenotypes of a cell.
Interestingly, with the advances in OMICs technologies, the general consensus nowadays
in cell biology research is that mRNA levels cannot be consistently relied upon to predict protein
abundance.4 Amongst the reasons are the complexity of post-transcriptional regulation processes
(i.e., riboswitches) as well as the multitude of post-translational modifications (PTM) in a protein
such as phosphorylation, acetylation, and glycosylation that act as signals in information
processing or as marks that mediate protein associations.4,

28, 29

Although one can attribute the

discrepancy between mRNA and protein levels to measurement variability and noise in data,
some studies have shown that this correlation reflects underlying biological mechanisms. 30, 31
Examples of the correlation between transcriptomics and proteomics data have been
registered across various domains of life. For example, studies in different developmental stages
of the human blood fluke Schistosoma japonicum concluded that around 40%–60% of the proteins
detected in S. japonicum were consistent with its transcripts.32 In yeast, it has been found that for
3

some genes, while the mRNA levels were of the same value, protein levels varied by more than
20-fold.30 Conversely, for some other genes, the transcript levels varied by 30-fold, while proteins
level remained invariant. In higher eukaryotes, such in the livers of mice treated for different
periods of time with three different peroxisome proliferative activated receptor agonist, the results
shown that the differential expression of mRNAs explained at most 40% of the differential
expression of proteins.31 Even in the small genome containing organohalide respiring bacteria
Dehalococcoides mccartyi, poor correlation of mRNA- and protein abundance for four tested
genes was explained by varying ribosome content and cell decay.33
These examples highlight the importance of proteomics data and how its integration with
transcriptomics can provide better or new insights into the regulation of cellular processes at a
genome-wide scale. Whereas a strong correlation between both transcriptomic and proteomic
data can serve as confirmation for an induced response to a treatment, the lack of strong
correlation can also help detect experimental errors or hint to the possibility of a biological
uncoupling between mRNA and protein expression. 34,

35

Studying the levels of proteins in an

organism offers insights to analyze translational status or post-transcriptional regulations and
even by itself, it can also be applied to observe effects that may not be apparent by considering
mRNA levels exclusively. MS-based proteomics can reveal the protein content of subcellular
structure and organelles, provides an alternative to discern higher-order structural features of
protein complexes, and contributes to functional evidence that is helpful in the characterization of
metabolic pathways.28

1.1.3 The practical implications of proteomics in biological research.
Before the advent of system-wide technologies, individual genes and their products, or
small clusters of related components in specific biochemical pathways, were studied by
techniques including, for example, site-directed mutagenesis, Western blotting, in vitro protein
assays, and in vivo cell imaging.36 The contributions of these now considered “classical”
experimental techniques has been invaluable to assess the presence, sequence, function, and
biochemical mode of action of one or a few specific proteins;4 however, the data they provide
open a small window into the mechanisms governing the organization of the cell and highlight
only a small part of a large interconnected network of functionally and physically interacting
proteins.
Instead, technological and experimental advances in mass spectrometry-based
proteomics, comprising mainly of comprehensive protein sequence databases (derived from
4

genomics and transcriptomics); sensitive and accurate MS instrumentation; an emerging
collection of software that can match MS spectra to protein databases; and protein separation
technologies like liquid-chromatography,4, 28 have allowed this technique to be now at the center
of systems biology studies, in which, not only one or a few distinct proteins are analyzed each
time, but the interplay of multiple ones and their roles as members of larger systems or networks
are studied.37
The impact that modern proteomics methods have had in our understanding of proteins
under the systems biology context can be summarized into four principal applications that are 1)
mining, 2) protein-expression profiling, 3) protein-network mapping, and 4) mapping of protein
modifications.4
In mining, proteomics has been used to make an inventory of the content of all or all the
possible proteins in a sample.37, 38 Although it can be considered a “brute-force” approach, the
advantage of complete and high quality protein databases with computational algorithms able to
match spectral data to peptides and proteins with adequate control of false positive hits, makes
proteomics mining a feasible strategy to confirm what could only be inferred from gene-expression
data or generate comprehensive proteome maps that can later be used as references for more
in-depth investigations. Early examples of mining involve large-scale proteome maps of
microorganisms such as yeast39 or the bacterium Deinococcus radiodurans with products from
more than 60% of the genes identified.40
The most common and versatile use of large-scale MS-based proteomics has been to
document the expression of proteins as a function of a cell or tissue state.4, 41 In protein-expression
profiling studies relative or absolute quantitative values of the observed proteins at different states
(i.e., developmental, disease, physical stimulus, etc.), are measured to infer, for example,
statistically significant changes of protein A to protein A in condition A to B, and attribute the
change in expression to that particular condition(s). Expression profiling studies have found an
appeal for biomedical applications as a means of detecting potential targets for drug therapy in
disease, where normal and diseased cells or tissues are compared to determine which proteins
are expressed differently in one state compared to the other.4, 24, 42-44
Proteins rarely function alone, instead, they depend on the association of various
components into macromolecular complexes. The interactions between proteins determine the
functions of signal-transduction cascades and biosynthetic or degradation pathways. 4 One of the
most commonly employed experimental techniques coupled to MS detection is affinity -capture,
where taking advantage of relative abundance levels of “prey” proteins and the endogenously
expressed “bait” ones, complete interactome maps in cells can be drafted. 8, 37, 45 For example, a
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study with 11 human cell types, determined the relative changes of the protein components of
182 complexes under five different temporal states. 46 Other more specialized and elegant ways
of studying complexes involve native mass spectrometry or MS based identification of crosslinked
residues (XL-MS),37, 47 which has been used in combination with cryo-electron microscopy to
identify substrate binding sites in molecular chaperones or to provide additional data to
complement molecular dynamics simulations.48-50
Finally, the dynamic nature of the proteome in any organism is due in part to the variety
of post-translational modifications (PTMs) that act to promote or repress the targeting, structure,
function, and turnover of proteins.4, 41 Although modified proteins can be detected with antibodies,
one question that is not always answered in such experiments is the specific location site of the
particular modification.4 MS based proteomics is ideally suited to study PTMs because changes
in the labeling of amino acids are reflected by shifts in mass that can be located with the resolution
of a single amino acid through peptide-fragment ion spectra.37 Regularly, mapping of protein
modifications via mass spectrometry requires of specialized PTM enrichment strategies to
overcome the expected natural abundance variance of modified peptides and/or proteins in a
cells or tissue.51,

52

The most frequently studied types of PTMs via MS/MS are phosphorylation,

ubiquitylation, the addition of ubiquitin-like proteins, glycosylation, methylation, acetylation and
other types of acylation.37 The study of PTMs by MS has been particularly gaining traction in the
last years, as new roles for “well-studied” PTMs are being found in common organisms. For
example, the lysine acetylation and succinylation in rice (Oryza sativa) has recently been
implicated in seed development.53

1.2 Overview of MS-based proteomics for biological research.

1.2.1 Mass spectrometry bottom-up proteomics as the powerhouse for largescale/high-throughput analysis of proteomes.
Mass spectrometry (MS) based proteomics research is usually conducted in two ways:
“bottom-up” and “top-down”. Top-down approaches involve the MS analysis of intact proteins54
and their proteoforms, encompassing all forms of genetic variation, alternative splicing of RNA,
and PTMs.55 Although in principle top-down approaches seem like the most straightforward way
for the detection and quantification of multiple proteins in a sample, analytical and technical
challenges such as the difficulty of solubilizing and ionizing entire proteins; the separation of
protein mixtures prior to MS analysis; the low sensitivity of measurements;56 and the complexity
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of matching intact and fragmented proteoform MS data to a protein sequence, 57 have limited their
application to the broad study of the proteome.
Instead, bottom-up proteomics approaches, which are based on the mass spectrometric
measurement of peptides generated by the enzymatic digestion of proteins,37 are nowadays the
standard for large-scale and high-throughput analyses of complex samples. Although in principle
the digestion of proteins to peptides increases the complexity of the samples under study; the
mass ranges and predictive tandem MS (MS2 or MS/MS) fragmentation patterns of peptides,
compared to those of large intact proteins,28 makes them more compatible with MS
instrumentation capabilities.
Until today, hundreds of bottom-up proteomics studies across all domains of life have been
published with the overarching goal of having a better understanding of the biological processes
occurring in cells and tissues.18,

58-60

Depending on the scope of the study, proteomics analyses

include not only the identification of proteins, but also the nature and position of any
posttranslational modifications (PTMs); the interpretation of dynamic quantitative changes
between conditions; and/or the study of protein conformations or interactions within larger protein
complexes or in the context of biological networks or pathways.
Generally, there are three approaches of how to achieve the aforementioned research
goals with bottom-up proteomics and these are:28,

37

(1) Global (also known as shotgun or

discovery) proteomics by means of data-dependent acquisition (DDA), aimed at achieving
unbiased and complete coverage of the proteome; (2) targeted proteomics using multiple reaction
monitoring (MRM) or parallel reaction monitoring (PRM), usually performed after discovery
proteomics experiments and that is aimed at the reproducible, sensitive and high-throughput
identification and quantification of a subset of known peptides of interest; and (3) multiplexed
fragmentation of all peptides that elute from liquid chromatography by data-independent
acquisition (DIA), which is nowadays seeing an increase of use in biological applications and is
aimed at generating comprehensive peptide fragment-ion maps for a sample. In this dissertation,
global proteomics by DDA and targeted proteomics using MRM were employed in the studies
presented in Chapters 3-5.

1.2.2 Global proteomics by data-dependent acquisition-mass spectrometry (DDAMS).
In global proteomics studies, peptide and protein identifications are maximized to give a
comprehensive catalogue of analytes in unknown samples or explaining the biological
7

process(es) under study. A complete and reliable MS based proteome map is also a prerequisite
for the development of targeted mass spectrometry techniques, as well as for DIA strategies.
After enzymatic digestion of proteins to peptides, the mass spectrometer is used to identify
the sequence of all peptide ions (charged peptides) through the generation of a diagnostic MS/MS
peptide fragment ion spectrum.24 The identified peptide sequences must then be assigned to the
proteins they originate from, through a nontrivial process called protein inference which is most
commonly performed with bioinformatic software that match peptides to proteins in a database
(i.e., a FASTA file with protein sequences).61
Traditionally, global or discovery proteomics are based on a spectra collection strategy
known as data dependent acquisition (DDA) 28 (Figure 1.1.A). According to this approach, mass
spectra of all the peptide ion species that coelute at a specific time from chromatography
(precursor-ion spectra) are recorded at the MS1 (or full scan) level.62 Depending on the intensities
of the recorded precursor ions, the instrument then determines groups of precursors that are
isolated and then fragmented to generate fragment ion-spectra or MS2 level scans.63 Because of
its dependency on the intensity of the peptide precursor ions detected at the MS1 level, global
proteomics by DDA is subject to preferentially fragment high-abundant precursors while low
abundant ones may not be sampled.63 However, one way to increase the sensitivity of these
analyses is by limiting the redundant fragmentation of abundant precursor, so that ions selected
for fragmentation are temporarily excluded in the following scans over a determined time. This
instrumental technique, known as dynamic exclusion, 64 improves the number of MS/MS spectra
collected and, consequently, the number of identified peptides and proteome coverage.65
However, even with dynamic exclusion, low intensity ions coeluting with high intensity peptides
may still not be identified making it one of the main limitations of global proteomics by DDA.

1.2.3 Targeted proteomics by multiple reaction monitoring-mass spectrometry
(MRM-MS).
Complementary to global proteomics approaches, in targeted proteomics experiments,
the goal is not to maximize peptide and protein detection, but to monitor and quantify, with
sensitivity and throughput, selected proteins of interest.66 Due to its focused and sensitive nature,
targeted proteomics is the gold-standard in biomarker development studies by proteomics and it
has lately been regarded as a technique that may replace Western-Blot or antibody-based assays
in the near future.67
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Using pre-existing information, such as that derived from global proteomics, characteristic
peptides ions from proteins of interest are selectively isolated and then fragmented over their
chromatographic elution time. Most of the targeted proteomics assays are performed in triple
quadrupole mass spectrometers (QQQ) via a spectral data collection method known as multiple
reaction monitoring-mass spectrometry (MRM-MS).68 In MRM-MS, distinct pairs of precursor ion
masses and cognate fragmentation masses, derived from existing datasets or large-scale spectral
libraries, are used for sensitive and specific determination of these pairs or transitions (Figure 1.1
B).69
Although QQQs have lower resolution and mass accuracy compared to the high-end mass
spectrometers used in traditional global proteomics experiments; QQQ instrumentation offers the
ability to detect peptides (and metabolites) that can vary in their abundance ranges by up to three
to four orders of magnitude in linear response, as well as high speed of spectra acquisition which
leads to good ion statistics and sensitivity.69,

70

Due to these characteristics, large number of

samples may be interrogated for quantitative abundance values of a predetermined number of
peptides without the need for time-consuming global proteomics experiments. Alongside the
robust and economical triple quadrupole instruments, high-resolution instruments such as
quadrupole orbitraps are used increasingly for targeted analysis, a variant known as parallel
reaction monitoring because it utilizes the entire MS2 spectrum as oppose to certain fragment
ions from a precursor.71
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Figure 1.1 Types of tandem mass spectrometry acquisition methods used in this dissertation.
For clarity of presentation, three peptides are shown in each case (square, circle and hexagon
shapes). (A) In data-dependent acquisition (DDA), peptides are selected for fragmentation based on
intensity thresholds. Common setups include the analysis of the top 5, 10 or 15 most abundant
peptides eluting at a given time. In this example, the peptide marked with “1”, as representation of
abundance, is selected in the first mass analyzer of an instrument (MS1), fragmented in a collision
cell, and the resulting fragments analyzed by a second analyzer (MS2). The process is then repeated
for different precursors (i.e., second and third place in abundance). MS/MS spectra recordings
collected in DDA are better visualized using the mass-intensity dimension. (B) In multiple reaction
monitoring (MRM) mode, the instrument cycles through a series of predefined sets of precursorfragment ion pairs (also known as transitions). In this example, a precursor ion is selected in the first
mass analyzer, fragmented in the collision cell, but instead of measuring every possible fragment ion,
just three fragments are monitored. MRM signals are better visualized as a series or overlappin g peaks
from the measurement of each transition in the time-intensity dimension.
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1.2.4 Relative label free and absolute quantification of proteins in bottom-up
proteomics.
Quantification is at the heart of every bottom-up proteomics study today. However, peptide
and protein quantitation by LC-MS/MS is not a trivial task. Although it would seem intuitively to
quantify peptides in a spectrum based on their MS-derived spectral peak intensities, these do not
often correlate with their relative abundance within a given analyzed sample. 72 This scenario is
even true for peptides originating from the same protein after enzymatic digestion and that in
theory are present in equimolar amounts. Several factors impact the way how peptides ionize
before entering the MS instrument and thus, their signal intensities. Amongst these factors are
ion suppression events that can be a consequence of the coelution of components from the
solvent and sample during chromatography;73 or the varying physicochemical properties of each
peptide that make them amenable to ionization (i.e., hydrophobic peptides ionize more efficiently
than hydrophilic peptides).74
Therefore, to achieve an adequate level of quantitative accuracy, each individual peptide
and/or protein are compared between different samples or experimental conditions.75 Hence,
several MS based strategies have been developed to achieve this form of relative quantitation.
These strategies can be distinguished by the goal and scope of each experiment. Broadly, relative
quantification strategies in proteomics are classified into two groups: Those using stable isotope
labeling and those that are label-free (LFQ), the latter, being the focus of this dissertation.
As the name implies, relative LFQ techniques do not employ any stable isotopes to label
different protein/peptide samples. In comparison to label-based approaches, LFQ approaches are
easier to implement, cheaper, and offer the ability to quantify a larger number of proteins with a
wider dynamic range, albeit, at the cost of sacrificing some level of quantitation accuracy.65, 76 The
two most commonly used LFQ techniques are based on spectral-counting (also known as ioncounting) and peak-intensity principles.77
In the spectral counting (SC) method, the number of MS/MS spectra collected for a given
protein across multiple LC-MS/MS runs provides the values necessary for relative quantification.78
This method is based on the empirical observation that the more abundant proteins are in a
sample, they yield a larger number of proteolytic peptides which are more likely to be sampled
and consequently, provide higher numbers of spectra.78 Relative quantification of proteins via SC
is then achieved by comparing the number of spectra between a set of runs. Although this
approach seems intuitive and attractive in practical terms, SC is nowadays considered more as a
“semi-quantitative”79 approach because in reality, the spectrum count of each peptide in a run
varies according to their chromatographic elution profile (i.e., peak width and retention time);75 in
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addition, it has been reported that the method is not sensitive enough to detect subtle fold changes
and that it tends to overestimate low-abundance peptides.80,

81

In the case of relative quantification by peak intensity, peptide chromatographic peak
areas or heights in different samples are obtained from extracted ion chromatograms (XICs) and
these values are used for quantification. Initially, peaks need to be filtered from background noise
and neighboring peaks and then isotopic patterns assigned by spectra deconvolution.72
Subsequently, retention times are adjusted to correctly match corresponding m/z peaks of
different LC-MS/MS runs. Finally, the normalized peak area or height enables accurate matching
and quantification values which can then be treated by statistical tests to measure significant
abundance changes. XIC-based methods are consistently more sensitive and accurate than SC
when using high-resolution mass spectrometers because these instruments can discriminate
between coeluting peptides of similar mass while allowing the accurate mapping of XIC to a
peptide.75 XIC-based quantitation is also capable of accurately discerning fold changes as low as
1.1 compared to the SC limit of ~ 1.4.82, 83
Besides the relative quantification of proteins, sometimes it is necessary to quantify lowabundance proteins in a sample or determine absolute amounts of proteins in complex mixtures
(i.e., molar amounts). These types of quantitation are frequently applied in a more targeted
context, rather than proteome wide and using specialized forms of MS, such as multiple reaction
monitoring (MRM) via tandem MS.68 Absolute quantification relies on the addition of known
concentration of isotopically labeled peptide standards to a sample. These standards are identical
to the endogenous peptides in the sample but are distinguished by a shift in mass as they have
an incorporated stable isotope in their sequences (i.e.,
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C, 15N).84 Stable isotope-labelled

standards and endogenous peptides coelute during chromatography and absolute quantification
is achieved by comparison of the peak area abundances of the internal standard peptide with the
corresponding native counterpart.70, 84
Absolute quantification via isotopically labeled standards, also known as AQUA,70
expands the quantitative capabilities of MS proteomics beyond relative comparisons, to the
calculation of molar amounts of specific proteins in complex mixtures allowing one to even
determine the stoichiometries of individual members in protein complexes. AQUA peptides are
the gold-standard for absolute quantification via bottom-up proteomics and have found a niche in
research dealing with protein biomarker development, where accurate quantification is critical to
establish limits of detection and quantitation.
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1.3 Bottom-up proteomics in environmental microbiology applications.

1.3.1 The role of bottom-up proteomics in microbial environmental bioremediation.
Anthropogenic activities cause the release of as many as 100,000 compounds in the
environment including petroleum derived and polycyclic aromatic hydrocarbons (PAHs),
polychlorinated

biphenyls

(PCBs),

pesticides,

nitroaromatics, quinones and other electrophiles.

therapeutic

85

drugs

transitions

metals,

These molecules have hazardous health

effects not only in humans but in the flora and fauna of ecosystems, and at the same time, can
be effectors behind the disequilibrium of microbial diversity that is essential in the regulation of
global nutrient cycles.86
Although ways to combat the negative impact of contaminants in the environment involve
the use of chemical cleanup methods, more recent technologies exploit the knowledge of the
metabolic potential of living organisms in removing natural and xenobiotic pollutants. These
bioremediation techniques have the broad goal of transforming or degrading contaminants into
nonhazardous or less hazardous chemicals and act as an ecofriendly and cost-effective
alternative to more traditional cleanup methods.87, 88
Importantly, the metabolic activities of bacteria, as well as their dynamic behavior and
ability to survive under extreme conditions, makes them the most important group of organisms
that are investigated for their potential in bioremediation.88 In fact, a large number of bacteria have
been reported for the degradation of different industrial wastes such as dyes, hydrocarbons,
chlorinated aromatics, pesticides and heavy metals.
The use of gene-centric approaches to interrogate bacterial communities in the
environment has led to the discovery of unique bacteria with bioremediation potential that were
not accessible by traditional microbiology techniques, and in certain cases it has facilitated their
subsequent

isolation

and

culture-dependent

characterization;

untargeted-nucleic

acid

measurements of bacterial communities can be benefited from global proteomics profiling,89
because the catalysts responsible for contaminant transformation are proteins expressed by the
bacteria. Furthermore, when trying to determine functionality in environmental bacterial samples,
mRNA and protein levels are generally not strongly correlated; 29 and this case is especially true
for bacteria living in perturbed systems.90
Thus, the mere study of individual genes and their regulation is not enough to fully
understand microbial adaptation strategies of bacteria living in polluted environments and postgenomic/transcriptomic analyses involving proteomics, are needed to investigate the physiology
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of complex microbial consortia at a molecular level. The functional insights provided by global
proteomics studies are useful to fill in the gap between the genetic potential and functional
diversities in microbial communities. In terms of bioremediation, proteome analysis can be used
to confirm the occurrence of specific metabolic activities of candidate bacteria with detoxification
abilities, tolerance to extreme environments and respiratory versatilities. In addition, the detection
of new catalytic enzymes in novel metabolic pathways, or of known proteins with marked changes
in their relative abundances in the proteomes of microbes in response to contaminants, can assist
in finding protein biomarkers or bioindicators that have the potential to monitor the dynamics and
sustainability of environmental quality.87

1.3.2 From the clinic to the river: Environmental monitoring of protein biomarkers
with targeted mass spectrometry.
Over the last decade, the emerging field of environmental microbial proteomics has
contributed to the determination of molecular mechanisms of microorganisms living in various
natural and polluted soil types, aquatic bodies and other environmental matrices, such as organic
wastes and mine spoils. The global profiling of proteins in microbial isolates or mixtures in the
environment has revealed taxa contributing to the expression of proteins and functional pathways
between enriched and control ecosystems.91 Comprehensive proteomics approaches have
provided the identification of key proteins involved in molecular responses related to xenobiotic
toxicity, homeostasis or contaminant degradation.87,

91-93

For example, proteomic analysis of

toluene-grown Pseudomonas putida DOT-TIE revealed the participation of four stress proteins
such as GroES, cold shock protein CspA2, translational elongation factor EF-Tu and a xenobiotic
reductase (XenA) in the tolerance of the bacteria to the solvent.94 Another case includes the citrate
synthase (gtlA) enzyme in Geobacter which abundance correlates with the activity of this bacteria
during in situ bioremediation of soluble uranium U(VI) to insoluble U(IV).95
Such information is not only useful to understand the catalytic roles of mic robes, but is
also helpful in determining sets of biomarker proteins which could be monitored in environmental
samples to provide evidence of the exposure or effects of one or more chemical pollutants, or to
determine the presence and contaminant degrading activity of an organism of interest.96 Indeed,
the identification of key proteins and catabolic enzymes from bacteria in the environment has
been envisioned as a promising way, other to gene-based approaches, to show that specific
bioprocesses are occurring in a sample and/or that a particular set of conditions that favor the
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degradation of a contaminant or class of contaminants is present. 97 However, challenges in the
detection of specific enzymes in complex environmental samples exist.
One of the biggest challenges is the detection of key proteins that can be of very low
abundance in an environmental matrix compared to others. Global bottom-up proteomics
techniques are generally biased towards finding peptides of the most abundant proteins in a
sample. Thus, due to the wide dynamic range of proteins that can be present at any time in an
environmental sample, biomarker proteins can be missed in global or discovery-based proteomics
analyses, especially if the conditions for their expression are not optimal. Besides, other
interfering substances that can be present in environmental matrices can compromise the quality
of protein identification by mass spectrometry (i.e., presence of humic acids98). Ideally too,
absolute quantitative information from the measurement of these proteins could be more valuable
to environmental diagnoses comparing levels of biomarkers within a sample at different conditions
or derived from different sampling sites than the relative abundance and largely descriptive
information provided by global proteomics approaches.92
For these purposes, targeted proteomics approaches via multiple-reaction monitoring or
parallel-reaction monitoring (explained in section 1.2.3) provide technical advantages to the
environmental monitoring of proteins of interest compared to global qualitative approaches. Not
only are the latter techniques more sensitive,68 thus increasing the chances of circumventing the
issues of low protein abundance and recoveries that are characteristic from environmental
samples; but in addition, they allow to test multiple samples in a fraction of the time that it takes
to run and analyze samples by global proteomics which could be useful when monitoring multiple
samples for environmental hazard assessment or bioremediation effectiveness. Targeted
proteomics also provides an interesting advantage to other protein-based identification methods
like western-blots in which multibiomarker tests targeting up to 100 proteins could be developed
to monitor a wide range of biological responses without the need of developing specific antibodies
for every target. Absolute quantitative information from proteins in the attomole-nanomole range
can also be obtained from targeted proteomics techniques with the use of heavy-labeled peptide
standards.70
Although most of targeted proteomics research has been developed and conducted with
microbial isolates99, 100 or clinical samples (i.e., plasma),101, 102 the selectivity, dynamic range and
reproducibility of targeted proteomics assays make them ideal for quantification of specific
peptides and proteins in complex environmental samples.103 Chapter 3 provides a glimpse of the
combined uses of global proteomics to selected specific peptides from reductive dehalogenases
expressed by different strains of the anaerobic bacteria Dehalococcoides mccartyi (Dhc) during
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dechlorination of polycyclic aromatic hydrocarbons,104, 105 and for the first time, their identification
in contaminated groundwater via targeted proteomics which is the first step towards the
development of an absolute quantitative assay to measure these proteins in sites undergoing
active Dhc-mediated bioremediation.

1.4 Isolation interference in bottom-up proteomics experiments.

1.4.1 The occurrence of chimeric spectra in DDA bottom-up proteomics
experiments.
In discovery-based bottom-up proteomics experiments where MS spectra data is collected
via data-dependent acquisition (DDA), peptides derived from the enzymatic digestion of proteins
in a sample are separated with liquid chromatography (LC), ionized via electrospray and then
detected by MS scans which report the mass-to-charge (m/z) values of the ionized molecules.
The peptide precursor ions (or peptides with a charge state) that enter the mass spectrometer are
further isolated based on their MS1 scan intensities and then fragmented to generate MS 2 or
MS/MS fragmentation spectra. The combination of both MS1 and MS2 information is then used to
identify peptides and proteins in sequence databases.
Thus, although it can be said that the most decisive parameter that determines which
peptides are observed in a DDA bottom-up proteomics experiment is their natural abundance in
a sample, this is not always the case. Since thousands of peptides are separated with LC before
MS detection, it is expected than more than one peptide ion could enter the mass spectrometer
at any given time. The coelution of peptides in LC introduces an element of randomness in each
run, as the appearance of a precursor ion spectrum at a given chromatographic retention time will
never be completely identical between runs (including biological and technical replicates).
Besides chromatographic conditions (discussed in more detail in Chapter 2), another DDA
setting that impacts the collection of MS/MS spectra is the precursor isolation width. The isolation
width is defined as the m/z range that the MS detector uses to isolate the precursor ions. In simple
terms, this works as a window that sits on top of the most abundant precursor monoisotopic peak
and which results on its isolation along with some of its isotope peaks, but potentially of other
coeluting peptides with a similar m/z as well. Setting the isolation width too narrow will result in
loss of sensitivity, and in extreme cases cut out a portion of the ion packets, thus resulting in
inaccurate measurements. In contrast, a wide isolation window may result in co-isolation and cofragmentation of even more neighboring peptides resulting in unidentifiable or low scoring spectra.
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In a typical DDA setup, isolation widths may range from 1 to 3 m/z, and it has been
suggested that these values give the best tradeoff between sensitivity and selectivity. However,
despite advances in LC-MS/MS instrumentation, and due to the complexity of the samples
analyzed in bottom-up proteomics, the co-elution, co-isolation and co-fragmentation of two or
more peptide ions with similar m/z at any given retention time still occurs. The MS/MS spectra
that results from these cases are known as chimeric or mixture spectra (Figure 1.2). The more
conservative estimates of chimeric spectra in proteomic DDA-based research are calculated as
over 11.2% of all MS2 spectra acquired,106 but others have calculated this to be as high as 50%
or more.107-109
Chimeric spectra in proteomics studies has negative effects that compromise peptide and
protein identification as well as relative quantification. First, the identification of peptides based
on their MS/MS spectra becomes more difficult because, for example, many database search
engines use the number of unassigned fragment ion peaks (which increases for chimeric spectra)
for scoring. Insufficient spectral quality due to low signal intensity and the presence of unexpected
modifications also exacerbates this issue. In addition, chimeric spectra reduces the accuracy of
quantitative isobaric tagging-based quantification methods such as isobaric Tags for Relative and
Absolute Quantifications (iTRAQ) or Tandem Mass Tag (TMT) strategies in which the contribution
of reporter ion intensities from co-fragmented peptides, causes the under-estimation of
protein/peptide abundance differences (a phenomenon termed as “ratio compression”). 110-112

Figure 1.2 Chimeric spectra in LC-MS/MS bottom-up proteomics experiments.(A) A threedimensional map of peptide precursor ions with signals in gray, pink, red, and green. The grey, red
and pink precursor coelute at a given retention time and have close m/z values. ( B) MS1 scans of the
three coeluting precursors. By DDA, the grey precursor and its isotopes would be targeted for
fragmentation, however, due to the presence of the other interfering precursor, more than one
precursor ion and their isotope peaks within the isolation window are sent to fragment. ( C) The MS/MS
spectrum contains fragment ions from the three precursor ions. Fragment ions from the grey precursor
have higher chances of being assigned to a peptide sequence compared to the fragments from the
other contaminating precursors.
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1.4.2 Exploiting chimeric spectra in database-based peptide searches to increase
proteome depth.
The complexity of the peptide mixtures and the limitations of the current MS technology
make chimeric spectra unavoidable in bottom-up proteomics experiments.107 However, various
approaches have been proposed to overcome their occurrence. These approaches can be
categorized into experimental and computational. On the experimental side, specialized methods
of acquiring data such as triggering MS/MS at or near chromatographic elution peak to minimize
co-selection and fragmentation, or reduce the size of isolation windows, have been tested,
however, at the expense of sensitivity. Another alternative is to improve the chromatographic
resolution of peptides eluting into a mass spectrometer to minimize peptide coelution, such as
using orthogonal chromatographic separations or separations based on ultra-high performance
liquid chromatography (see section 2.3), with the former having a penalty of increased measured
times and the latter of affording costly equipment.
Computationally, although chimeric spectra in bottom-up proteomics is known to reduce
peptide identification rates of algorithms used in database searches, they also present the
opportunity to identify more than one peptide from a MS/MS spectrum. In addition, software that
can deconvolute chimeric spectra is more attractive in terms of sensitivity, cost and analysis time.
The new approach used by these algorithms of finding “more than one peptide per MS/MS
spectrum” challenges the “one peptide per MS/MS spectrum” dogma of conventional databasedriven algorithms and they require further adaptation of computational workflows, with the biggest
challenge being the scoring and validation of chimeric spectra. 108 The confident score of the most
abundant peptide in a spectrum is not easily comparable to the score of a second coeluting
peptide, for example. Even in regular database searches, some spectra may receive higher
scores than others because they have more peaks or because their precursor mass results in
more peptide candidates from database for consideration.113, 114 Therefore, it has been suggested
that scoring functions that account for spectrum or peptide-specific effects can make the score
more comparable and thus help assess the confidence of identifications across different
spectra.108
In theory, methods that consider more than one peptide per MS/MS spectrum can
potentially double the sensitivity in recovering peptide information from chimeric MS/MS spectra.
Although this goal has not been achieved, improvements in scoring functions as well as better
management of computational resources, have enabled the development of several software
options for chimeric spectral deconvolution that are able to identify more peptides than their single
search counterparts. Early software like ProbIDTree, for example was able to increase peptide
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identification rates between 20-30% compared to the popular search engine SEQUEST. 115
Andromeda, another widespread used search engine in bottom-up proteomics, was able to
increase peptide identifications by ~ 10% when enabling the identification of the second least
abundant precursor ions in chimeric spectra to a dataset published originally without it.116 The
DeMix algorithm demonstrated peptide identification efficiencies that were 1.5 times higher than
that of Andromeda and 2.5 times higher than Mascot, albeit at reduced computational speeds.11 7
More recently, the search engine Amanda, which is optimized for high resolution and high mass
accuracy data, has been modified to deconvolute chimeric spectra via an optimized algorithm that
considers retention time for scoring and validation of spectra, showing impressive gains of up to
63% more unique peptides compared to a conventional search strategy. 118
With all the available tools, what is then limiting their widespread use by the bottom -up
proteomics community? A limitation is that they typically replace the search engine in the data
analysis, potentially disrupting pipelines already established and relied upon in laboratories; while
another one is to methodologically demonstrate the identification gains that these tools provide in
a wide array of LC-MS/MS workflows, such as those considering less advanced HPLC peptide
separations to more sophisticated ones, or in other words if it is worth exploring the idea of using
a multiple-peptide matches-per-spectrum (mPSM) database search strategy. In this dissertation,
the research presented in Chapter 4 tested the capabilities of the most recent iteration of the
search engine Amanda across several LC setups and other factors influencing the acquisition of
chimeric spectra in the analysis of HeLa cell tryptic digests and suggest that this can be a strategy
to increase throughput and depth in bottom up experiments.

1.5 LC-MS/MS based peptidomics.

1.5.1 Small and mighty: Proteolytic cleavage products (PCPs) across different
domains of life.
Amongst the group of low molecular weight organic analytes (defined arbitrarily by a MW
cutoff <18 kDa) mediating different biological processes in organisms are peptides or proteolytic
cleavage products (PCPs) of less than 100 amino acids in length. These molecules are the
products of either native protein turn-over or protein maturation events (Figure 1.3). PCPs in the
latter group can be further classified as functional, bioactive peptides or non-functional remnants
of the protein maturation process.
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Figure 1.3 Biological origins of PCPs. (A) PCPs can be the products of protein degradation/turnover
mechanisms. (B) Bioactive and non-functional PCPs can be produced from the maturation of a protein
precursor, for example, a precursor with a N-terminal signal sequence; a precursor protein with NSS
and other domains, or from a protein precursor without a NSS. The mechanisms of how these PCPs
are produced may or may not be understood. Bioactive PCPs in different organisms have structural
characteristics such as post-translational modifications (PTMs).
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Particularly, bioactive PCPs in prokaryotes and eukaryotes have been linked to cell
development and division,119-121 cell-to-cell communication122 and environmental response.12 3
Intriguingly, bioactive PCPs have also become the targets of bioanalyses for biomedical and
agricultural applications.124-127
Protein turnover is an indispensable process for cell maintenance and regulation that is
coordinated by the action of proteases and peptidases. For example, the mammalian proteasome
cleaves ~70% of intracellular proteins and is recognized as a dynamic complex that modulates
cellular function in health and disease.128 In the same manner, for plants, different proteases and
peptidases participate in events like protein remobilization on leaf senescence,129,
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the

breakdown of storage proteins during seed germination,131, 132 and the recycling of misfolded and
damaged proteins.133 Thus, PCPs derived from protein turnover events contribute to the total pool
of native peptides in a cell. Although the products of protein turnover can act as sources of
nutrient recycling in cells (i.e., in plants) many of their functions remain to be characterized.
Bioactive PCPs instead are the products of protein maturation and their functions have
been studied with more detail. These types of PCPs can be synthesized by the removal of a Nterminal signal sequence (NSS) in a nonfunctional precursor or, alternatively, a precursor can be
enzymatically modified in other regions to yield a mature form.134, 135 Most bioactive PCPs in cells
are secreted to the extracellular space where they have regulatory functions mostly through the
interactions with specific receptors. Notable examples of bioactive PCPs from protein precursors
include plant antimicrobial peptides (AMPs)133, 135 and neuropeptides in mammals which signal
between neurons and influence a wide range of physiological processes. 134,

136

Bioactive PCPs

differ vastly in amino acid composition, length, 3D structure, and function.
Discovery and characterization of PCPs has benefited from the application of MS
techniques. These techniques are part of a specific subdiscipline of proteomics termed
peptidomics. Peptidomics is defined as the comprehensive characterization of the total peptide
content in a biological system using MS.134, 137 Typically, peptidomics studies are focused on
bioactive molecules but products from the transient degradation of proteins are also captured on
them. Although both peptidomics and proteomics are related, there are fundamental differences
between these fields. For example, experiments in the former field use enrichment strategies to
optimize the identification of as many endogenous peptides as possible, and the absence of an
enzymatic digestion step is also a common characteristic of them that helps to capture native
proteolytic mechanisms. Although it may seem that peptidomics experiments are easier to
conduct than proteomics ones there are several factors that make peptidomics a bit more
challenging than proteomics, these are explained in the next section.
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1.5.2 Challenges in the identification of PCPs by LC-MS/MS: Natural protein
dynamic ranges, databases and PTMs.
Several optimization strategies to improve PCPs detection by MS-based global
peptidomics have been deployed and each one covering different biological and methodological
challenges that are consequences of their low molecular weights (4–10 kDa), low abundances
and transient expressions, sequence diversity, as well as complications in data analysis.
Regarding sample preparation, the separation of PCPs both from small molecules (i.e.,
metabolites, salts, detergents) as well as from larger proteins needs to be addressed before
analysis by MS. For example, it is well known that in blood serum and plants tissues, where the
dynamic range of protein concentrations varies by ~10 orders of magnitude,138,
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the natural

abundances of proteins like albumin and RuBisCO, respectively, can hinder the detection of lowabundance proteins and peptides.140,
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Thus, experimental strategies that enrich for PCPs in

different biological matrices have been successfully applied. Methods include 2D separations with
gels,142 differential solubilization,139 organic solvent precipitation138,
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and the use of molecular

weight cut-off filter membranes.144, 145 The parallel combination of several separation schemes
has also been reported.9
Endogenous peptides range considerably in size and properties, which makes them
technically challenging to work in mass spectrometry. Because of their size, PCPs may not
contain a cleavage site for protease digestion, or they can yield short fragments which in
consequence reduces the fidelity of identifications mapped to protein databases. Therefore,
peptidomics experiments usually omit steps of enzymatic digestion which is also helpful in
capturing native proteolytic mechanisms. Native peptides can also yield charged molecules with
+5 and +10 charge states, which complicates the deconvolution of data by MS software.146
Another challenge in peptidomics research is how to map the identified peptides to protein
precursors. In proteomics there is no need to identify every possible peptide from a protein to
positively identify it, and proteins with single identifications are usually discarded; but in
peptidomics, it is possible to have identifications based on single peptides.147 If doing regular
database searches, that is, mapping of collected spectra to peptides and proteins in a database,
peptidomic analyses need to allow for a range of cleavage sites and post-translational
modifications (PTMs).148 For example, several bioactive peptide families from plants contain
PTMs on their Pro and Tyr residues,135 while neuropeptides in mammals may present a range of
modifications in Ser, Thr, Tyr or Asp residues.134 Without the constraints of sites for trypsin or
another protease in the data analysis, database searches can become a real challenge, and the
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false positive rate of peptidomics identifications compared to proteomics has been estimated that
it could be 100 times higher.147
To alleviate these issues, researchers have employed samples known to be enriched in
endogenous peptides and reduced databases with known families of bioactive peptides as well
as their potential variants. However, this sort of “targeted’ approach hinders the identification of
novel or less characterized peptide species. Besides the use of specific protein databases for
MS-based proteomics identification, technical improvements in de novo peptide sequencing
algorithms, which derive peptide sequence information directly from the mass spectral peaks and
not from protein databases, has now become an attractive alternative to broadly profile the
presence of endogenous PCPs. This resource has also been coupled to database searches in a
hybrid approach called de novo-assisted peptide database search.149 Chapter 5 describes in
detail LC-MS/MS peptidomics workflow that was applied for the comprehensive identification of
PCPs in the symbiotic interactions between a species of the perennial plant Populus and the
ectomycorrhizal basidiomycete Laccaria bicolor. Such workflow involved some of the
experimental techniques and the de novo-assisted peptide database search strategy mentioned
here.

1.6 Dissertation summary.
Peptide identification is at the core of bottom-up proteomics workflows. Although the
identification of peptides is more amenable to the technological capabilities of liquid
chromatography and mass spectrometry when compared to intact proteins, the complexity of the
samples analyzed in bottom-up studies make it unavoidable for some peptide identification
information to be lost. In this dissertation, different MS based proteomics methodologies and
technological advances were explored to detect and rescue peptides of interest in complex
biological matrices, akin to the analogy of finding peptide mass “needles” in a haystack of protein
diversity.
Chapter 3 shows the first published demonstration of the feasibility of deploying a targeted
bottom-up proteomics approach in environmental samples for the identification of specific
peptides that can serve as surrogates to confirm the presence or absence of bacterial proteins
with bioremediation potential. Chapter 4 evaluates the in-silico selection of minimum lists of
unique peptides found amongst groups of functionally related glycoside-hydrolase proteins, and
which could be used in a targeted proteomics experiment to determine the presence of these
groups of proteins in anaerobic bioreactors, instead of individual proteins that are part of a group.
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Chapter 5 evaluates the performance of a new software package to improve proteome depth and
coverage by rescuing peptide identifications buried under chimeric spectra and suggests a new
experimental strategy to employ in bottom-up global proteomics experiments. In Chapter 6 some
of the recent experimental and bioinformatics approaches to detect and quantify endogenous
produced peptides in organisms by MS/MS were evaluated. Specifically, the diversity of peptides
expressed in a symbiotic plant-fungal root system was characterized and based on relative
abundance values, analytes with potential roles in the establishment of the association between
organisms were identified. Finally, Chapter 7 presents a perspective of the newest technological
advances in the field of bottom-up MS proteomics and describes how these may be applicable to
the studies presented here and the benefits they would provide.
Herein, broad explanations of the experimental methods including protein extraction and
digestion protocols; LC-MS/MS instrumentation for global and targeted proteomics, as well as
computational algorithms used to develop Chapters 3-5 are presented. Detailed Materials &
Methods sections can be found in each chapter.
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CHAPTER 2
Experimental methodologies, mass spectrometry instrumentation and
bioinformatic approaches used for proteomics analyses in this dissertation
2.1 Overview of a bottom-up proteomics workflow.
In general, every bottom-up experiment consists of five major stages which are adapted
each time according to the sample under analysis and these are (1) protein extraction, (2) protein
digestion, (3) peptide analysis by nano-liquid chromatography (LC) and MS/MS detection, (4)
database searches, and (5) downstream processing of data (Figure 2.1).24, 36, 37, 41
Sample preparation for bottom-up proteomics experiments can be basically summarized
into protein extraction and digestion. Cells are lysed using a combination of detergents like SDS,
sonication or bead beating. After a round of centrifugation, proteins are recovered and then
submitted to denaturation with a chaotrope, disulfide bridge blocking and protease digestion. 36 In
general, trypsin digestion is preferred due to its ability of generating peptides that are on average
~ 14 amino acids in length and ~1.8 kDa in molecular weight and which are amenable to the
subsequent electrospray ionization process.150, 151 In addition, after extracting proteins from cells
or tissues, some protocols employ SDS-polyacrylamide gel electrophoresis (SDS-PAGE)
fractionation to analyze fractions of interest.8 Gel bands containing the proteins of interest are
excised and then digested in situ using trypsin or any other protease, and then extracted.
Before peptide mixtures are introduced into the mass spectrometer, they are separated
by one or more steps of high-pressure liquid chromatography in very fine capillaries which are
connected in line with the MS instrument. This step is crucial as it improves the detection
capabilities of the instrument by de-complexing the samples under analysis. As a hypothetical
example, it has been described that any typical human cell may be able to yield ~ 6 million tryptic
peptides.4 In addition, the small internal diameter (~3-5 µM) of the LC nanocolumns ensure that
the best sensitivity and efficiency of separation are achieved. 36, 152 As peptide mixtures become
more complex, orthogonal chromatographic separations that exploit different physicochemical
characteristics of peptides such as hydrophobicity (i.e., reverse phase C18) and charge (strong
cation-exchange, SCX) can improve the resolution of the separations. Multiple solvent gradient
strategies are used to elute the peptides from the chromatographic columns into the MS
instrument, but the most common ones employ chromatographic gradients that change the
percentage of organic solvent (i.e., acetonitrile) from low to high.
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Figure 2.1 Overview of a bottom-up proteomics experimental pipeline. A typical bottom up MSbased proteomics experiment consists of five stages. First, proteins are extracted from the biological
system under investigation (i.e., cell lysate or tissues). Proteins are then enzymatically digested to
peptides, as these are more amenable to the operational capabilities of a mass spectrometer. Peptide
mixtures are then separated by one or more steps or liquid chromatography and eluted into an
electrospray ion source where they are nebulized in small, highly charged droplets. Peptides enter the
mass spectrometer as protonated molecules where they are analyzed using different modes of spectra
data acquisition. The MS and MS/MS spectra are stored and matched against protein s equence
databases using computational search algorithms. Finally, post-processing of the data with adequate
statistical testing highlights groups of proteins relevant to the biological problem under investigation.
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During peptide elution, an electric potential is placed on the liquid flowing from the LC
column causing the solution to spray.36 The spray is a fine mist of droplets that encompass the
peptide ions as well as components from the LC mobile phase. 4 These droplets are then
desolvated by either applying heat or a curtain of nitrogen gas from which peptide ions are
liberated. Peptide ions pass from the electrospray source into the mass analyzer, were the
majority of the remaining solvent from the droplets is pumped away by the vacuum system.4
Different theoretical models dealing with the formation of droplets and the liberation of ions have
been proposed (explained in more detail in section 2.4), but both agree that the efficiency of how
each molecule ionizes, depends on their physicochemical propierties.36
Inside the mass spectrometer, mass spectra of the peptides eluting at a certain time point
are taken, which in literature are commonly referred as MS1 spectra or “normal mass spectra”.
Through a series of real-time software decisions, MS1 peptide precursor ions are prioritized for
fragmentation and a series of “tandem MS”, MS/MS-, MS2- or fragmentation spectra are captured
for each precursor ion.24, 37 As mentioned in Chapter 1, the most common spectral acquisition
mode run in bottom-up proteomics experiments is by data-dependent acquisition (DDA) which is
a process that consist of the isolation of a given peptide precursor ion, fragmentation with
energetic collision with gas, and recording of the MS/MS spectrum.24 The MS and MS/MS spectra
are typically acquired for about one second each and stored for matching against protein
sequence databases via software algorithms.24
The databases for protein identification can be derived from public repositories of protein
sequences like NCBI or Uniprot or be sample specific and generated from genomic or
transcriptomic sequencing information. Proteins in the database are digested in-silico to generate
predicted peptides which are subsequently fragmented in-silico to obtain predicted fragmentation
patterns. The experimental precursor mass is used to search for predicted peptides, and the
experimentally generated MS/MS spectra can be matched to predicted fragmentation patterns to
determine peptide sequences. Once peptide sequences are determined, they are traced back to
the source proteins. Finally, post-processing of the data employing different statistical analyses,
ensures that groups of observed proteins are relevant for the biological phenomenon under
investigation.
Here in, background information pertinent to the workflow of the different bottom-up mass
spectrometry-based proteomics techniques employed in the development of Chapters 3-5,
including sample preparation, and mass spectrometry measurement and data analysis, is
presented while detailed protocols are outlined in the “Experimental procedures” sections of each
chapter.
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2.2 Protein extraction and digestion.

2.2.1 Being mindful about the sample: Considerations before starting a bottom-up
proteomics experiment.
Modern bottom-up mass spectrometry techniques have been deployed to analyze a wide
range of samples with environmental and clinical importance. The current technology used for
bottom-up proteomics studies is nowadays sufficiently advanced to provide the in-depth
characterization of very distinct biological matrices,37 including, for example, acid mine drainage
biofilms153 and cerebrospinal fluid.154 However, an initial understanding of their complexities helps
informing the steps to take in an experimental workflow. Thus, although every bottom-up
proteomics pipeline consists of the four steps described in section 2.1, each one has to be
adapted according to the samples under analysis and the overall goal of the study.41
Prokaryotic and eukaryotic cells are very different in size and complexity. The genome
sizes of bacteria, plants and humans, or even between different species of bacteria and plants,
may translate into very different numbers of proteins that can be expressed at any given time or
condition in a cell. When proteins are digested, and depending on which protease is used, the
number of peptides analyzed by LC-MS/MS can be in the hundreds of thousands or even more.
For example, a theoretical calculation in a human cell puts the number of peptides that could be
produced with a trypsin mediated digestion near the 6 million.4 Depending on how complex the
peptidome background is, the type of LC separation to employ is critical in order to minimize
coelution of peptides and ion suppression events.
The types of organic structures that are part of cells also determine the procedures to
conduct for protein recovery. Due to the presence of multiple layers of cellulose, plant cells are
particularly strong and difficult to disrupt; while bacterial cells are easier to break,155 but within
them, Gram-positive bacteria cells are more troublesome to work with due to the presence of a
thick layer of peptidoglycan and lipoteichoic acid surrounding the membrane.156
The natural abundances of proteins in a given sample impacts the ability to detect targets
of interest by bottom-up proteomics. Proteins can be expressed at levels as low as 101-102
proteins per cell, although some are expressed at much higher levels as 104-106 proteins per cell.4
Depending on the goal of the study, one may be interested in the identification of less abundant
proteins. For instance, bottom-up proteomics pipelines that study proteins in plasma and try to
determine biomarkers of clinical interest, are always confronted with the challenge that the
dynamic range of protein abundances is 10 orders of magnitude in concentration from albumin to
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the least abundant proteins.157 In these cases, protein depletion or enrichment strategies can be
employed to increase the chances of identifying targets of interest.158
Recovery of biomass from bacterial cell isolates in suspension to bacterial cells from
environmental samples is different. Low complexity samples like microbial pure cultures, defined
enrichments, or symbioses (i.e., co-cultures) usually comprise one or few species that are present
in high cell numbers, whereas environmental samples such as those derived from soils,
sediments or aquatic sources may comprise different species and be c haracterized by low
microbial biomass levels.72 For example, in marine water columns, cell numbers range from 5 x
104 to 5 x 105 cells per mL.159 In order to obtain sufficient cell material, water volumes from 1L to
20L need to be processed by differential filtration. 72 Aside from their characteristic low protein
abundance, environmental samples can contain perturbing substances that impact the
measurement of peptides by MS. In soils, the most representative case is the presence of humic
acids which are known to cause unwanted modifications in proteins, 160 suppress the electrospray
ionization of analytes,161 and make loading samples to LC columns harder due to flow
obstructions.162
These initial sample considerations are examples that can dictate the success of bottomup proteomics experiments.

2.2.2 Cell lysis and protein extraction via the SDS-TCA and CME methods.
The goal of cell lysis and protein extraction protocols is to recover as much protein as
possible while minimizing contamination by other biomolecules that are present in the sample
(i.e., lipids, cellulose, nucleic acids, etc.).4 Depending on the type of samples, some protocols
may need to homogenize tissues first, employing treatments with beads, sonication and/or liquid
nitrogen.155 After tissue disruption, cells are lysed with physical and/or chemical-based methods,
but most commonly with a combination of both so as to physically break apart cell walls and
membranes and then allowing the chemical agent to solubilize proteins. 155, 163 In addition, some
protocols may employ protease inhibitors like phenylmethylsulfonyl fluoride (PMSF), 4 or
ethylenediaminetetraacetic acid (EDTA),164 to increase the yield of protein extraction, as the
rupture of cellular structures provokes the liberation of hydrolytic enzymes that degrade proteins
slowly.155
Briefly, physical methods of cells lysis include ultra-sonication, bead osmotic shock,
freeze/thawing treatments and mechanical blending;165 while chemical lysis methods commonly
employ detergents, which aid in destabilizing the structure of cell membranes, breaking lipid29

protein interactions and solubilizing proteins.155 The choice of detergent is a critical decision step
in bottom-up proteomics sample preparation protocols as some of them are known to interfere
with enzymatic digestions, and most of them interfere with LC-MS/MS, sometimes damaging
mass spectrometers and clogging LC columns.166 Thus, factors such as the critical micelle
concentration (CMC), or the ability of detergents to form micelles that can affect their efficacy and
posterior removal from a sample, are important considerations when preparing a lysis buffer.163
It is worth mentioning that lysis, extraction, and protein denaturation can all happen in the
same step with certain experimental protocols. In this dissertation, the projects developed and
presented in Chapters 3-5 all used a combination of either sonication or bead beating of cells in
lysis buffer containing between 2-4% SDS. SDS has reported CMC values of 6-8 mM and its
micelles have an approximate molecular weight (MW) of 17.8 kDa, 163, 167 which means that it can
be removed easier from a solution by buffer exchange or dialysis when compared to other
detergents like Triton X-100 or Tween 80.163
Once the cells are lysed, they need to be separated from any other biomaterials and
detergents. Since the presence of lipids and genomic DNA is known to cause MS signal
suppression and chromatographic interference,163 their removal is important. This can be
achieved by precipitating proteins out of the cell lysate solution using trichloroacetic acid (TCA)168170

and rounds of centrifugation, which is one of the most popular procedures to eliminate nucleic

acids, polysaccharides and salts from the cell lysate solution. 155 In general, getting rid of other
biomolecules helps in acquiring “cleaner” spectra from which to obtain protein identification data.
TCA precipitation can then be followed by detergent removal using cold acetone (0 to -20 °C).163
Acetone is effective in removing SDS from proteins precipitated by TCA and is added to sample
mixtures to a composition of 80%.171 This method was employed for samples in Chapter 3.
Another form of protein precipitation and clean up technique is methanol-chloroform
precipitation (CME).163,
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This technique is particularly efficient in recovering membrane

proteins.163, 173 In the CME methodology, methanol, chloroform and water in volume ratios of 4:1:3
are added to cell lysate solutions followed by three additional volumes of methanol. Briefly,
proteins are first separated from other unwanted materials on the water-organic interface and are
then pelleted by “washing” the sample with methanol. The efficiency of this procedure has been
described to approach 100% for a variety of protein concentrations and detergent solutions.16 3
CME was the main protein recovery strategy employed for samples prepared in Chapter 5 of this
dissertation.
At the end of protein precipitation methods, it is common to have a protein pellet that is
often dried to some extent. This situation, added to the high degree of protein heterogeneity, and
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the stability of protein-protein interactions can complicate their downstream processing by any
enzymatic digestion method.155 Hence, protein pellets need to be solubilized back in an adequate
buffer containing several additives that prevent protein aggregation.

2.2.3 Protein solubilization with urea or SDC buffers and DTT and IAA.
Strategies for fully resolubilizing protein pellets involve the use of buffers with additives
that help in denaturing proteins and maintaining them in solution, as well as other physical
treatments like vigorous vortexing174, 175, ultra-sonication174, 176 or shaking. The three main classes
of additives added to re-solubilization buffers are: (1) chaotropes, which are used to prevent
protein aggregation; (2) detergents, that increase the solubility of several proteins; and (3)
reducing agents, that “break” disulphide bonds in proteins.4, 155, 177
Chaotropes disrupt hydrogen bonds and inter- and intra- molecular hydrophobic
interactions in proteins by altering the solution ionic strength and pH. Thus, these agents
destabilize or denature the native structures of macromolecular protein assemblies.4,

155, 177

In

particular, urea has been widely used in proteomics experiments at concentrations between 8-9
M to help maintain proteins in solution.155 One consideration when using urea as the main
chaotrope, however, is that heating must be avoided in order to prevent its hydrolysis and other
non-desirable side reactions;155 as such, physical treatments like ultra-sonication and incubations
in thermomixers are not recommended to be used in concert. In this dissertation, urea was
primarily used for protein denaturation in the development of Chapter 3.
As an alternative to chaotropes, detergents can be used typically in concentration ranges
that vary between 1-4%.155 Detergents are useful in preventing hydrophobic interactions, but
careful selection of which of them to use and how compatible are they with remaining experimental
steps are important considerations. In particular, sodium deoxycholate (SDC), which is a soft ionic
detergent,163 has been employed in recent bottom-up proteomics approaches as a substitute of
SDS, due to observed reductions in technical variation during sample preparation,178 its ability to
increase the solubility of hydrophobic proteins, and compatibility with downstream trypsin
digestion.179 SDC is also easily removed after peptide digestion by crashing it out of solution with
the addition of formic acid and then adding a water-immiscible organic solvent such as ethyl
acetate,180 into which the detergent is transferred while digested peptides can be recovered in the
aqueous phase. This strategy was employed for the experiments in Chapter 5.
To prevent protein renaturation before enzymatic digestion, a reduction step of disulfide
bridges in proteins is conducted with agents like dithiothreitol (DTT) or dithioerythritol (DTE) .4, 177
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This step is often followed with the addition of reagents such as iodoacetamide (IAA), that are
used to alkylate free sulfhydryl groups in proteins,155 in order to protect them from re-oxidation
events. Through the entirety of this dissertation, the combined actions of DTT and IAA were used
in the steps of protein solubilization. Importantly, one must also be aware that some of the agents
mentioned here (i.e., IAA181) may produce unwanted effects in the sample if left for extended
periods of time or used under the wrong temperatures; but it is through experimentation as well
as tricks learned in the art of sample preparation that they are used in different degrees and
combinations.

2.2.4 Protein digestion in MS bottom-up proteomics with trypsin.
If there is one protein to which proteomic scientists own their career to is trypsin. Trypsin
is considered as the gold standard of protein digestions in bottom-up proteomics protocols due to
its robustness, specificity and broad availability at a reasonable cost.4, 28, 150, 177, 182 Specifically for
LC-MS/MS applications, companies sell trypsin as a highly purified enzyme that is extracted from
either porcine or bovine pancreas. Trypsin is a serine protease that cleaves exclusively at the
carboxyl side of arginine (R) or lysine (K) residues in a protein, unless either of these are followed
by a proline residue. Compared to other proteases that act only on one amino acid, the dual
specificity of trypsin means that it acts more frequently in proteins in theory producing more tryptic
peptides for analysis. For example, a 50 kDa protein will yield about 30 tryptic peptides.4
Because of the spacing of R or K amino acids in a protein, which is approximately one
residue per every 10–12 amino acids,155 trypsin generates peptides that are of suitable lengths
(~10-15 amino acids)183 and MWs (~ 5-30 kDa)150, 155 to chromatographic separation and that fall
within the ideal mass range of mass spectrometers.182 In addition, the presence of C-terminal
lysine or arginine residues is beneficial, as they efficiently protonate under acid conditions and
this in turn helps peptides to ionize and to produce rich fragmentation spectra that enhances
protein identification.28, 155, 182 In fact, a protein can be confidently identified with the information
produced by only one tryptic peptide.4 Other advantages of trypsin for bottom up proteomics work
is that the enzyme displays good activity both in solution and in in-gel digestion protocols.4
As with any other reagent used in bottom-up pipelines, some considerations are important
when using trypsin for protein digestion. In this sense, digestion conditions like time, temperature,
pH and enzyme-to-protein ratios can influence the specificity and efficiency of trypsin. 151 It has
been recommended that in order to maximize protein identification in global proteomics studies,
a digestion of pH 7, temperature of 37 °C and enzyme-to-protein ratio of 1:50 can maximize
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protein identification.182 The latter parameter varies in published articles where the values can
range from 1:100 to as high as 1:2.5,183-188 with targeted proteomics studies using lower enzymeto-protein ratios to maximize peptide yield. Regarding time, this factor also changes from study to
study, but it is common practice to incubate protein samples with trypsin for 1-3 hours and then
conduct a second round of overnight digestion.155
Importantly, although it has many advantages for bottom-up proteomics, trypsin is not
free of flaws. For some applications, it has been reported that the short length of tryptic peptides
(≤ 6 residues) are not optimal for MS fragmentation and can restrict proteome coverage. 189 Other
studies have reported that whenever there are cases of adjacent K or R residues in a protein,
trypsin will prefer to act on those that are located on its C-terminus side, and will fail to produce
peptides from its N-terminus.183 PTMs can also inhibit trypsin cleavage.190, 191
In this dissertation, trypsin digestion was used to produce peptides for subsequent
measurement through LC-MS/MS although, due to the different applications presented in Chapter
3-5, with digestion parameters adapted each time.

2.2.5 Peptide clean up before loading into a LC column.
Peptide mixtures should ideally be loaded into a LC column without any compounds that
may compromise their MS/MS detection. Excess salts or trace amounts of detergents are known
to interfere with peptide ionization and add chemical noise in the mass spectra.158 Additionally,
detergents can clog LC columns, and salts can accumulate in the ion transfer capillary of the
mass spectrometers.192 For these reasons, peptide sample cleanup procedures are important to
perform before LC-MS/MS.193 These protocols can be either on-line using trap columns or off-line
using several commercially available products.158
On-line cleanup/desalting occurs as the sample moves through a pre-column that is
connected to the analytical LC column where peptide separation takes place; however, the initial
flow-through going through the pre-column is diverted to waste. After peptides have been washed
extensively, they can now be eluted into the analytical column. For off-line cleanup/desalting,
devices that employ reversed-phase stationary resin (i.e., C18) packed in pipet tips, spin columns,
or syringes are used. These products have varying binding capacities ranging from 1 to 25 µg
protein.192 For example, StageTips, are ordinary pipette tips with inserted small disks made of
beads with reverse phase surfaces embedded in a Teflon mesh.194 The fixed nature of the beads
allows flexible combination of disks with different surfaces (i.e., cation-exchange or anion-
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exchange) to obtain multi-functional tips.194 C18 stage tips were used in Chapter 3, while C 18 spin
columns were employed for peptide cleanups in Chapters 4 and 5.
In addition to peptide clean-up, all the peptide mixtures obtained at the end of every
experimental protocol in Chapters 3-5 were concentrated using a SpeedVac and then
resuspended in a solvent mixture whose organic content and pH matched the starting
chromatographic conditions in each case.

2.3 Peptide separation by nanoLC.

2.3.1 Basics of peptide chromatographic separation by nanoLC.
The number of peptides that can be produced from a proteolytic digestion protocol
presents an analytical challenge to any modern mass spectrometer. For instance, even in a
common bacterial system, theoretical calculations have predicted that the number of peptides
produced could be higher than 62,500 and these could have abundance differences higher than
105.195 Thus, ways to de-complex, or simplify a peptide mixture, before it is measured with a mass
spectrometer are necessary. This goal has been achieved with nano liquid chromatography
(nanoLC), which is a fully automated form of liquid chromatography, that allows to separate
peptides with high speed, resolution and sensitivity.196
Similar to the more traditional high-performance liquid chromatography (HPLC) at the
microscale level, in nanoLC, chromatographic columns with small internal diameters ≤ 100 µM,36,
197, 198

and packed with a stationary phase, are used to inject peptide mixtures. Peptides bind to

the stationary phase and are then separated by flowing a mobile phase at nL min-1 flow rates that
changes its composition over time either in variable steps or continuously.36, 197 The low volumes
and flow rates of nanoLC are beneficial to the electrospray ionization (ESI) technique, which acts
like a concentration-dependent detector in mass spectrometers, and help improve the detection
sensitivity of the measurements.36, 196
By exploiting the physicochemical properties of the naturally occurring L-α-amino acids
found in proteins,196 optimal stationary phases as well as mobile phase compositions may be
selected to achieve a successful chromatographic separation of peptides in bottom-up proteomics
experiments. For example, the number and distribution of charged groups on the side chains of
amino acids influences the polarizability and ionization status of a peptide, as well as their
hydrophobicity.196 Thus, chromatography modes that make use of peptide hydrophobicity, like in
reverse phase (RP) chromatography, or charge, like in ion exchange (IEX) chromatography; can
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be used independently or in combination to deconvolute samples reaching a mass spectrometer.
Other separation modes in bottom-up proteomics research are hydrophilic interaction (HILIC)
chromatography; and affinity chromatography (including immobilized metal ion-affinity and
biospecific chromatography).8, 72, 198
In this dissertation work, RP and strong cation exchange (SCX) separations were used for
the diverse proteome measurements presented through Chapters 3-5. Both types of separation
are described in more detail in the following subsections.

2.3.2 HPLC vs. UHPLC
With the goal of improving analyses times, while at the same time maintaining acceptable
chromatographic resolution in a complex peptide mixture, improvements to conventional
nanoHPLC strategies have been tested in bottom-up proteomics experiments. One of those
developments is ultra-high-pressure liquid chromatography (UHPLC). Compared to conventional
nanoHPLC which uses pumps and plumbing that can support flow backpressures up to 450 bar,
nanoUHPLC uses instrumentation that can tolerate up to 1400 bar197,

199

allowing the use of

smaller inner diameter columns packed with stationary phases made of particles sizes with
diameter sizes < 2 µM,200 instead of stationary phases consisting of particles having diameter
sizes of 5 µM that are employed in nanoHPLC.
The decrease in stationary phase particle sizes and internal diameter of analytical columns
and plumbing has brought many benefits to peptide detection with tandem mass spectrometry.
One of those is greater column efficiency, measured by the number of theoretical plates, which
can be described as a number of imaginary layers across the length of column in which an analyte
is in equilibrium with the stationary and mobile phases. The plate model theory states that the
higher the number of theoretical plates in a column at a given length, the better the quality of the
column and the narrower the peaks.196 Columns packed with stationary phases < 2 µM and used
in combination with UHPLC pumps, have many more theoretical plates than columns used in
HPLC separations (Figures 2.2 A-B). The former translates into narrower chromatographic peak
widths at baseline that are on average 2-4 seconds compared to 10 seconds in HPLC,201 which
in turns improves the resolution of peptide separation, with some studies reporting improvements
by a factor of 3 when conducting UHPLC versus HPLC under similar analysis times. 202, 203
Better chromatographic resolution also means that regions in a chromatogram that look
crowded in HPLC can be better differentiated in UHPLC and this improves peptide identification
by computational algorithms. Furthermore, the narrower peak elution profiles also improves
35

column capacities, or the number of peaks that can be accommodated in certain column
segments, which consequently brings a reduction in the number of analytes that coelute at a given
time and hence, less chance of chimeric spectra occurrence204 which is an ever present problem
in bottom-up experiments and is described in more detail in section 1.4.
The sharpening of chromatographic peaks in UHPLC also boosts the sensitivity of the
analysis.204 Peptides that were undetectable in HPLC due to broader chromatographic elution
profiles, can now present higher chromatographic peak areas in UHPLC that allow for their
sequencing via MS/MS. Increases in sensitivity when compared to traditional HPLC have been
reported. Other advantages of UHPLC compared to HPLC runs are shorter analysis times 205 and
the use of small sample volumes (≥ 0.5 µL).206 Interestingly, the introduction of UHPLC to bottomup proteomics analyses have enabled “single-shot” proteomics studies, in which complex
proteomes are analyzed in-depth with the aid of long 1D chromatographic columns (25-50 cm)
and LC gradients (300-500 mins).152, 200, 204, 207
However, the main disadvantage of UHPLC is that the equipment to run these types of
experiments is more expensive than that used by HPLC and its correct implementation requires
of delicate handling and expertise. Thus, alternatives to increase throughput and depth in bottomup analyses using regular HPLC have been tested. In fact, one of those ways was explored in
more detailed in the research presented in Chapter 4.

Figure 2.2 1D-liquid chromatography setups. The square grids below each column represents the
number of theoretical plates. (A) One-dimensional (1D) separation with a C18 packed column using
particle sizes > 2 µM employed with HPLC pumps. (B) 1D separation employing C18 particle sizes <
1.7 µM and typically employed with UHPLC pumps due to the high backpressure caused by the
decrease in particle sizes.
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2.3.3 Reverse phase liquid chromatography (RP-LC).
Reverse phase liquid chromatography (RP-LC) exploits peptide hydrophobicity to
separate peptides in a column.4, 8 In this type of chromatography, the stationary phase consists
of a nonpolar phase, which in bottom-up proteomics is usually made of C18 chains that are bound
to base silica material.72 Peptides are first loaded to the analytical column in an acidic mobile
phase containing a low percentage of organic solvent. After peptides are retained, elution
happens by gradually increasing the content of organic solvent in the mobile phase over time.
The retained peptides elute in order of increasing hydrophobic interaction with the stationary
phase; with peptides having lower hydrophobicity eluting first.4
In case of samples that are suspected to have low amounts of peptides, trap columns (∼
10–20 mm length) with larger inner diameters (usually 300 µm) can be used for enrichment;72
alternatively, they can be used to perform desalting washes of peptides retained in the stationary
phase. These trap columns can be operated either off-line or on-line196 with the main C18
separation column. In the off-line mode, peptide mixtures can be loaded to the trap column and
subsequently desalted using a pressure cell to then be interfaced with the separation column in
the LC instrument. Instead, in the online mode, the LC instrument is configured to do automatic
valve switching which allows the selection of mobile phase pathways for first loading the peptides
into the trap column (without loading them into the separation column), then do desalting (without
sending the flow through to the separation column) and finally conduct the analytical separation.
Although RP-LC separation is reproducible, selective, and effective for the separation of
peptides in bottom-up proteomics,198 it may reach its limits with samples of high complexity. After
enzymatic digestion, the thousands or hundreds of thousands of peptides in a sample may exceed
the peak capacity of RP-LC columns. The co-elution of too many peptides as well as their large
ion abundance differences may also cause undesirable ion suppression events during
electrospray ionization. Hence, separations that can provide increased peak capacities and
resolving power can improve peptide detection, thereby increasing proteome coverage and
dynamic range.208

2.3.4 Two-dimensional liquid chromatography (2D-LC).
Before the adoption of UHPLC systems for reverse phase-based separations,
multidimensional separation techniques were introduced as an alternative to increase the
separation power provided by RP-HPLC. Multidimensional LC couples two (or more) different
consecutive LC chromatographic separation methods (or dimensions, hence the name
37

“multidimensional”) to improve peptide separation.209 To increase the resolving power of any
multidimensional LC system, the chromatographic phases need to be “orthogonal” to each other
or, in other words, exploit different physical properties of peptides such as charge, hydrophobicity
or molecular weight210 while at the same time being technologically feasible to implement.
For bottom-up proteomics in particular, two-dimensional strategies that combine the use
of SCX, as first dimension, and RP, as second dimension, have been widely employed and
adapted over the years.208 Especially with the demonstration conducted by the Yates group in the
seminal paper introducing the applicability of the multidimensional protein identification
technology (MudPIT), as an alternative to “gel-free” separation method, the strategy of combining
SCX with RP became widely adopted. This application demonstrated that it was capable of
identifying ~25% of the complete yeast proteome within a single experiment.39
In a 2D-LC system including SCX as first dimension and C18 as second dimension
(Figure 2.3), peptides are first loaded into a SCX packed column in acidic mobile phase (pH <
4.0). This causes amino acid residues in peptides to be protonated and able to interact with the
negative charged sulfonyl groups of the SCX resin.72 Each peptide adsorbs to the SCX resin with
affinities that are proportional to the overall number of positive charges on them.4 Once peptides
are loaded, elution happens gradually or stepwise with mobile phase “pulses” or “steps” at
increasing salt concentrations.4, 72 Each salt pulse releases different groups of peptides that are
captured on a RP column which is positioned downstream of the SCX column. In the RP column,
peptides are separated based on hydrophobicity in similar fashion to a regular one-dimensional
RP-LC strategy.
The fractionation based on electrostatic interaction is highly orthogonal to RP.72 Similarly
as using a trap column for 1D-RP-LC, chromatographic separations in a 2D strategy can be
executed off-line, for example, by manual collection of peptide fractions from SCX; or on-line,
involving a valve switching mechanism with an adequate setup so as not damage any component
of the system with the different mobile phases used.211 The performance of a 2D separation was
compared to a RP-UHPLC strategy in Chapter 4.

38

Figure 2.3 2D-liquid chromatography setup. A 2D separation strategy exploiting the orthogonality
of a strong cation exchange (SCX) packed column interfaced with a C18 packed column is shown.
The square grids below each column represents the number of theoretical plates.

2.4 Fundamentals of electrospray ionization (ESI).
ESI is the process by which gas-phase peptide ions are produced in the source of a mass
spectrometer to enable subsequent mass analysis.4 ESI is classified as a soft-ionization
technique, which means that hardly any internal energy is transferred to the ions thus minimizing
in-source fragmentation signficantly.62 In this technique, a protonated or deprotonated molecule,
represented by the symbols [M+H]+ or [M−H]−, can be generated, respectively. In particular, for
the analysis of peptides in bottom-up LC-M/MS, [M+H]+ peptide ions are produced and measured
as their positive charge is favorable for fragmentation via MS/MS and several of their LC
chromatographic characteristics are improved at acidic pH. 4 The presence of multiple protonaccepting sites in peptides (i.e., amine groups), and in particular of those derived by tryptic
digestion (bearing lysine or arginine residues), causes them to exist as a mixture of singly, doubly
or triply charged ions in solution.4
The ESI process involves the placement of an electric potential of 2-3 kV between the
liquid flowing from the LC column through a fused silica column or needle, and the counterelectrode in the mass spectrometer (Figure 2.4).22 In the positive ion mode and for ionic analytes,
such as positively charged peptides, the electric field, when turned on, goes inside the solvent
carrying the molecules. This causes the polarization of the charged molecules in the liquid. In the
positive mode, an enrichment of positive ions occurs near the surface of the solvent meniscus
leaving the fused silica or needle, while negative ions, if present, try to get away from it.212 These
polarizing forces cause the formation of the “Taylor cone”213, in which the distortion of the
meniscus creates a cone-shaped spray that points towards the counter electrode of the mass
39

spectrometer. The increase of surface due to the cone formation is resisted by the surface tension
of the liquid.212
If the applied field is sufficiently high the spray tip becomes unstable and a fine jet emerges
from it. The surface of the jet is charged by an excess of positive ions. The repulsion between the
charges on the jet causes the jet to break up into small charged droplets. 212 The size of the
droplets formed from the cone jet is dependent on its diameter and studies have proposed and
observed that the majority of the droplets produced have approximately the same size.214, 215 The
droplets are positively charged due to an excess of positive electrolyte ions at the surface of the
cone and the cone jet. As charged droplets get expelled and travel towards the mass
spectrometer, the solvent that they carry gets evaporated, causing their shrinkage and an
increase in the electric field the electric field normal to their surface.

Figure 2.4 Illustration of the electrospray ionization process. Protonated peptide mixtures are
separated by liquid chromatography and then sprayed from the front-column emitter towards the mass
spectrometer. Initially, large solvent droplets containing hundreds, or thousands of peptide ions are
sprayed. As these droplets move towards the heated capillary in the spectrometer, solvent evaporates
from the surface of the droplets, and ions are forced together until charge repulsion causes peptide
ions to leave the droplet. The high voltage potential placed between the emitter and the mass
spectrometer pulls the ions into the high vacuum region of the latter
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As the droplets get smaller, the increasing repulsion between the charges at their surfaces
increases and it overcomes the cohesive force of their surface tension. This phenomenon leads
to the fission of the droplets that releases a series of small and charged secondary or progeny
droplets. This condition of instability, is also called Coulomb fission or “explosion”, and is
explained by the Rayleigh equation216:
𝑄𝑅𝑦 = 8𝜋(𝜀0 𝛾𝑅3 )1/2
Where:
QRy = Charge of the droplet
𝛾 = surface tension of the solvent
R = radius of the droplet
𝜀0= electrical permittivity
The shrinkage of the droplets at constant charge fission at or near the Rayleigh limit, and
the release of a jet of small, monodisperse charged progeny droplets has been confirmed by a
number of experiments.212 Further evaporation of the solvent leads to a higher occurrence of
droplet fissions. Ultimately, very small charged droplets enter the mass spectrometer and lead to
the formation of gas-phase ions by processes which are mainly explained by two theoretical
models.
The first model is the charge-residue model of Dole.217 In this model, the sequence of
droplet disintegration proceeds until the microdroplets contain only one preformed analyte ion per
droplet. By evaporation of the solvent, the preformed analyte ion is released to the gas phase.
The second model is the ion-evaporation model proposed by Iribarne and Thomson,218 in which
gas-phase ions are released from highly charged microdroplets, because the local field strength
is high enough for preformed ions to be emitted into the gas phase.62 Both of these models are to
some extent complementary and there is no consensus of which one is actually more important
in the actual ion production of a particular analyte.
Given the importance of droplet evaporation during ESI, the generation of smaller droplets
is more favorable in term of sensitivity and the ability to preserve noncovalent molecular
associates. This can be achieved by using nanoLC, where the analyte is sprayed, for example,
from silica capillary with tip diameters of 1–5 μm rather than from the 100 to 150-μm tips that are
used in conventional ESI. This mode of operation is called nanoESI and usually allows the use of
gentler operating conditions such as temperature, gas flows, and needle voltages.219 Compared
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to conventional ESI, decreasing the flow rate to nL/min rates, leads to increased ionization
efficiency by 50~60%, greater sensitivity and better tolerance to the salts and other impurities.
nanoESI has become the most used ionization technique in peptide and protein analysis and as
such all the MS instruments used for the experiments in Chapters 3-5 used a nanoESI source.

2.5 Fundamentals of mass spectrometric detection.

2.5.1 Figures of merit in mass spectrometric detection.
There are several types of mass spectrometers available for the detection and
measurement of peptides in bottom-up proteomics; however, the type of results obtained are
heavily influenced by the capabilities of each instrument as well as the complexity of the sample
under study. Hence, before introducing the most common types of spectrometers used in bottomup proteomics work, and describing in more detail the specific ones employed in this dissertation,
it is important to first define the analytical figures of merit that are used to evaluate the
performance of each type of instrument. These figures of merit are: mass resolution, mass
accuracy, and the acquisition speed, or the time needed to acquire one data point in a
chromatogram.62
The resolution, also known as the “resolving power” of an instrument, is defined as the
ability to distinguish two ions with similar mass-to-charge (m/z).72 More specifically, and according
to the International Union of Pure and Applied Chemistry (IUPAC) definition, mass resolution is a
dimensionless unit that is the product of 𝑚⁄∆𝑚, where m is the mass of the ion and Δm is either
the peak width at full-width-half-maximum (FWHM) between two equal-intensity peaks, or at a
10% valley definition between two equal-height peaks.8, 220, 221 Typically, mass spectrometers (or
more rigorously mass analyzers) can provide unit-mass resolution or high-mass resolution.6 2
Instruments that provide high-mass resolution are able to differentiate the isotope clusters of a
compound which enables the detection of the “monoisotopic ion”, or the ion that is composed of
only one isotope of each element (i.e., 1H, 12C, 14N and 16O).72 An example of how the resolving
power of a mass analyzer impacts peptide identification in bottom-up proteomics is shown in
Figure 2.5.
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Figure 2.5 Mass resolution in mass spectrometry-based bottom-up proteomics studies impacts
the correct identification of peptides. (A) Two peptides with similar monoisotopic mass generate
doubly charged ions with close m/z values. (B) Simulation of isotope profiles of both peptides in (A)
using a resolving power (RP) of 1000 which is typical of standalone quadrupoles or ion trap mass
analyzers. (C) Simulation of isotope profiles of both peptides in (A) using a RP of 60,000 which is
available in Thermo Scientific Q Exactive hybrid mass spectrometer. The MS-Isotope program of the
Prospector suite of proteomics tools was used to generate the isotope profiles.

The mass accuracy of an instrument determines how close the experimental mass values
for ions (accurate mass) in a sample are to their theoretical ones (exact mass).4 Low-resolution
instruments generally allow the m/z determination for single-charge ions with an accuracy of ± 0.1
units (in nominal mass).62 While instruments that provide high-mass resolution, as mentioned
before, enable the determination of a monoisotopic mass with accuracies that are better than ±
0.01 Da,72 referring to the masses of the most abundant natural isotopes of the elements present
in the ion or molecule. In practice, to achieve mass accuracies that are between the operational
parameters of each instrument, these need to be m/z calibrated as needed with special solutions
recommended by the manufacturers. For high-resolution instruments, the accuracy is expressed
either as an absolute mass error or as a relative error (in ppm), and this is calculated from: 62
(𝑎𝑐𝑐𝑢𝑟𝑎𝑡𝑒 𝑚𝑎𝑠𝑠 − 𝑒𝑥𝑎𝑐𝑡 𝑚𝑎𝑠𝑠)
𝑥 106
(𝑒𝑥𝑎𝑐𝑡 𝑚𝑎𝑠𝑠)
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Mass accuracy is an important parameter for the identification of biomolecules in mass
spectrometry, because the experimental mass values of ions are often compared to exact mass
values calculated by software such as those used in peptide/protein database searches in bottomup proteomics.4
Scan speed or the acquisition rate of an instrument,200 refers to the number of spectra that
is acquired per unit time in a particular m/z range. Fast scan speeds are required for rapidly
changing events such as to monitor peptides coming out from chromatography.221 For example,
in global proteomics studies using data-dependent acquisition, mass spectra are continuously
acquired between a low m/z and a high m/z range within a preset period of time (mostly ≤1 s).62
Sensitivity in mass spectrometry measurements has two widely accepted definitions: (1)
It can refer to the change in signal per unit change in concentration of analyte;222 or (2) it can be
described as the smallest amount of an analyte that can be detected at a certain defined
confidence level or from background noise.4 Considering this latter definition, the limit of detection
(LOD) is determined from the analyte signal-to-noise ratio (S/N) and is the lowest concentration
of a molecule where its signal can be distinguished from system noise. 223 Instead, the limit of
quantification (LOQ) is defined as the lowest amount of an analyte in a sample that can be
quantitatively determined with precision and accuracy.222 Both LOD and LOQ values are usually
plotted in calibration curves which depict a range of concentration-response values that can be
measured with reliability and reproducibility.

2.5.2 Overview of tandem mass analyzers and detectors used in bottom-up
proteomics applications.
Mass spectrometers measure the mass-to-charge ratio (m/z) of gas phase ions,23 or in
proteomics, of peptide ions. The three main components that made up a mass spectrometer are
the ion source, which produces the ions from the sample (i.e., the nanoESI source); the mass
analyzer, which resolves ions based on their m/z ratio; and finally, the detector that as the name
implies, records the number of ions that are resolved by the mass analyzer.4, 23, 72 All the data or
spectra are plotted as a function of ion abundance versus m/z which can then be retrieved for
manual or computational-assisted interpretation. From these m/z values the mass of the analytes
can later be determined.
Mass analyzers are central to MS technology. At the most fundamental level, analyzers
use some type of static or dynamic electric and magnetic fields to selectively separate ions. For
bottom-up proteomics applications, and importantly, workflows that use nanoESI sources, the
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most common types of analyzers employed are quadrupoles, ion traps (quadrupole ion trap, linear
traps, Orbitraps) and time-of-flight (TOF) analyzers.4 Although most of these analyzers may be
used as stand-alone systems, most often they are combined into hybrid systems that allow the
collection of tandem MS data from which peptide sequences can be deduced.62 All of them vary
in their physical principles and analytical performance (Table X), however, they all are used in
bottom-up proteomics to perform the measurement of peptide ions through tandem MS/MS.
The high-speed data acquisition in mass spectrometers needs to be backed by fast
electronics, including analog-to-digital converters (ADCs).224 Electron multipliers are the most
widely used types of detectors used in combination with quadrupole and ion-trap instruments.62
Detection of ions in multipliers is based on the repeated emissions of secondary electrons,
resulting from the repeated collisions of energetic particles at a suitable surface. With TOF
instruments, microchannel plate (MCP) detectors, which are arrays of miniature electron
multipliers oriented parallel to one another, are applied, as they are more suitable for ion detection
when the ion beam is more spread in space.225 In orbitrap MS systems, the signal of all ions with
different m/z values is based on the detection of high-frequency image currents.226
The projects presented in Chapters 3-5 of this dissertation employed a triple quadrupole
and a hybrid Orbitrap analyzers to conduct targeted and global proteomics analyses of the
samples under study, respectively. Their operational principles are described in more detail in the
following sections and their performance metrics summarized in Table 2.1.

Table 2.1 Performance metrics of the instruments used in this dissertation
Instrument

Mass
resolution

Mass
accuracy✝

Mass
range

Sensitivity

Data
acquisition
speed

TSQ
Quantum
Ultra
Discovery
Max

Up to 7500
(FWHM) at
m/z 508 of
polytyrosine

300- 500
ppm

101500
Da

PicomolesFemtomole

Up to 5000
Da/sec

Q Exactive
Plus

Up to
140,000280,000 at
m/z 200

506000
Da

AttomoleFemtomole

Up to 12 Hz
resolution
setting of 17,500
at m/z 200

1 – 3 ppm

✝ Mass accuracy range calculated f or molecules at m/z 300-500.
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2.5.2.1 Targeted proteomics via multiple reaction monitoring MS on a triple
quadrupole (MRM-MS).
The triple quadrupole is a hybrid MS system that is well suited for targeted proteomics
studies that collect spectral data via MRM-MS. To understand its basic mechanism of operation,
it is important to first describe a quadrupole and how it works. A quadrupole is a mass analyzer
that is made of four circular-shaped rods that are arranged in parallel.4,

62

By applying direct

current (DC) and radiofrequency (RF) voltages to the rods, a dynamic electromagnetic field is
produced which results in a complex oscillating movement of the ions from beginning to end of
the analyzer.4, 72 Depending on the DC/RF combinations applied to the rods, ions with different
m/z values can be transmitted to the detector one after another. The transmission of distinct ions
by continuously changing the voltages can be mathematically modeled with the Mathieu
differential equations.227
Quadrupoles are low resolution mass analyzers that provide mass accuracies <0.3 Da
and scan speeds as high as 10 000 u/sec in a mass range of 10–2000 Da.62, 72 When three
quadrupoles are combined in series, they form a triple quadrupole instrument (also known as
“triple quad” or “QqQ”). A QqQ is composed of two quadrupoles, “Q1” and “Q3”, that are controlled
by DC and RF potentials and act as mass filters that transmit ions of given m/z ratios; both of
them are separated by a quadrupole “q2”, which is operated in the RF-only mode.4 In q2,
fragmentation of ions is achieved by collision-induced dissociation (CID), in which neutral gas
atoms, for example argon, are used to impart internal energy to the bonds of the ions under
analysis, causing them to break.37 These fragment ions can then be separated according to their
m/z by Q3 and then passed to the ion detection system.
The research project presented in Chapter 3, used a TSQ Quantum Ultra instrument
manufactured by Thermo Fisher Scientific (Figure 2.6). The TSQ mass spectrometer consists of
an ion source interface, ion optics, mass analyzer section (quadrupoles), and an ion detection
system. The instrument can be interfaced with several ionization sources, but for the experiments
in Chapter 3 a nano-ESI source was employed. The ion source interface consists of elements
that help in ion desolvation and maintain vacuum inside the system. The ion optics focus the ions
produced in the electrospray source and transmit them to the mass analyzer, these are divided in
Q00 ion optics, which are located closer to the ion source interface, and Q0 ion optics. The mass
analyzer region consists of quadrupoles Q1, Q2, Q3 and three lens sets with diverse functions
including, for example, minimizing collision gas entering to Q1 (lens L22 and L21) and Q3 (lens
L32 and L33) from Q2; retain collision gas in Q2 (lens L23 and L31); shield from the different
voltages applied to the quadrupoles and focus the ion beam. According to the manufacturer, the
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design of the Q2 quadrupole, which are quadrupole rods bent through a 90-degree arc, is helpful
in preventing the transmission of unwanted neutral species to the detector, thus lowering the noise
level in the data. Finally, the TSQ instrument is equipped with a high-sensitivity detection system,
located at the rear of the vacuum manifold behind the mass analyzer which has been designed
to increase signal and decrease noise levels.
The TSQ quantum can be operated to collect MS1 signals from all ions coming the
ionization source or in the “full-scan” mode, but alternatively, and more frequently, it is used to
selectively induce the fragmentation and detection of ions coming to the ion source. This type of
spectral data acquisition is known as multiple reaction monitoring-mass spectrometry (MRM-MS)
and is the basis of targeted proteomics measurements. On MRM-MS, the voltage settings applied
to Q1 only allow peptide ions with specific m/z to pass through it. Ions then enter q2 where they
collide with the neutral gas to produce fragment ions and neutral fragments. The fragment ions
are then analyzed based on their m/z by Q3, which scans repeatedly over a mass range. Although
they lack mass accuracy and resolution, MRM-MS measurements are more reproducible and
sensitive than DDA methods used for global proteomics applications. Another advantage is the
ability to determine absolute abundance values from the peptides and proteins under study
using,228 for example, the AQUA strategy described in section 1.2.2. In theory, up to 1000 proteins
can be targeted in a single LC-MRM-MS run after careful selection of ion transitions.228 Due to
their consistency and quantitative accuracy, targeted proteomics measurements provide an
alternative to test biological hypotheses generated from global proteomics approaches.229

Figure 2.6 Schematic of the TSQ Quantum Ultra mass spectrometer used for targeted
proteomics measurements via MRM-MS for the project presented in Chapter 3. Image taken from
the hardware manual provided by Thermo Scientific.
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2.5.2.2 Global proteomics through spectral data-dependent acquisition on a Q
Exactive hybrid quadrupole-Orbitrap.
The Orbitrap mass analyzer was developed 20 years ago230 and it is considered a
technical improvement to linear ion traps. Different than quadrupoles, where ions are measured
and fragmented “on the fly”,4 in ion traps, ions are collected and stored over time in order to
perform MS/MS analyses. The Orbitrap is an electrostatic trap that consists of two outer
electrodes and a central electrode to which a constant electrostatic potential is applied.72 Ions are
attracted to the inner electrode where they orbit around it while at the same time maintaining an
axial oscillation with a frequency that is characteristic of their m/z values.23 Ions of different
velocities spread into rings with different rotational frequencies, but same axial frequency.72 The
image currents that are generated from these movements are captured by two outer electrodes
and Fourier transformed into the time domain to produce mass spectra.23
Orbitraps provide high mass resolutions of up to 240,000 that contribute to measure
analytes with mass accuracies < 3 ppm of up 4000 m/z.72 The operational characteristics of
Orbitraps make them ideal instrument for experiments that try to identify all possible proteins in a
complex sample and those global proteomics strategies using spectral data-dependent
acquisition (DDA). Although stand-alone orbitrap systems have been produced, Orbitraps are
combined in hybrid systems to perform tandem MS analyses of peptides. 62 In fact, the first
commercial introduction of the Orbitrap analyzer was as a hybrid instrument combining a low
resolution linear-ion trap with the high-resolution Orbitrap (LTQ-Orbitrap).231
Nowadays, however, of the many possible Orbitrap configurations, hybrid quadrupole–
orbitrap analyzers are widely used in bottom-up global proteomics research.37 These type of
instruments were first introduced by Thermo Scientific with its Q Exactive line of instruments. In
particular, the projects presented through Chapters 3-5 used a Q Exactive Plus spectrometer to
acquire global proteomics data via DDA. This instrument consists of six main components,
including the ion source, an injection flatapole that pre-filter ions according to their m/z ratios, a
quadrupole mass filter for precursor ion selection, curved linear trap (C-trap), a high energy
collision cell (HCD cell), and Orbitrap analyzer (Figure 2.7).
Briefly, on DDA acquisition, ions coming from the electrospray source are transmitted into
the quadrupole via the flatapole that acts like an ion focus device and as an ion-prefiltering device.
The proprietary technology by Thermo is called the “Advanced axial beam guide” and uses an
axial bent flatapole that reduces noise by preventing neutrals and high-velocity clusters from
entering the quadrupole. The segmented quadrupole, known as the “HyperQuad”, transmit and
filter ions according to their m/z ratios but with improved transmission efficiencies to that of a
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regular quadrupole. Upon finding the presence of the most intense or abundant analytes due to
the nature of the DDA mode, the HyperQuad isolates sends them into the “C-trap”, which is a
“C”-shaped RF-based quadrupole where the ions are cooled and aligned using nitrogen gas.72,
232

The ions are then injected into the Orbitrap analyzer to acquire MS1 spectra. Besides, to

acquire MS/MS data, the unit-mass resolved peptide precursor ions selected by the quadrupole
are also passed through the “HCD collision cell”,62 which consists of higher-energy RF-only
collision octapoles where the precursor ions are fragmented. The resulting product ion packets
are then injected tangentially 72 into the Orbitrap mass analyzer for detection. This process keeps
repeating until the most abundant precursor ions eluting at a given time are fragmented and mass
analyzed.
The Q Exactive Plus offers mass resolutions up to 140,000 at m/z 200, with mass
accuracies < 3 ppm in a range between 50-6000 m/z. Furthermore, because high-collision
energies generate more fragment ions that can be measured with high mass resolution and
accuracies in the Orbitrap, the identification of peptides and proteins in a complex mixture by
database search algorithms is improved.

Figure 2.7 Schematic of the Q Exactive Plus mass spectrometer used for global proteomics
measurements via DDA in Chapters 3-5. Image taken from the hardware manual provided by
Thermo Scientific.
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2.6 Fundamentals of tandem MS (MS/MS).
Tandem mass spectrometry, commonly abbreviated as MS/MS or MS 2,8, 38 involves the
mass analyses of precursor ions as well as of their fragment or product ions in regular mass
analyzers like ion traps, or in hybrid instruments like a Q Exactive. The process is also described
as the acquisition of MS1 spectra from precursor ions of interest and of their fragment ions or
MS2 spectra. MS/MS improves the specificity of peptide detection in bottom-up proteomics
experiments and enhances the signal-to-noise ratio of the collected spectra. When MS/MS
spectra is acquired in mass analyzers that allow the collection of ions over time and their
fragmentation like ion traps, the process is referred as “tandem-in-time”; whereas in instruments
like QqQ, in which ions are not accumulated over time and fragmentation occurs in a different
mass analyzer, the process is referred as “tandem-in-space”. There are multiple methods to
induce the fragmentation of peptide precursor ions in a mass spectrometer but the most common
ones used for structural elucidation of peptides obtained from protease digests are: (1) collisional
induced dissociation (CID),62 in older instruments like ion traps or TOF analyzers, and (2) higher
energy collisional dissociation (HCD) in more newer instruments like the hybrid Q Exactive Plus.
In CID, precursor peptide ions are allowed to collide with inert gas atoms (i.e., Helium,
nitrogen or argon) in an ultrafast collision event (~10-15 sec).62, 233 Some of the kinetic energy is
converted into internal vibrational energy, which ultimately (and preferentially) breaks the amide
bonds in peptides. This type of fragmentation produces series of b and y fragment ions on the
structures of peptides that can be useful to determine their amino acid sequences (Figure 2.8).38,
62, 234

In HCD fragmentations, helium is preferentially used as the collision gas and the collisions

impart several thousands of electron-volts of energy instead of the <100 eV in CID.62 Generally
speaking, more informative and complex spectra is obtained from HCD, because of a wider range
of potential fragmentation pathways.62
Other types of fragmentation that are employed in bottom-up proteomics but are used for
specialized applications such as to determine the location of PTMs in peptide sequences or
proteins are electron-capture dissociation (ECD) and electron-transfer dissociation (ETD). Both
of these techniques are based on the interactions of multiple-charge peptides ions with low energy
electrons (~ 1 eV) to produce the cleavage of the N-Cα bond in peptides.235-237 In ECD, the low
energy low-energy free electrons are generally generated from an electron-emitting surface, while
in ETD, electrons are transferred to protonated peptides from radical anions of compounds such
as fluoranthene.62,

72

ETD and ECD produce c and z fragment ion structures from precursor

peptides while keeping PTMs intact.62
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Figure 2.8 Example of the most common fragment ions observed and used during the analysis
of peptides/proteins by bottom-up proteomics. (A) The backbone of the bovine serum albumin
tryptic peptide “AWSVAR” shows the corresponding C-terminal y-ions and N-terminal b-ions that can
be generated during fragmentation using collision induced dissociatio n (CID) or high-energy collision
induced dissociation (HCD). (B) Shows the sequence and monoisotopic mass of the different fragment
ions illustrated in (A), for example, the y4 fragment ion is made of amino acids “S-V-A-R” and has a
mass of 432.256 Da.

2.7 Downstream processing of MS/MS data in global and targeted proteomics.

2.7.1 Introduction to database search driven algorithms in bottom-up global
proteomics research.
In this dissertation, two approaches to analyze global proteomics data from bottom-up
proteomics pipelines were used: Database search strategies conducted through the application
of different software for the projects described in Chapters 3 and 4; and de novo-assisted
database searches through the PEAKS software, used in Chapter 5 (Figure 2.9). Descriptions of
each strategy and software package employed are presented in the following sections.
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Figure 2.9 Peptide identification strategies used in this dissertation. (A) An acquired MS/MS
peptide spectrum in a bottom-up proteomics run. (B) Peptide identification performed by database
searching where experimental MS/MS spectra is correlated with theoretical spectra predicted for each
peptide contained in a protein sequences database. This strategy was employed in Chapters 3 and 4.
(C) The de novo-assisted database searching strategy of the software PEAKS was used in Chapter
5. Through a sophisticated algorithm, PEAKS computes a de novo sequence with local confidence
score on each amino acid, represented here by the percentages shown above each residue. Setting
up a confidence threshold of < 30%, for example, low confidence amino acids are substituted by their
mass values, represented here with *. The sequence tag is then mapped to a protein database. The
CAA score reported by the software is the number of common amino acids in the alignment.
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2.7.1.1 Peptide identification by database searching.
The manual interpretation of peptide tandem MS spectra to derive peptide sequences is
an error-prone and time-consuming process that is exacerbated with the hundreds of thousands
of spectra that can be collected in global proteomics analyses of cell cultures or communities of
microorganisms. These reasons have enabled the development of computational algorithms or
programs that are used to directly correlate peptide ion spectral MS1 and MS/MS (MS2) data, as
well as their respective intensities, to candidate peptide sequences in a database without having
to interpret each MS/MS spectrum manually.
Today, more than a dozen database search algorithms, each providing technical
advantages such as faster computational times, improved confidence scores, and better
accessibility to users without strong computational backgrounds are available for large-scale
protein identification. In addition, the database search approach fits well with the emerging
database resources brought about by genome sequencing which each day keeps providing of
more accurate and complete protein databases.4
The first algorithm or engine to identify proteins by matching MS/MS data to database
sequences was SEQUEST, introduced by the Yates group in 1995.16 SEQUEST core
functionalities have been adapted and improved in many other programs developed over the
years,116, 238-242 including the ones used in this dissertation. Thus, a brief description of these core
functionalities is warranted to have a better understanding of the new capabilities provided by
other software.
In brief, SEQUEST (as well as other database search algorithms) take three main inputs
from the user: a peak list containing the spectra to search, a sequence database (i.e., a FASTA
file), and the search settings to match the search to the experimental setup (i.e., protease used
and type of instrument employed).243The software then performs the following steps: in-silico
digestion of the protein database, spectrum preprocessing, matching, preliminary scoring and
cross-correlation analysis.
Before the search starts, the protein database is digested in-silico to produce a candidate
peptide list.4 The user has to specify digestion parameters such as maximum amino acid length
and the protease that was used in the experiment, for example. Once the search starts, each
experimental MS/MS spectrum in the form of instrument proprietary files is “cleaned” by keeping
the top 200 most abundant m/z values. This process ensures that noisy spectra are removed from
further analysis thus improving the performance and accuracy of the subsequent steps. Next, the
algorithm uses peptide precursor m/z values and their MS/MS data, detected in the experiment
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and registered in the RAW file, to select candidate peptides in the database. Importantly, this
process is constrained to a user defined mass tolerance which impacts the number of peptide
candidates that the algorithm considers for matching. In-silico MS/MS spectra are then generated
from each of the candidate peptide sequences in the database and compared to the experimental
MS/MS spectra. A preliminary score to determine how well a theoretical versus experimental
spectrum match one another is computed taking into consideration the (1) the summed intensity
of matched ions, (2) the continuity of each fragment ion series and (3) the percentage of ions
found versus those that were expected. This preliminary score acts as a filter to select the top five
hundred peptide candidate sequences to compute a cross correlation score (Xcorr) of them, which
represents an average of differences between the experimental to the in-silico generated m/z
values. In addition, SEQUEST also uses another score, named DeltCn, that captures the scoring
difference between the lowest ranked peptide scores and the XCorr value of the best match which
informs the user how well the software was able to separate the top peptide-spectrum match
(PSM) compared to the second best PSM.
Around the time that SEQUEST was released there was no control of the quality of the
matches that were assigned by the software. Although the algorithm was scoring the best peptide
sequence match to a given experimental spectrum, it could not efficiently distinguish matches of
poor quality.4, 244 Thus, the user had to go back to the raw spectral data and use a combination of
knowledge and visual inspection to decide which matches to accept and which ones to reject.
This type of approach, however, made comparisons between datasets subjective and once again
time-consuming. Therefore, more practical ways to classify correct and incorrect PSMs
assignments were developed.
Today, proteomic studies use statistical approaches to provide a global assessment of
confidences and estimate a false discovery proportion (FDP) of false positive hits in a dataset, or
those PSMs accepted by the algorithm, but that are not real hits. This FDP is more commonly
known in proteomics research as the false discovery rate (FDR), although this has been regarded
as an oversimplification of the term.245 FDRs can reflect the overall credibility of the identified
PSMs in a study.246 In bottom up proteomics, the most commonly used and accepted method for
computing the FDR is the target-decoy strategy (TD).247 Simply, the strategy requires that all
experimental MS/MS spectra are searched against the reference protein database (target)
appended with a reversed, shuffled, or randomized version of itself (decoy).248
The underlying assumption in TD is that the number of false PSMs in a decoy search will
follow the same search score distribution as sequences matches from the target database.24 8
Therefore, an entire data set can be filtered at various search score cut-offs, and a corresponding
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FDR can be computed as ( 2 ∗ 𝑁𝑑⁄𝑁𝑡 ) ∗ 100, where Nd is the number of decoy peptide matches
and Nt is the total number of matches.249 An acceptable FDR should be conservative such that it
ensures that the number of false discoveries selected does not exceed the number of estimated
and accepted ones245 with these values ranging in literature from 1% to 5%. The FDR calculation
can be performed by the same PSM software or by taking the results to standalone programs like
Percolator, which is a popular semi-supervised machine learning algorithm that dynamically
learns to separate target from decoy peptide-spectrum matches.250 Once an acceptable FDR is
achieved and the PSMs have been statistically validated, protein identifications can then be
inferred, and if desired, quantified, from the detected peptides.
With each passing day, new search engines are being developed and improvements in
computational speed and lower FDRs, especially in PTM analyses, are being implemented or
have been implemented in old ones.244 For example, one of the newest iterations of SEQUEST,
SEQUEST-HT, takes advantage of multi-core CPUs to improve its informatic speed as well as of
a new algorithm to optimize peptide sequence database management, in addition, the program
is able to handle fragmentation data from ETD or HCD approaches251 bringing its capabilities up
to date.

2.7.1.2 Protein inference.
After a list of confident PSMs has been obtained, the next step is to assemble the identified
peptides back into proteins and provide statistical confidence levels for each of them to arrive to
a meaningful biological explanation. However, this task is not trivial. Because the connectivity
between peptides and proteins is lost in bottom-up proteomics pipelines, the assembly of peptides
back into proteins is challenging.
The diversity of proteins sizes in any given organism, may led to a very small number of
confident peptide identifications available for small proteins. In addition, and because of their
different physicochemical properties, even peptides originating from the same protein are not
equally likely to be identified in proteomics experiment. Although with proper statistical control at
the PSM level the identification of a single peptide can be enough to provide evidence of the
presence of a certain protein in a sample, this is not enough to discriminate between two proteins
sharing extensive homology which is a common situation in the proteomes of higher eukaryotes
organisms like plants and humans.
The presence of shared or degenerate peptides252 in a proteome is particularly
troublesome and has not found common ground in the proteomics community. To date, groups
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around the world use a diverse set of approaches to tackle the problem of protein inference and
these can be grouped in:61, 252 (1) Rule based strategies, such as methods that disregard shared
peptides from the dataset and only consider confident peptides that are unique, or those mapped
to only one protein;253 (2) combinatorial optimization algorithms, or methods that rely on
constrained optimization formulations of the protein inference problem resulting, for example, in
the minimal protein lists that cover some or all confidently identified peptides; and (3) probabilistic
inference algorithms that formulate the problem probabilistically and assign identification
probabilities for each protein in a database.
Each of these methods have their advantages and disadvantages. For example, those
that only consider unique peptide identifications may see a significant loss of protein information
in datasets from eukaryotic organisms which can lead to underestimations of protein content due
to the presence of shared peptides originating from whole-genome duplications, protein families
or alternative splicing variants. Because of this, several suggested guidelines on how to deal with
the protein inference problem have been published254,
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and by far the most commonly

suggested strategy is the minimum set cover formulation (MSC).
In the MSC, a minimal list of proteins based on the principle of parsimony coupled with an
Occam’s razor constraint, is used to explain all the identified peptides in a dataset.61 This
approach classifies proteins by their level of ambiguity: 61 proteins that consist of only distinct
peptides are classified as distinct proteins; proteins are classified as differentiable when they
contain at least one peptide that is unique to that protein, as well as one or more peptides that
map elsewhere in the proteome; indistinguishable proteins consist of only shared peptides and in
these scenarios it is recommended to collapse all of these proteins into a single entry in the protein
summary report as there is often no basis to eliminate any of them.
Like FDR software, multiple protein inference software options are available. In this
dissertation, MSC approaches were used in all the programs used to derive proteins. Minimal
lists have several advantages that allows a consistent calculation of the number of proteins
identified in the experiment and simplifies the interpretation to only those proteins that are
conclusively determined to be present in the sample.
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2.7.2 Overview of database search engines used in this dissertation.

2.7.2.1 Myrimatch-IDPicker.
A computational pipeline consisting of the open-source software Myrimatch and IDPicker,
were used to obtain global proteomics information from the experiments presented in Chapter 3.
Peptide sequences were derived from the database search algorithm MyriMatch; while proteins
were assembled with IDPicker, an algorithm which assembles a minimum protein list from peptide
identifications filtered to a specified FDR.
Myrimatch238 was developed based on the foundations of SEQUEST but improved the
matching criteria of experimental tandem spectra to theoretical spectra to provide more confident
results. Its first step is a tunable preprocessing step that ranks fragment ions by their intensity and
retains, by default, only 98% of ions in each scan. All the retained peaks are divided into three
classes based on their intensities (i.e., high, medium, and low). As such, the highest intensity
class is expected to have the least number of peaks, while the lowest intensity class will have
many more peaks.
The second step consists on the in-silico generation of theoretical MS/MS spectra from all
possible peptides in a protein database. To achieve the latter, MyriMatch employs basic
fragmentation rules but also a novel system for modeling fragments by considering ion charge
state differences. The third step is the comparison of acquired experimental spectra to the
predicted one. In this process, the measured m/z value are first matched to the predicted m/z
values based on the type of instrument used and by coupling the intensity class information. For
each experimental spectrum, the software examines each m/z location and computes two
probabilistic scores. The “MVH score” is based on a multivariate hypergeometric distribution of
hits, while the “mzFidelity score” is based on a distribution of fragment mass errors. The algorithm
then uses the MVH scores to rank the candidate peptide sequences and, when needed, it uses
the mzFidelity score as a tiebreaker. Finally, a cross-correlation (Xcorr) value is computed to
independently validate the best PSM ranked by the MVH score.
The list of best scoring PSMs from Myrimatch is then imported to IDPicker256 to assemble
a list of proteins. IDPicker contains a module for calculating confidently identified peptides using
an FDR-based approach. The peptides that are accepted based on an FDR threshold are used
to compute a minimal list of proteins.252 The algorithm starts by collapsing a peptide-protein
bipartite graph such that all peptides and proteins connected to the same proteins and peptides
are grouping into nodes containing multiple peptides or proteins. It then finds a set of disconnected
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subgraphs within a bipartite graph using a depth-first search. Finally, it performs an MSC
optimization in each of those subgraphs.

2.7.2.2 CharmeRT.
Chapter 4 evaluated the performance of the computational framework CharmeRT which
consists of the peptide identification algorithm MS Amanda257, developed specifically for high
accuracy/high-resolution mass spectrometry data, and Elutator, which is a mPSM validator that
improves upon the principles of Percolator. Both tools are included in Proteome Discoverer, a
commercial software licensed by Thermo Fisher Scientific that comprises a selection of mass
spectrometry-related tools.
MS Amanda comprises three major steps: spectrum preprocessing, matching of
theoretical-to-experimental spectra, and probabilistic scoring. In the preprocessing step,
precursor ion peaks are removed from the list of experimental spectra, and MS/MS spectra are
cleaned by only selecting between 1 to 10 of the most intense peaks in segments of 100 Da.
Afterwards, in-silico generated fragment ions of each candidate peptide precursor (targets and
decoys) from the protein database are matched to the best experimental precursors and their
fragments within specified MS1 and MS2 mass tolerances. The software then proceeds to
probabilistic scoring of PSMs, which according to the authors is based on a binomial distribution
function that incorporates peak intensities to determine favorable outcomes (successes) and
possible outcomes (sample space) in a specific manner. Importantly, the version of MS Amanda
used in the CharmeRT framework includes a “second search” approach that assigns more than
one peptide precursor ion to experimental spectra and in this way, deconvolutes chimeric
spectra.118
The validation of the multiple PSMs (mPSMs) that can be identified by MS Amanda is
done through Elutator. This tool utilizes additional information not considered in Percolator, such
as peptide elution retention time predictions, as well as recalibrated masses for precursors and
fragment ions to improve the validation of mPSMs.118 According to the original paper, the
combined use of Elutator with MS Amanda increased the numbers of identified PSMs by 17-51%
for the first search and between 106-149% for PSMs derived from second searches in a HeLa
proteome dataset compared to a version of CharmeRT in which no retention time prediction was
used in Elutator. This means that the impact that auxiliary information used in Elutator has on the
identification of mPSM benefits spectra of lower quality or that derived from chimeric spectra.
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2.7.2.3 De novo-assisted peptide database searches with PEAKS.
Alternative to the popular database searching algorithms to identify peptides and proteins
in a bottom-up global proteomics experiment, the deduction of amino acid sequences from
MS/MS spectra can also be conducted via de novo algorithms. De novo peptide sequencing is
independent of protein databases and is analogous as to search for a peptide in a space
containing all possible peptides.249 Historically, de novo algorithms have been deemed to give
less accurate results than their database counterparts, as well as to be less efficient due to the
non-restricted search space that comes with a cost in computational time and resources.
However, with the introduction of high-resolution MS instruments, the performance of de novo
sequencing software has been significantly improved.
One of those software packages is PEAKS,149 a commercial software released in 2002 by
Bioinformatic Solutions and that has become an industrial standard for automated de novo
sequencing.249 PEAKS has the capability of incorporating de novo sequencing results into
database searches.149 According to its developers, the combination of de novo sequencing to
improve the creation of a preliminary list of protein or peptide candidates with an improved scoring
function results in significantly improved sensitivity and accuracy. This mode of operation, more
commonly known in the field as de novo-assisted database search, was employed in Chapter 5
of this dissertation to identify small endogenous proteins (≤ 100 amino acids) and/or their peptide
products in a plant-microbial interface system. Although more details are described in Chapter 5,
it is important to state right now that these biomolecules were not submitted to any in vitro
enzymatic digestion treatment before (i.e., with trypsin). Avoiding this step means that their
identification by MS/MS captures important cellular processes such as endogenous
posttranslational processing.
In particular, combining de predictability of de novo searches to identify small endogenous
proteins or peptides in any biological system is advantageous due to the following reasons: (1)
There is no need to generate an in-silico peptide library via regular database search that can
cover potential or expected enzymatic cleavages occurring naturally in a system. Database
search algorithms are particularly not efficient in the computational resources they use when
conducting an “open-search” to generate multiple versions of proteins (i.e., digested with trypsin,
chemotrypsin, LysC, etc); and (2), since small protein products may not be well represented in a
database, having information that is not biased towards the use of one may help identify novel
proteins for analysis.
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In total, PEAKS DB performs six algorithm steps to identify peptides from tandem MS
spectra and this has been summarized with ease and described in more detail in the original
publication to which the reader is referred to.149

2.7.3 Targeted proteomics data analyses with Skyline.
In Chapter 3, a targeted proteomics methodology was developed and applied to
groundwater samples to investigate the presence of bacterial biomarkers of interest. Targeted
proteomics has gained significant attention in proteomics research due to the specificity,
sensitivity and robustness that it brings to the identification and, most importantly, absolute
quantification of predetermined peptides acting as surrogates for specific proteins (targets) that
are present within a large dynamic concentration range in complex matrices.103, 258 Thus, even if
bottom-up global and targeted proteomics experiments measure peptides in a sample, the type
of data acquired from each experiment looks quite different and needs to be processed and
interpreted by computational pipelines adapted to their particular requirements.
Technological advances in mass spectrometry instrumentation and the promise that global
proteomics had for systems biology investigations, led to the early emergence of software
packages that were specifically intended to deal with the complexity of the spectral data acquired
through DDA approaches. Thus, when targeted proteomics investigations started to have an
active role in research, software tools to analyze the spectral data collected from these types of
experiments lagged behind. Although early efforts tried to breach the gap in bioinformatic
developments, the tools that came out of it were limited in scope and the field was mainly
dominated by proprietary software specific to a particular instrument vendor.259 Hence, to tackle
these issues and provide users with an open-source alternative that at the same time could
facilitate sharing of data files and methods between multiple instruments, the MacCoss
Laboratory at the University of Washington started the development of the Skyline project.
Skyline259 is a windows client application for building and analyzing selected reaction
monitoring (SRM)/multiple reaction monitoring (MRM), parallel reaction monitoring (PRM –
targeted MS/MS and DIA/SWATH), and targeted DDA data. Over the last ten years, the project
commanded by Brendan McLean, its main developer, has become a standard in commercial
and academic targeted proteomics research around the world. The appealing of the software is
its focus on end user design which allows to create complete targeted proteomics pipelines all
the way from method development (reviewed in Section 1.2.1.2) through data analysis, with
ease.
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Due to its capabilities and broad adoption by the community, Skyline was used in
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Chapter 3 of this dissertation to test MRM-MS methods and analyze the results obtained from
them.
Without going into many details in MRM-MS method building, Skyline works like a text
editor document in which a user can input protein sequences, digest them in-silico with a
protease and generate lists of transitions, consisting of peptide ion precursors and fragment
ions, that can be imported to an instrument (for this dissertation, a triple quadrupole) for
acquisition via MRM-MS. Skyline also provides additional support for more advanced
techniques like “scheduling” which enables the measurements of tens to hundreds of individual
peptides by allowing only a subset of the targeted peptides to be measured in a given time
window.228 Options to optimize collision energies for each measured peptide, so as to get
adequate fragment ion intensities, are also available.
Once an MRM-MS run or sample campaign is over, Skyline can take as input multiple
raw spectral files in either instrument-vendor specific or generic formats and process them
sequentially or in parallel to identify the targeted peptides and calculate their peak areas. Peak
detection and integration in Skyline is composed of six algorithm steps that are: 260 (1)
Chromatographic extraction, (2) Resampling, (3) Peak detection, (4) Peak grouping, (5) Peptide
identification and, (6) Peak area calculation. These steps, specifically for processing of MRMMS data, are summarized below.
First, Skyline extracts the necessary information like m/z, retention times and intensities
from the measured chromatograms in each MRM-MS raw file. The success of this step depends
on the adequate initial setup of the instance of Skyline that will be used to import the results,
such as retention time window width or the mass accuracy of the instrument that was employed
to take the measurement. Then, Skyline conducts resampling, in which it calculates an interval
in a peak that captures as much MS2 information as possible. This is done through linear
interpolation and normalizes the irregular collection of MS2 scans that are common in all tandem
mass spectrometry data acquisition types.260 The resampled data are then searched for areas
that represent peaks and this is performed by the Chromatogram Retention time Alignment and
Warping for Differential Analysis of Data (CRAWDAD) Peaks algorithm,261 which finds a set of
local maxima, local minima and inflection points forming a viable peak.
The next step is to create peak groups for each targeted peptide and/or its modified
versions (i.e., heavy labeled standards). Due to the nature of the MRM data acquisition type,
specific pairs of peptide precursor-fragment ions or transitions are measured over a certain
period of time (i.e., when it elutes from the LC), so the extracted ion chromatogram of a peptide
resembles a collection of peaks that coelute at a specific time. During peak grouping, Skyline
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considers similarity with apex retention time (RT), start RT, and end RT that are drawn from the
local maxima and inflection points from the resampling step.260 After groups of peaks have been
defined, the program now performs “peak picking” which is the evaluation of multiple peak
groups that can represent the peptide of interest. During this step, the top 10 peak groups are
assessed for seven different features (i.e., log intensity, coelution count, shape score, etc) that
are weighted with particular coefficients and summed to give a final score to the peak group.
Finally, Skyline calculates peak areas, or areas under the curve (AUCs) for the selected peak
groups and reports them in ion counts units. In this process, the software integrates the area
within the peak boundaries and subtracts the background areas from it. Total area values sum
the AUC values of coeluting transition chromatograms. In addition, and particularly important for
absolute quantification, the software can calculate the amount of endogenous peptide present in
a sample by single point calibrations to a heavy standard or by a calibration curve.
Once raw data are automatically processed, Skyline creates visual displays of the data
that allow researchers to quickly inspect its quality and identify issues with it. Although automated
peak detection and boundary settings are generally reliable in Skyline, and with each software
update there have been refinements to the peak picking process or bug fixes, manual curation of
the data ensures reliable identification and quantification of each targeted peptide. For example,
the software can show detailed chromatograms for each peptide with peak boundaries and
indicators for retention time and dot product correlation scores of MRM spectral data of each
picked peak compared to DDA spectral data captured in the same or other instrument. Retention
times and peak areas can be plotted and grouped by proteins or by replicate groups allowing to
check the reproducibility of the measurements. The mass error of each selected peak, which is
calculated in Skyline as a weighted mean of the mass error in all the integrated points across the
annotated chromatogram,260 can be inspected to detect interference at the transition level.
Certainly, the manual curation process of targeted proteomics data in Skyline can be a bit time
consuming, however, the software makes it more amenable to the end user. Examples of this
process will be shown in Chapter 3.

2.8 Post-processing of bottom-up proteomics data.
The amount of information obtained from bottom-up proteomics experiments, especially
in global proteomics studies, can be overwhelming. The dissection or interpretation of the
matrices or lists of peptides and proteins obtained in proteomics experiments is a multifaceted
process that integrates different aspects of bioinformatics and statistics.262 This is particularly true
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for those studies that seek to answer questions of primary scientific interest through the
interrogation of protein abundance values that can be considered as a true reflection of the state
between samples. In global studies, normalization and missing value imputation are two steps
that occur before applying any statistical inference test to a dataset. 263
Normalization is the process of removing systemic bias in LC-MS/MS data that are
introduced during the various steps of sample processing and data generation.264 For example,
differences in the amounts of sample loaded for analysis, ionization efficiencies in complex
samples, degradation of packing material in LC columns, and drifts in the performance of mass
spectrometers over time,263,

265

all have the potential to influence the measured peptide and

protein expression levels leading to erroneous conclusions from a quantitative perspective. Data
normalization reduces the effect of these sources of bias. Normalization strategies have been
reported to be dataset dependent,266 and each address systematic bias differently. For example,
global adjustment techniques try to center intensity values of peptides around the global mean,
median or some other fixed value in a dataset and they can correct for differences in the amount
of sample loaded for analysis, but it cannot capture more complex biases. 263 Instead, scatterplot
smoothing techniques such as lowess regression267 are able to capture non-linear intensitydependent biases and are therefore more flexible than global adjustments.263
After normalization, another key challenge in quantitative proteomics studies is to address
missing peptide abundance values. These cases are more prevalent in global proteomics studies
than in targeted ones, where as much as 50% of peptide values can be missing in datasets.268,
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There are multiple reasons behind peptide missing values but, broadly, they can be caused

by biological, analytical or unknow effects. In fact, the underlying mechanisms of these types of
missing values have been categorized by statisticians as independent of the value itself or missing
at random (MAR) or dependent on the data, also known as not missing at random (NMAR)
values,269 and they are not particular to proteomics but can occur in other types of techniques
yielding matrices of experimental data such as in microarray-based gene expression.
Missing information in global proteomics datasets can have negative effects in the
interpretation of meaningful biological data as it prevents the complete and accurate extraction of
quantitative protein values and functional information.269 Although one can ignore missing values
from the data, this option would dramatically reduce the size and completeness of it and some
important biological information may escape analysis. Fortunately, however, as with the case of
transcriptomics and microarray data analysis, numerous methods of data imputation for
proteomics have been reported to tackle the issue of missing peptide values and have been
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suggested to be contextualized according to each dataset, proportion of missing values and their
nature.268
In the present work, the random tail imputation (RTI) approach269 was employed to treat
missing values in global proteomics data. RTI performs well in the presence of left-censored
missing values,268 which for MS based proteomics analysis are frequent, as peptides whose
abundance are close enough to the limit of detection of the instrument have a higher rate of
presenting missing values.268 The assumption is that the proteomics dataset can be modeled by
an empirical abundance distribution and that the majority of the missing data are left-censored
and can be drawn from the tail of the distribution.263, 269 For the global proteomics data presented
in Chapters 3-5, distributions with mean and standard deviations simulating low abundance
values below the noise level were computed first, and then missing values were imputed with
random numbers generated from this distribution. The values imputed in such way vary thus
diminishing the effects of variance underestimation.
After data has been normalized and imputed, the next step is to find protein abundance
changes that can provide meaningful information to the goal of the study. For this purpose, a
significance test can be carried out. Statistical tests are based on the idea that false discoveries
are extremely frequent, unlike true discoveries, which are scarce. Thus, if enough data is
available, a “null hypothesis”, or a standard based on false discoveries in the data, can be
established and based on this null hypothesis and its distribution, the similarity between a putative
discovery and the null distribution can quantified by a test statistic. Concretely, for any given
quantified protein, the null hypothesis is that of nondifferential abundance or at last that the
difference in abundance can be explained by random fluctuation. Thus, by rejecting a null
hypothesis and accepting the alternative hypothesis or that a protein exhibits differential
expression not explained by random fluctuations, a list of significant proteins can be identified.
Accordingly, the similarity between the abundance changes of a protein compared to a null
distribution of abundances can be measured using any statistic of the Student family. Because
the Student’s statistics are difficult to interpret, they are replaced by p-values which for
proteomics, values below 0.05 or 0.01 are values used to reject the null hypothesis. Depending
on the comparisons, other statistical tests like ANOVA can be implemented, such as with the data
presented in Chapter 5.
Finally, there are many ways to visualize the curated results from a bottom-up proteomics
experiment. Qualitative data such as the number of peptides and proteins identified within
replicates and conditions can be shown in bar charts,270 and common and/or unique sets of
proteins identified in one or up to four conditions271 can be clearly illustrated with Venn diagrams.
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Quantitative proteomics data is commonly displayed through volcano plots in which the fold
change (log2 transformed) is plotted versus the p-value (-log10 transformed).272 This kind of plot
highlights proteins with high fold changes and low p-values and is well suited for illustrating
changes in large datasets. Individual expression levels of hundreds or even thousands of proteins
across multiple conditions can be visualized by color intensity in heatmaps. Unsupervised
hierarchical clustering of the data in heatmaps enables the visualization of groups of proteins
which expression can be up- or downregulated in certain conditions. PCA plots are also ways to
investigate underlying differences between replicates and conditions in quantitative proteomics
results.273 Multiple software packages are available to researchers such as Perseus262 or
InfernoRDN274 to visualize proteomics results.
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CHAPTER 3
Evaluation of the application feasibility of a LC-MRM-MS targeted proteomics
approach for the detection of Dehalococcoides mccartyi protein biomarkers in
chloroethene contaminated groundwater
Text and figures were adapted from the following published journal article:
Villalobos Solis, M.I., Abraham, P.E., Chourey, K., Swift, C.M., Löffler, F.E. and Hettich,
R.L. (2019) Targeted detection of Dehalococcoides mccartyi microbial protein biomarkers as
indicators of reductive dechlorination activity in contaminated groundwater. Scientific Reports, 9.
Authors contributions: Manuel Ivan Villalobos Solis (M.I.V.S.) planned the study alongside
Robert L. Hettich (R.L.H.) and Frank E. Löffler (F.E.L.). M.I.V.S. and Karuna Chourey (K.C.)
collected biomass from groundwater samples. M.I.V.S. and K.C. prepared samples for global and
targeted proteomics. M.I.V.S. developed the MRM assay, performed proteomics data analyses
and wrote the main manuscript. Paul E. Abraham provided critical reviews and proof -read the
manuscript. All authors reviewed and approved the final version of the manuscript.
Notes: Supplemental figures and tables mentioned in text are available at
https://doi.org/10.1038/s41598-019-46901-6 and their numbering reflects that of the online
material.

3.1 Introduction.
Dehalococcoides mccartyi (Dhc) bacteria are key players in bioremediation strategies for
groundwater aquifers contaminated with the industrial solvents tetrachloroethene (PCE) and
trichloroethene (TCE), which are common groundwater pollutants classified as toxic and
carcinogenic to humans. Specialized Dhc bacteria grow under anoxic conditions by deriving
energy from the reductive dechlorination of PCE, TCE, and the degradation products cis-1,2dichloroethene (cis-DCE) and vinyl chloride (VC) to ultimately yield environmentally benign
ethene.275-279 The ability of some Dhc strains to detoxify chlorinated ethenes makes them also
functionally unique compared to other bacterial groups such as Geobacter, Dehalobacter,
Desulfitobacterium, Sulfurospirillum, which are not able to reduce PCE beyond cis-DCE.276
Various Dhc strains have been maintained in axenic cultures or in consortia supplied with
a chlorinated ethene as electron acceptor, and several reductive dehalogenase (RDase) genes
and their products have been identified as biomarkers of dechlorination activity. 33,

278, 280

Quantitative polymerase chain reaction (qPCR) measurements of the Dhc 16S rRNA gene and/or
RDase genes in contaminated groundwater enabled comparative studies of the distribution and
abundance of Dhc strains and RDase genes in response to bioremediation treatment (i.e.,
bioaugmentation and/or biostimulation).281-283 However, as with other existing nucleic acid-based
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measurement approaches, the challenge of qPCR measurements of 16S rRNA gene and/or
specific RDase genes is their inability to reveal the actual metabolic activity. Several studies have
demonstrated that the sole presence of RDase genes and also their transcripts does not
necessarily correlate with dechlorination activity.284-287
Consequently, proteomics approaches to measure the expression levels of proteins
involved in the reductive dechlorination processes of Dhc has been gaining traction in recent
years. One of these approaches is targeted proteomics via liquid chromatography-multiple
reaction monitoring-mass spectrometry (LC-MRM-MS), which enables the absolute quantification
of proteins of interest by measuring proteotypic peptides derived from their enzymatic digestion.
Although the application of LC-MRM-MS to pure and mixed cultures of Dhc has been
demonstrated, its utility to groundwater collected from sites impacted with chlorinated ethenes
remains to be proven.33,

103, 288

Herein, we aimed to test the feasibility of developing and

implementing a targeted proteomics approach via LC-MRM-MS for the detection of Dhc proteins
to inform about Dhc reductive dechlorination activity in groundwater samples from sites impacted
with chlorinated ethenes.
To effectively track the presence of the targeted Dhc biomarker proteins, we first selected
candidate proteotypic peptide sequences observed in high-mass-accuracy/high-resolution global
proteomics datasets of actively dechlorinating pure cultures of Dhc strains 195, FL2, and BAV1.
After signal evaluation of the selected peptides by LC-MRM-MS on a triple quadrupole mass
spectrometer, the most robust and reproducible transitions (pairs of peptide precursor and
fragment ions m/z values) were used to detect the targeted Dhc proteins in groundwater collected
from six geographically distinct locations. Peptide identifications in groundwater samples were
supported by comparing their fragmentation profiles to those obtained from pure cultures or, in
several cases, by comparing fragmentation profiles and retention times to spiked-in, unlabeled,
synthetic peptide standards. Furthermore, 16S rRNA gene qPCR and global proteomics
measurements performed for each groundwater sample allowed a comparative assessment with
the LC-MRM-MS data.

3.2 Experimental procedures.

3.2.1 Dehalococcoides mccartyi (Dhc) cultures and growth conditions.
Biological duplicates of actively dechlorinating axenic cultures of Dhc strains 195 and FL2,
known to express the RDase TceA (TCE→VC and ethene), as well as strain BAV1, which
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expresses the BvcA RDase (DCEs→VC→ethene), were prepared and used to monitor the
abundances of the targeted Dhc proteins in both global and targeted proteomics measurements.
For the purpose of method development, the targeted proteomics approach also used a culture
of the PCE-to-ethene dechlorinating Bio-Dechlor INOCULUM (BDI) consortium known to contain
several Dhc strains and a PCE-to-cis-DCE-dechlorinating Geobacter lovleyi strain,277 amended
with PCE as electron acceptor. Cultures were grown in completely synthetic, defined mineral salts
medium as previously described.289 Approximately 100 mL of culture (~1x1010 cells) were passed
through Sterivex 0.22 µm filter units (EMD Millipore Corporation, Billerica, MA, USA) to collect the
biomass. Filters were stored at -80ºC prior to protein extraction and digestion. Dhc cell numbers
were calculated by qPCR measurements of 16S rRNA genes as previously described. 280 The
known Dhc genomes contain a single copy of the 16S rRNA gene and RDase genes, and the
gene copies were measured with qPCR equal the Dhc cell numbers.290

3.2.2 Biomass recovery from groundwater samples.
Biomass was obtained from volumes of groundwater samples collected from sites
impacted with chlorinated ethenes. Sample 33NA-4 (360 mL) was collected from a contaminated
site in Brazil. Samples M17 (745 mL), M18 (1,350 mL), 97 (1,000 mL), 116 (962 mL), and 129
(964 mL) were collected from contaminated sites in the United States. The entire volumes of
groundwater were filtered through Sterivex 0.22 µm pore-size filter units to concentrate the
biomass and then stored at -80°C prior to protein extraction and digestion.

3.2.3 Sample preparation for global and targeted proteomics analyses.
Filtered cells from axenic cultures of Dhc strains 195, FL2, BAV1 (n=2 biological
replicates), the BDI Consortium, as well as the M17, M18, 97, 116 and 129 groundwater samples
(n=1) were processed by adding 2 mL of SDS lysis buffer (4% SDS in 100 mM Tris‐HCl, pH 8.0)
to the Sterivex cartridges followed by incubation in a water bath at 97ºC for 15 minutes and
incubation at room temperature for 1 hour. The SDS lysis buffer was recovered and the filters
rinsed once more with fresh lysis buffer. As previously described, proteins were extracted from
cell lysates by trichloroacetic acid (TCA) precipitation and proteolytically digested with trypsin
following denaturation and disulfide bonds being reduced and blocked. 291
Frozen filter membranes with biomass from the 33NA4 groundwater sample (n=1) were
removed from the cartridges and cut into ~ 1 cm pieces using a sterilized razor blade and then
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suspended in 5 mL of SDS lysis buffer (5% SDS in 50 mM Tris-HCl, pH 8.5; 0.15 M NaCl, 0.1 mM
EDTA; 1mM MgCl2; 50 mM DTT). Cells were heat-lysed as described earlier292 and the
supernatant containing the whole cell lysate transferred to new tubes. Proteins were then
precipitated by TCA. Lysate mixes were centrifuged at 21000 g x 20 min to obtain a protein pellet
which was washed with chilled acetone, air dried and solubilized in 6M guanidine buffer 293.
Following protein solubilization, proteolysis was initiated using trypsin. All peptide solutions were
desalted on 200µL C18 stage tips (Thermo Scientific, Waltham, MA) and stored at -80ºC prior to
global proteomics analysis. For targeted proteomics runs, volumes of processed samples were
loaded directly onto capillary back columns and desalted off-line.

3.2.4 Global proteomics of axenic cultures and groundwater samples.
Global proteomics measurements of the axenic cultures of Dhc strains 195, FL2 and BAV1
(n=2 biological replicates), the BDI consortium (n=3 technical replicates), as well as groundwater
samples (n=3 technical replicates) were obtained with an Orbitrap Q Exactive Plus mass
spectrometer (Thermo Fisher Scientific, San Jose, CA) equipped with a nano-electrospray (ESI)
source and interfaced with a Proxeon EASY-nLCTM 1200 system. Proteolytic peptide aliquots from
pure cultures (1 µg), consortium BDI (2 µg), and groundwater samples (2 µg) were suspended in
solvent A (0.1% formic acid, 2% acetonitrile) and injected onto a 75 μm inner diameter
microcapillary column packed with 35 cm of Kinetex C 18 resin (1.7 μm, 100Å, Phenomenex,
Torrance, CA). Peptides were separated using a 90 minutes gradient at a flow rate of 250 nL/min
from 2 to 30% solvent B (0.1% formic acid, 80% acetonitrile), followed by an increase to 40%
solvent B within 10 minutes and a 10-minute equilibration with 98% solvent A. Specific details of
the MS/MS data acquisition parameters have been reported previously. 294
Tandem MS spectra from pure cultures of Dhc strains 195, FL2, BAV1, and the BDI
consortium culture were searched against individual or concatenated databases of Dhc strains
downloaded from UniProt (for strains 195, GT, VS, CBDB1, BAV1 02/2017). The IGS Annotation
Engine was used for structural and functional annotation of the Dhc strain FL2 protein sequences
(http://ae.igs.umaryland.edu/cgi/index.cgi, Reference: PMID:21677861) and the web-based tool
Manatee was used to view and download protein annotations (http://manatee.sourceforge.net/).
The tryptic digest of the BDI consortium was searched with a database assembled from the
proteomes of the six strains of Dhc and Dehalobacter restrictus DSM 9455 (Supplementary
Table S5). Spectral data collected from groundwater samples were searched against a database
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encompassing the proteomes of bacterial isolates known to coexist with Dhc or known to inhabit
aquifer and sediments (Supplementary Table S7).
In addition to common contaminant proteins, the reversed protein sequences were
appended and used as decoys to discern the false-discovery rate (FDR) at the spectral level. For
standard database searching, the tandem fragmentation spectra (MS/MS) were searched with
Myrimatch v2.2 algorithm4 set to parameters described before.5 Resulting peptide spectrum
matches were then imported, filtered and organized into proteins with IDPicker v.3.16 software.
To achieve a final peptide-level confidence > 99% (or false discovery rate FDR < 1%), proteins
were identified with at least two distinct peptides sequences and a minimum spectra of 2 per
protein.
Protein intensity values from each global proteomics dataset were calculated by summing
together the MS1-level intensities of peptide precursors that were derived from IDPicker using
IDPQuantify.295 Extracted ion chromatograms (XICs) were identified using ± 30 s lower and upper
retention time tolerance and ± 10 ppm lower and upper chromatogram tolerance. Protein
abundance values were normalized by dividing the protein intensity values by their length (i.e.,
number of amino acids), performing a log2 transformation, and mean central tendency adjusted
with the software platform Inferno RDN (https://omics.pnl.gov/software/infernordn).
Using the Perseus software,262 we removed proteins in pure cultures of Dhc strains 195,
FL2 and BAV1 that were stochastically sampled by requiring quantified proteins to be observed
in both biological replicates per strain. For the BDI consortium and groundwater sample sets (n=
2 and 3 technical replicates, respectively) proteins observed in at least one run were considered
for comparison to targeted results as their sporadic identification by global proteomics may have
been due to their low biological abundances and thus we could have a probability of observing
them employing LC-MRM-MS. Missing values were then imputed with random numbers from a
simulated Gaussian distribution of low abundant proteins (down-shift value of 2.5 and width of
0.3). All proteins identified by LC-MS/MS were clustered at > 85% amino acid sequence identity
with the UClust algorithm of the analysis tool USearch v10.0. 296 Venn diagrams were generated
with the web application jvenn (http://jvenn.toulouse.inra.fr/app/index.html).

3.2.5 RDase phylogenetic tree construction.
To provide insight into the diversity of the RDases sequences present in the proteomes of
Dhc strains 195, FL2, and BAV1, their phylogenetic relationships were evaluated with the software
MEGA 7.297 A total of 52 RDases and two outgroup RDase sequences from Desulfitobacterium
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hafniense strain Y51 (Q8L172) and Dehalobacter restrictus DSM 9455 (AHF10441) were aligned
with the MUSCLE algorithm.298 All columns in the alignment of the protein sequences containing
gaps and missing data were eliminated, leaving a total of 56 amino acid positions in the final
dataset. A phylogenetic tree using the Maximum Likelihood algorithm based on the JTT matrix based model was then constructed.297,

299

Initial trees for the heuristic search were obtained

automatically by applying Neighbor-Join and BioNJ algorithms to a matrix of pairwise distance
estimates using a JTT model, and then selecting the topology with superior log likelihood value.
Estimation of the relative confidence scores in phylogenetic groups were determined by using
1000 bootstrap replications of the data set.300 The tree was rooted with the outgroup RDase
sequences from Desulfitobacterium hafniense strain Y51 and Dehalobacter restrictus DSM 9455.

3.2.6 LC-MRM-MS method development.
Initial lists of peptides (7-18 amino acids, without Methionine residues) and their transitions
(+2 charged precursors, singly charged y3 to terminal y-fragment series) from the targeted
proteins identified in data-dependent global proteomics analyses of axenic cultures of strains 195,
FL2 and BAV1, were evaluated by analyzing 500 ng, 2 µg and 8 µg of total tryptic digests via LCMRM-MS.
For each measurement, peptides were loaded onto capillary back-columns (150 µm x 120
mm) packed with ~ 50 mm Kinetex 5 µm C18 resin and chromatographically separated on inhouse pulled nanospray emitters (100 µm x 170 mm) packed with ~ 160 mm of Kinetex 5 µm C18
resin. Chromatographic separation consisted of a linear gradient of solvent B (70% acetonitrile,
0.1% formic acid) at 300 nL/min from 2 to 60% within 90 minutes. After each sample run, wash/reequilibration runs were queued. The TSQ instrument was operated with a dwell time of 20 ms,
scan width set at 0.002 m/z, and Q1/Q3 at 0.70 full width at half maximum (FWHM). Spray voltage
and capillary temperature settings in the ion source were set at 1.75 kV and 270°C. Collision
energies for each peptide were calculated using the default linear equation specific to a Thermo
Scientific TSQ Ultra instrument provided in the Skyline environment. Raw LC-MRM-MS spectral
data collected were imported into the software package Skyline v3.7 (http://skyline.
maccosslab.org)

260, 301

and the signals were manually analyzed to determine the quality of the

peptide signals in an extracted ion chromatogram (XIC).
In addition, peptide sequence specificities were also assessed in-silico with the Tryptic
Peptide Analysis tool of Unipept 3.2 and Protein BLAST searches. Briefly, The Peptidome
Clustering tool of the web application Unipept 3.2302 was used to compare the percentages of
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pairwise similarity between the in-silico generated peptidomes of six Dhc strain proteomes
databases (i.e., Dhc strains 195, FL2, VS, GT, BAV1, and CBDB1) against the peptidomes of
representative bacterial isolates that have been obtained from groundwater, aquifer, sediment, or
soil (see SI for additional information). Peptidome similarity percentages were calculated based
on the minimum similarity method and then clustered by the UPGMA algorithm. To assess if other
protein records stored either at UniProt or NCBI could produce the selected peptides before
monitoring in groundwater, in-silico specificities were evaluated using the Tryptic Peptide Analysis
tool of UniPept 3.2 (equating isoleucine and leucine residues) and Protein BLAST searches
against non-redundant protein sequences (replacing the N-terminus of each peptide with either K
or R residues, respectively). Peptides were deemed as Dhc-specific if they were not found in the
proteins of any other bacterial species by means of both in-silico searches.

3.2.7 Analyses of the commercial bioaugmentation culture BDI and groundwater
samples by LC-MRM-MS.
Peptide and transitions signals selected before were monitored in technical triplicate runs
of consortium BDI and groundwater samples using the same LC-MRM-MS setup as for pure
cultures. Amounts of tryptic digests analyzed were 4 µg of BDI sample; 10 µg of M17, M18, 97
and 129 groundwater samples; and 20 µg of groundwater samples 33NA4 and 116. To validate
peptide identifications in complex samples, we required the following criteria: (A) Co-elution of all
selected transitions per peptide; (B) average dot-product (dotp) correlation scores > 0.80 for
transition intensity ratios between the signals detected in groundwater to those observed in the
respective pure culture; and (C) peptide signal reproducibility in all technical runs. (D) For a subset
of the target proteins (n=6), we required strong agreement between the average transition ratios
(dotp > 0.80) and retention times (≤ 3 mins differences) of the endogenous peptides with spikedin synthetic unlabeled peptide standards.
For the six target proteins, a collective set of 11 synthetic unlabeled peptide standards
were purchased as purified lyophilized solids (>95%, Thermo Scientific, Waltham, MA) and
reconstituted to standard solutions in solvent A (peptides marked with Δ in Supplementary Table
S3). A total of 5 pmol of each peptide standard were spiked to 4 µg of BDI sample; 10 µg of M17,
M18, 97 and 129 groundwater samples; and 20 µg of groundwater samples 33NA4 and 116. For
additional validation, high-mass-accuracy / high-resolution global proteomics data filtered at a
peptide false discovery rate (FDR) level < 1% were used to verify the presence of the target
peptides and proteins in the groundwater samples.
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3.3 Results & Discussions.
3.3.1 Global proteomics exploration of axenic Dhc cultures enables selection of
candidate peptides for targeted proteomics.
The global proteomics datasets (Supplementary Table S1) collected from measurements
of pure cultures of Dhc strains 195, FL2, and BAV1 provided a set of candidate peptide sequences
from housekeeping and reductive dechlorination biomarker proteins (Table 3.1) that were the
starting point for the targeted method development (Figure 3.1).33, 103, 288
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Table 3.1 Dhc protein biomarkers used as initial targets in this study.
Targeted
biomarker
[Designation]

Biomarker
description

Strain
195 a

Strain
FL2 b

Strain
BAV1 a

60 kDa chaperonin
[GroEL]

Housekeeping
protein. Inf orms
presence of Dhc.

Q3Z6L3

demc_1274

ABQ17815

Formate
dehydrogenase,
alpha subunit
[FdhA] c

General marker of
active dechlorination
processes.

Q3ZA14

demc_808

ABQ16756

Trichloroethene
reductive
dehalogenase
[TceA]

Process specif ic
marker of active
dechlorination
(TCE→VC)

Q3ZAB8

demc_738

✖d

Vinyl chloride
reductive
dehalogenase
[BvcA]

Process specif ic
marker of active
dechlorination
(DCEs, VC →
Ethene)
Housekeeping
protein.
General
activity/presence of
Dhc.
Housekeeping
protein.
General
activity/presence of
Dhc.
Structural protein.
Presence of Dhc.

✖

✖

ABQ17429

Q3Z7S9

demc_108

ABQ17463

Q3Z7T6

demc_114

ABQ17470

Q3Z6N3

demc_1296

ABQ17793

Elongation f actor Tu
[EF-TU]

Ribosomal protein
L7/L12 [rpL7/L12]

BNR/Asp-box repeat
domain protein
[S-layer]
a Protein

database f rom Dhc strains 195 and BAV1 were downloaded f rom Uniprot (IDs. UP000008289
and UP000002607, respectively). b The IGS Annotation Engine was used f or structural and f unctional
annotation of the Dhc strain FL2 sequences (http://ae.igs.umaryland.edu/cgi/index.cgi, Ref erence:
PMID:21677861) and the web-based tool Manatee was used to view and download protein annotatio ns
(http://manatee.sourcef orge.net/).c Dhc bacteria are unable to grow using f ormate. Cells extracts lack
any f ormate dehydrogenase ability. Recent work has assigned the FDH protein and its subunits an
electron transf er role to the RDases during reductive dechlorination reactions. See Kublik et al., (2016)
f or more details. d ✖ - protein is not present in the respective proteome.
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Figure 3.1 Workflow for the selection of peptide signals in pure cultures of Dhc strains 195, FL2
and BAV1. Each peptide peak group was submitted to a series of validation and refinement steps to
identify peptide candidates having consistent fragmentation patterns, linearity in AUCs and ability to
be generated upon tryptic digestion in groundwater monitoring. ** Only available for 11 targeted
peptides.

Global proteomics analyses resulted in proteome coverages of 59%, 57%, and 60% for
Dhc strains 195, FL2, and BAV1, respectively. These percentages are close to the ~60% that has
been obtained before in shotgun proteomics studies of Dhc strains 195, CBDB1, and DCMB4.103,
303-305

Overall, the analytical dynamic range of the proteome measurements spanned ~5 orders

of magnitude. All the targeted housekeeping and structural proteins (i.e., chaperonin GroEL, Slayer associated protein) and those indicative of active dechlorination (i.e., FdhA, TceA, and
BvcA) ranked amongst the top 50% most abundant proteins (Figure 3.2A). Each biomarker was
also found with similar normalized intensities within each strain dataset (Supplementary Figure
S1). The resulting percentages of sequence coverages and the number of peptide spectrum
matches per target protein demonstrated comparable efficiencies of tryptic digestion achieved
between the Dhc strains included in the analysis (Figures 3.2B & 3.2C).
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Figure 3.2 Global proteomics metrics from the analyses of three pure cultures of Dhc. Relative
percentage of contribution to the total intensity of the proteins identified with a peptide -level confidence
> 99% in the global proteomic analysis of axenic cultures of Dehalococcoides mccartyi strains 195,
FL2 and BAV1. Targeted proteins ranked amongst the numbers of proteins contributing to half of the
total measured intensities (below the dashed line, numbers next to strain names). (B) Targeted protein
sequence coverages obtained from the cultures processed in this study. (C) Total number of peptide
spectrum matches (PSMs) for each targeted protein. RDases per strain are homologues of TceA in
strain 195 and FL2, and BvcA in strain BAV1. The numbers in the bar chart (rep resented by light
colors) are the fraction of +2 peptide charged precursors meeting the selection criteria for LC -MRMMS analysis described in Materials & Methods.

The expression of FdhA proteins observed in cultures of strains 195, FL2, and BAV1 is in
agreement with studies that have reported high abundance values of these proteins compared to
RDases and hydrogenases in Dhc pure and Dhc-containing mixed cultures that are actively
dechlorinating.104,

105, 306-308

In addition, measured mRNA levels of the Fdh subunits have been

reported to be dependent on the presence of a chlorinated electron acceptor but not on the
presence of hydrogen.309 Recent studies of the Fdh complex of Dhc strain CBDB1 (iron-sulfur
molybdoenzyme complex I (CISM)) revealed a tight spatial association between FdhA and the
RDase CbrA (ID. CbdbA194).310 Supported by in-vitro dehalogenation activity assays, these
observations suggest that FdhA serves an integral role in the respiratory chain of Dhc (i.e., FdhA
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serves as an electron-channeling module between the Hup hydrogenase and the RDase),311 and
as such, can serve as a general biomarker of Dhc dechlorination activity.
RDases enzymes are biomarkers of active dechlorination processes and can provide
additional information regarding specific chlorinated compounds that undergo reductive
dechlorination. The types of chlorinated compounds used by RDases makes the Dhc group
functionally diverse.306, 312-314 The TceA RDase in the proteomes of strains 195 and FL2 and the
BvcA RDase in the proteome of strain BAV1 were observed amongst the top five most abundant
proteins in each dataset, respectively.
Sequence identities of the protein biomarkers selected in each strain were also evaluated.
In total, 617 protein groups (> 85% amino acid sequence identity) were common between the
three Dhc strains analyzed (Figure 3.3). These protein groups encompass homologues of the
targeted GroEL, EF-TU, rpL7/L12, and FdhA proteins. Interestingly, the putative S-layer sequence
of strain BAV1 and the annotated S-layer proteins of strains 195 and FL2 did not group together.
The TceA homologues of strains 195 and FL2 clustered at 99% identity, while RDase BvcA was
found amongst the 61 unique protein groups of strain BAV1. These observations highlight that
candidate peptide sequences from protein biomarkers can target multiple Dhc strains or can be
potentially used as strain-specific targets when monitoring mixed cultures or environmental
samples.

Figure 3.3 Number of protein groups (> 85% sequence identity) identified in each culture.
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In addition to the TceA homologues and BvcA, 18 other RDases were identified in these
shotgun proteomics measurements, albeit, at lower abundances (Supplementary Figures S2AC). The protein sequence coverages of the other identified RDases were on average below 60%,
except for two other RDases (demc_816 in strain FL2 and Q3Z6A6 in strain 195). The
identification of multiple RDases in actively dechlorinating Dhc cultures is related to the various
sets of RDase genes present in single Dhc genomes (i.e., 17 rdhA genes in strain 195, 24 rdhA
genes in strain FL2, and 11 rdhA genes in strain BAV1308). The co-expression of RDases by single
Dhc strains has been reported before and has been hypothesized as a mechanism of adaptation
to use naturally occurring and anthropogenic organohalogens. 290,

315

To provide insight into the diversity of the expressed RDases and better validate the
biomarker selection, we evaluated the phylogenetic relationships between the RDases present in
the proteomes of Dhc strains 195, FL2, and BAV1. The selected TceA homologues from strains
195 and FL2 formed a subcluster, while the targeted BvcA did not group with any of the remaining
RDases, nor did any of the second most abundant RDases in each dataset cluster with any of the
targeted enzymes (Supplementary Figure S2). These results demonstrate the sequence
conservation of TceA and BvcA as compared to other RDases expressed by other or the same
Dhc strains. Moreover, the substrate ranges of TceA homologues and BvcA are known, while the
participation of other RDases in reductive dechlorination reactions remains to be proven
experimentally.308 The higher expression and sequence coverages obtained for the TceA and
BvcA RDases (Supplementary Figures S2A-S2C) resulted on average in four times higher
numbers of tryptic peptides than those obtained for other expressed RDases, which was helpful
for the development of the targeted assay.

3.3.2 Selection of Dhc MRM-MS observable peptides and in-silico evaluation of
their biological specificities.
Evaluation by LC-MRM-MS was conducted on 79, 81, and 66 peptides from the targeted
proteins previously identified in the global proteomics datasets of cultures of Dhc strains 195, FL2,
and BAV1, respectively. By examining three different loading amounts of total digested protein
(i.e., 500 ng, 2 µg, and 8 µg) and manually analyzing the data to determine the quality of the
resulting peptide signals, 29 peptides and 142 transitions from the digest of strain 195, 22 peptides
and 107 transitions from strain FL2, and 17 peptides and 83 transitions from strain BAV1, were
selected. Examples of the type of signals chosen and discarded from these steps are shown in
Supplementary Figures S3 and S4. From this initial selection, the top five transitions ranked by
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contribution to total area under the curve (AUC) per peptide were preserved, resulting in a total
of 55 peptides (unique and shared between strains) equivalent to 270 transitions.
Essential for targeted proteomics experiments is to ensure that the selected peptides
uniquely identify the proteins of interest.228 The coexistence of multiple Dhc strains with other
bacterial species in groundwater

276, 289, 290, 316

creates a challenge for the selection of unique

peptides. A preliminary in-silico comparison between several Dhc proteomes, as well as the
proteomes of other organohalide-respiring bacteria commonly found in groundwater aquifers or
sediments, demonstrated that Dhc strains shared greater similarities (≥ 47%) amongst their
peptidomes compared with those of other bacterial species (≤ 4% similarity between the
proteomes of Dhc strains 195 and VS with Dehalogenimonas lykantroporepellens strain BL-DC9) (Supplementary Figure S5). Although this analysis supported the development of a Dhc
species-level targeted proteomic assay and its application to contaminated groundwater, the
sequence specificities of each remaining peptide candidate selected were further assessed
individually with the Tryptic Peptide Analysis tool of Unipept 3.2 and Protein BLAST searches.
Peptides were deemed as Dhc specific when they were not found in any other bacterial protein
sequence available in UniProt and NCBI nr databases, and when several strains shared the
candidate peptide sequence by means of both-silico searches; as semi-specific, when they were
found in proteins derived from related organohalide-respiring bacteria; and as non-specific, when
they were found in proteins of non-organohalide respiring bacteria. Compiled results from these
in-silico searches are presented in Supplementary Table S2.
Out of the seven peptides selected for monitoring the presence of the housekeeping
chaperonin GroEL, peptide DGVITIEESR was the only one non-specific to Dhc, which was
surprising considering that homologues of this protein are found in diverse bacterial classes.317
From the targeted EF-TU proteins, peptide TTLTAAITR was found in more than 100 UniProt
protein entries, and similar observations were made for peptide ELTSLGLK from the ribosomal
protein L7/L12. The presence of peptides DGVITIEESR, TTLTAAITR, and ELTSLGLK in the
proteomes of non-organohalide respiring bacteria prompted us to remove them from the list of
selected peptides, which resulted in the loss of the rpL7/L12 marker protein from the assay.
Candidate peptides from the annotated FdhA (general biomarker of Dhc activity) and Slayer (structural housekeeping) proteins were specific to Dhc and in certain cases provided strain
level resolution. For example, the in-silico analysis demonstrated that the FdhA peptides
GTELISVDCR and SELEVISSLFSR were specific to Dhc strain 195, while peptide
TDNNTNYSYINAIK was specific to the FdhA in Dhc strain BAV1. All peptides of the S-layer
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protein were specific to five or less Dhc strain proteomes stored in UniProt, a useful characteristic
for environmental monitoring of certain Dhc strains.
The expression of RDases from bacteria other than Dhc can complicate their exclusive
use as specific biomarkers of Dhc-mediated reductive dechlorination in groundwater. 287 For
example, the in-silico searches of the six peptides selected in total for TceA and BvcA RDases
revealed that these are also found in RDase sequences of other organohalide-respiring bacteria
like Dehalogenimonas. Thus, the information that the shared RDase peptides selected here could
provide in contaminated groundwater needs to be interpreted in concert with information from
other biomarker proteins, such as FdhA, to have a more direct line of evidence that Dhc -specific
biologically driven dechlorination is happening at a site.
Additionally, the identification of shared RDase peptides in an MRM assay, combined with
other experimental measurements like Dhc 16S rRNA gene-targeted qPCR, can provide insights
into the identity of the bacterial species carrying out dechlorination processes. Altogether, these
observations suggested that a panel of protein biomarkers should be utilized for the most detailed
characterization of Dhc mediated dechlorination processes in groundwater. Supplementary
Table S3 shows the complete list of peptides and their transition m/z values per protein used for
LC-MRM-MS analysis of groundwater.

3.3.3 Application of the selected biomarkers for targeted proteomics analyses in
the PCE-to-ethene dechlorinating consortium BDI.
Peptides and transitions selected in axenic Dhc cultures were initially tested in a tryptic
digest of the nonmethanogenic PCE-to-ethene dechlorinating BDI consortium. BDI harbors
multiple Dhc microorganisms, including strains BAV1, FL2, and GT.277, 318 The known microbial
diversity of BDI allowed an easier validation of peptide identification with criteria that included,
amongst others, the comparison of dot-product (dotp) correlation scores for transition intensity
ratios between the signals detected in samples to those observed in pure cultures or to samples
spiked with 5 pmol of internal standards (Supplementary Table S4).
Through LC-MRM-MS analyses, 13 peptides were identified out of the 37 that were
targeted. Among these, GroEL peptides with high representation in the proteomes of multiple
strains of Dhc were observed (Figure 3.4). However, we also detected the presence of the more
conserved GroEL peptide LEGDEATGVSIVR, which according to the UniPept searches, is only
present in the proteomes of Dhc strains 195, KBTCE2, CG4 and KBTCE3 (Supplementary Table
S2). Interestingly, in relation to the identification of peptide LEGDEATGVSIVR, we also detected
the EF-TU peptide NSFPGDEIPIVR, which is specific to the proteomes of the same Dhc strains
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as peptide LEGDEATGVSIVR, thus suggesting that these microorganisms are part of the Dhc
population in BDI.
Active dechlorination activity was inferred through the presence of four FdhA peptides and
one of the targeted TceA peptides. As with the previous cases of the GroEL peptide
LEGDEATGVSIVR

and

the

EF-TU

peptide

NSFPGDEIPIVR,

the

FdhA

peptide

GSAGEYPVICTTVR found in the proteomes of strains 195, KBTCE2, CG4 and KBTCE3 also
suggested the involvement of these strains in dechlorination processes. In fact, the additional
detection of the TceA peptide YFGASSVGAIK, which acts as a marker of specific functional
information (i.e., TCE→VC, ethene transformations), and is also found in the proteome of Dhc
strain 195, narrowed down the possibility that this strain was present in culture BDI.
Hence, to inquire in the evidence provided by targeted proteomics about the presence of
additional but not yet recognized Dhc strains in consortium BDI, we decided to explore the
microbial diversity of this culture by means of high-mass-accuracy /high- mass-resolution global
proteomics analyses. By assembling a proteome database of other known strains of Dhc, the BDI
spectral data indeed shown that organisms representing Dhc strain 195 were present this culture,
as we were able to detect unique peptides matching proteins specific to certain strains (i.e., to the
S-layer protein of Dhc strain 195). The complete list of protein identifications in BDI is presented
in Supplementary Table S8.

Figure 3.4 LC-MRM-MS Dhc biomarker identification in a tryptic digest of the PCE-to-ethene
dechlorinating consortium BDI. The Fig. shows the average raw peak area under the curve (AUC)
values of the targeted peptides identified in three technical replicate LC-MRM-MS runs. Error bars are
the standard error of the mean. Peptides marked with Δ were identified with supporting evidence from
spiked-in unlabeled standards. The inserts below the graph show the specificities of the peptides,
determined in-silico, to the proteomes of the six most common isolates of Dhc bacteria.
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Global proteomics analyses also revealed the absence of the BvcA enzyme in BDI, which
agreed with the targeted results. This information was also corroborated with prior qPCR
experiments showing that Dhc strain BAV1 carrying the bvcA gene was lost from consortium BDI
after transfer with PCE.276 The lack of Dhc bacteria expressing BvcA in BDI seems to be
compensated, however, with bacteria expressing VcrA (i.e., strains GT and VS). VcrA was not
targeted in the MRM assay due to the lack of pure cultures of strains GT and VS, but expression
levels of this enzyme were confirmed by global proteomics in consortium BDI, where it may play
a role in the dechlorination of cis-DCE to ethene. The involvement of microorganisms expressing
VcrA, was also supported by the targeted detection of FdhA peptides matching to the proteomes
of Dhc strains VS and GT.

3.3.4 Application of the selected biomarker panel for targeted proteomics
analyses of chloroethene contaminated groundwater.
Seven groundwater samples collected from various international sites impacted with
chlorinated ethenes were analyzed by targeted proteomics. Amongst the identified contaminants
were TCE, cis-DCE and VC. These compounds are substrates and intermediates of the anaerobic
reductive dechlorination reactions carried out by Dhc bacteria that ultimately yield ethene as the
end product. Ethene was detected in these samples at various concentrations. The detection and
concentrations of these chemicals provide some level of information about the degree of
dechlorination in each sample and are tabulated for each groundwater sample in Supplementary
Table S6).
qPCR measurements performed on groundwater samples M17, M18, 97, 116, and 29
(33NA4 samples for DNA extraction were not available) showed average total bacterial 16S rRNA
gene copies/mL values ranging from 2.6x107 ± 1.4x106 in sample 116 to 9.8x105 copies/mL ±
4.9x105 in sample M18 (Figure 3.5). qPCR measurements of 16S rRNA genes of relevant
organohalide respirators (Dhc, Dehalobacter, and Dehalogenimonas) demonstrated the presence
of Dhc bacteria in all samples, with the highest abundance of Dhc 16S rRNA genes quantified in
sample M17. At the M17 sampling location, Dhc represented ~20% of the total bacterial 16S rRNA
genes (2.0x105 ± 1.7x103 copies/mL). According to empirical information from bioremediation site
regulators, they have found that values higher than 1 x105 copies/mL of organohalide respirators
such as Dhc are needed for observable dechlorination to occur. Thus, the qPCR data above
suggested that M17 has appropriate Dhc cellular abundance for dechlorination, whereas the other
samples has cellular abundances that appear to be below this minimum threshold.
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Figure 3.5 qPCR measurements of bacterial, Dhc, Dehalobacter and Dehalogenimonas 16S
rRNA gene copy numbers. Gene copy numbers of tceA and bvcA are also shown. Values are given
on a log scale and each bar represents one DNA extraction quantified in triplicate. DNA-based
analyses were not performed for sample 33NA4 due to limited availability. tceA genes were detected
but not quantifiable in samples M17 and M18.

As discussed previously, the identification of Dhc genes does not necessarily indicate that
Dhc is actively dechlorinating TCE or any other chlorinated ethene. Amongst the reasons for this
observation are the lack of correlation between dechlorination activity and the abundance of Dhc
16S rRNA genes and the variable translation rates of RDase transcripts observed in pure and
mixed cultures.286, 287 Additionally, in groundwater samples, Dhc microorganisms may be present
but not contributing significantly to dechlorination processes due to inhibitory mechanisms (i.e.,
the presence of perfluoroalkyl acids319) or competition with other organohalide-respiring bacteria
having more favorable chances of growth. Due to these factors, the identification of Dhc protein
biomarkers of dechlorination would provide more definitive information about whether Dhc active
involvement in the dechlorination processes in these samples.
Analysis of the groundwater samples included in this study by targeted proteomics,
identified Dhc biomarker proteins and peptides only in groundwater samples M17 and 33NA4
(Figure 3.6). A few of the other samples were viscous and consisted of black oily, sticky material
that complicated filtering in Sterivex cartridges and potentially limited DNA and protein extraction
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and subsequent measurement. This may be an issue in general sampling at some sites but was
beyond the scope of this manuscript.
GroEL proteins were observed in both M17 and 33NA4 samples and were identified by
peptides that are highly conserved across the proteomes of multiple Dhc strains, including those
of the six isolates (Figures 3.6A and 3.6B). Besides detection of GroEL in both M17 and 33NA4
samples, targeted peptides from the housekeeping EF-TU and structural S-layer biomarkers were
also detected in groundwater M17 (Figure 3.6B). For example, the EF-TU peptide
ILDTAEPGDAVGLLLR, which differs by a single threonine residue compared to the peptide
identified in consortium BDI, and is present in multiple Dhc strains, demonstrated the utility of
targeted proteomics to differentiate single amino acid changes in the sequences of the analytes.
The additional detection of the S-layer peptide AGIIDVPATADDATK in sample M17, which is
found in four Dhc proteomes, including those of strains GT and FL2, also suggested that specific
Dhc strains were present in this sample.
Evidence of dechlorination activity was obtained by the detection of two and three FdhA
peptides in samples M17 and 33NA4, respectively (Figures 3.6A and 3.6B). Common between
both samples was the detection of the FdhA peptides ALGIVYLDSQAR and SELEVISSLLSR,
which can be found in 25 and 19 Dhc proteomes, respectively, of the 31 Dhc proteomes available
in UniProt (as of July 2018). Peptide ALGIVYLDSQAR has been selected as MRM target for
absolute protein abundance quantification in published reports examining pure and mixed Dhc
cultures,33,
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which also points to its high conservation amongst Dhc strains and robust

characteristics for mass spectrometric analyses. In addition to the ALGIVYLDSQAR and
SELEVISSLLSR peptides, the detection of the FdhA peptide TDTNDYSYVNAIK in groundwater
sample 33NA4 suggested that organisms representing Dhc strains 195, KBTCE2, CG4 and
KBTCE3, were involved in active dechlorination.
Supporting the FdhA observations in samples M17 and 33NA4 and hence, the potential
of active dechlorination, we also identified a TceA peptide in sample 33NA4 and a BvcA peptide
in M17. For instance, the TceA peptide YFGASSVGAIK in sample 33NA4 (Figure 3.6B)
suggested the involvement of Dhc strains expressing the tceA RDase (e.g., strains 195 and FL2)
in the dechlorination reactions leading to the transformation of TCE to VC and ethene. Similarly,
the BvcA peptide STVAATPVFNSFFR in sample M17 (Figure 3.6A), pointed to active
transformation reactions of cis-DCE to ethene by strain BAV-type Dhc.
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Figure 3.6 LC-MRM-MS Dhc biomarker identification in a tryptic digest of groundwater samples
M17 and 33NA4. Average raw peak area under the curve (AUC) values of the targeted peptides
identified in LC-MRM-MS runs of tryptic digests from groundwater samples (A) M17 and (B) 33NA4,
respectively. Error bars are the standard error of the mean (n= 3 technical replicates). Peptides marked
with Δ were identified with supporting evidence from spiked-in unlabeled standards. The inserts below
each graph show the specificities of the peptides, determined in -silico, to the proteomes of the six
most common isolates of Dhc bacteria.

The data provided by LC-MRM-MS thus contrasted with the initial qPCR information, in
which Dhc 16S rRNA genes were detected in all groundwater samples, but peptides of the
targeted proteins were not identified in four of them (M18, 97, 116, or 129). This suggested that
either the targeted proteins were not expressed in these samples, the proteins were of too low
abundance to be detected by targeted proteomics, or the enzymatic digestion of the proteins in a
sample could have produced a different set of peptides to the ones targeted. To provide insight
into these issues, high-mass-accuracy and high-mass-resolution global proteomics data was also
collected. For this purpose, the proteomes of six Dhc isolates and other bacteria that have been
isolated from aquifers or sediment material contaminated with organic chlorinated compounds
were combined into a database for MS spectra search (Supplementary Table S7).
Global proteomics revealed that the samples having the highest numbers of Dhc protein
identifications were samples M17 (125 groups) and 33NA4 (38 groups), in which peptides from
Dhc biomarkers were also detected by LC-MRM-MS. Indeed, the Dhc dechlorination biomarkers
BvcA for sample M17, TceA for 33NA4, and FdhA for both, were also identified in the global
proteomics datasets (Supplementary Table S8). The detection of TceA in sample 33NA4 and
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the absence of Dhgm proteins by global analyses suggested that the YFGASSVGAIK peptide
detected before by targeted proteomics had a Dhc origin. We also observed that except for Slayer proteins that were identified by a different set of peptides to the ones targeted in samples
129 and 116, all the other Dhc biomarkers were not detected by means of global proteomics
analyses in samples 129, 116 and 97 (Supplementary Table S8) which largely agreed with the
targeted proteomics results. In groundwater M18, instead, Dhc GroEL, EF-TU and S-layer
proteins were identified but with a different set of peptides. The low numbers of Dhc protein groups
detected in samples M18, 129, 116 and 97, which included proteins that are not directly involved
in mediating dechlorination processes, in combination with the aforementioned Dhc 16S rRNA
gene data, suggested that Dhc cells were present but not actively dechlorinating in these samples
or expressing levels of proteins that fall below the detection limits of the proteomics approach.

3.4 Conclusions.
This work demonstrates that the identification of Dhc biomarker proteins in contaminated
groundwater through targeted proteomics is feasible. Although the approach presented here
requires further optimization to provide absolute protein abundance metrics (i.e., molar amounts),
the panel of proteins and peptides selected should be useful for further development of a robust
quantitative assay.
Successful implementation of targeted proteomics for Dhc containing groundwater, in
comparison to pure or mixed anaerobic bacterial cultures, requires knowledge of the specificity of
the peptides selected from Dhc biomarkers in a broader microbiological context. The in-silico
peptidome analyses conducted in this study suggested that a panel of Dhc specific and semispecific peptides (albeit, found in other bacteria with dechlorination capabilities) from proteins
relevant to dechlorination activities (FdhA and RDases), should be used in concert to provide a
more accurate identification of Dhc in samples.
Regarding this last point, environmental studies utilizing targeted proteomics to monitor the
presence and infer the activity of Dhc microorganisms in contaminated groundwater, need to
define the goal of their research – i.e., is it important to know the presence of active dechlorination
in general, or is it also necessary to resolve down to the species/strain level what microbe (i.e.,
Dhc strain) is most active? These are distinct questions – in many cases, the former question can
take precedence at sites impacted with specific chlorinated pollutants. Either way, the information
provided by targeted proteomics in combination with data contributed by other well-established
technologies like qPCR, can offer a more complete view of key microbes and their activ ities
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contributing to contaminant detoxification. Results from gene-centric qPCR and proteomics will
provide better guidance on bioremediation decisions, assist remediation project managers to
efficiently manage remediation, and provide regulators with a relevant line of evidence that
contaminant attenuation is occurring.
Contrary to regular targeted proteomics workflows, this project highlighted the use of semispecific peptides to target dechlorination biomarkers and how it was still possible to employ them
to obtain useful information regarding the presence of biomarkers in a sample. Of course, this is
also related to the question under investigation, but this feature made us wonder of the capability
of targeted proteomics methodologies to provide information on groups of functionally related
proteins, instead of individual analytes, by making use of shared peptides between them.
Provided that these groups of proteins can inform about certain biological processes that are
necessary for the stable functioning of a system, or that they can inform about some aspect of
the underlying biology within it, then, the first step would be to evaluate how feasible is to select
shared peptides amongst these proteins. This question was evaluated in the next chapter of this
dissertation.
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CHAPTER 4
In-silico assessment of the selection of a minimal set of unique peptides
for glycoside-hydrolases families for the development of a targeted
proteomics methodology: Demonstrations with a global non-system
specific and a system-specific approach

Authors: Villalobos Solis, M.I., Chirania, P. and Hettich, R.L.
Authors contributions: Manuel Ivan Villalobos Solis (M.I.V.S.) planned the study alongside
Payal Chirania (P.C.) and Robert L. Hettich (R.L.H.). P.C. developed all Phyton scripts to parse
and condense metadata. M.I.V.S. analyzed the data, consulted references, and reported findings.
R.L.H provided reviews to the study.

4.1 Introduction.
Lignocellulosic biomass that is the residual product from activities like agriculture, forestry,
food-processing, industry and wastewater treatment, consists of ~ 75% of polysaccharides that
can be used to produce biofuels (i.e., ethanol) and biogas (i.e., mixture of CO 2, methane and other
trace gases).320, 321 Lignocellulosic biomass does not compete directly with food or feed crops for
biofuel production and high biomass can be obtained with low inputs of energy, water, fertilizers,
and pesticides.320,

322

However, the extraction of the energetic content from lignocellulosic

biomass is a challenge. Lignocellulosic materials are made primarily of cellulose (35-50%),
hemicellulose (15-35%), the non-polysaccharide aromatic polymer lignin (10-35%), and to a
lesser extent of pectin, proteins, ash, salt and minerals. 323-325 These components create a highly
resistant and recalcitrant structure that is difficult to degrade chemically and enzymatically.
One approach to release the energetic content of lignocellulose consists in employing the
native metabolic capabilities of aerobic and anaerobic microorganisms like fungi and bacteria to
deconstruct lignocellulose into its fundamental components. Biological delignification and
depolymerization of polysaccharides found in lignocellulose have been gaining momentum over
the past decade due to advantages like mild reaction conditions, less energy demands, and less
waste generation compared to chemical pretreatment/enzymatic hydrolysis. 326-328
Particularly for the release of free sugars from polymers buried in lignocellulose, research
has focused on the different types of carbohydrate active enzymes (CAZymes) that aerobic and
anaerobic bacteria use to hydrolyze lignocellulose biomass. 329 From the CAZymes, the group that
are primarily involved in the breakdown of polysaccharides found in lignocellulose are bacterial
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free or cell-associated glycoside hydrolases (GHs).330 GHs are enzymes that hydrolyze the
glycosidic linkage between two carbohydrates or between a carbohydrate and a noncarbohydrate group.331,

332

The enzymatic activities of bacterial GHs in lignocellulosic

environments are broadly classified in:331, 333, 334 (a) endoglucanases, that hydrolyze the internal
glycosidic bonds along a cellulose chain; (b) exoglucanases, that act first on reducing and
nonreducing ends of a cellulose chain and then hydrolyze the rest of the substrate in a processive
manner; and (c) β-glucosidase, that hydrolyze only terminal, non-reducing glucose units from
soluble cellodextrin and cellobiose.
The ability of bacterial communities to degrade cellulose/hemicellulose through the
expression of GHs and other CAZymes has been employed in biochemical transformation
technologies for bioenergy production. One of such technologies is the production of biogas from
lignocellulose containing wastes (i.e., woody biomass and municipal solid waste) in anaerobic
digesters (ADs). In these types of bioreactors, the metabolic capacity of hydrolytic bacteria is
synergistically combined with the activity from other “satellite” acidogenic, acetogenic, and
methanogenic microbes.335-338 Hydrolytic bacteria in these consortia use CAZymes to
depolymerize polysaccharides into simple sugars that fermentative bacteria use to transform to
organic acids. The acidogenic bacteria then convert these acids into H 2, CO2, and acetate, which
in turn methanogenic archaea transform to methane and CO 2. 339, 340 In return for the provision of
substrate, satellite microbes may provide essential nutrients and vitamins that the cellulolytic
degrading bacteria can use, or they could provide protective agents against the inhibitory effects
of certain products released during the metabolic cross-talk.329, 337
The success of ADs to use complex polysaccharides as source for biogas depends on the
activity of cellulose-hydrolyzing bacteria.341 Therefore, it has been recommended that anaerobic
digesters start with an inoculum containing such type of bacteria.336 However, even with a starting
bacterial community, physical, chemical and biological variables can impact the hydrolytic
performance of a bioreactor.340 For example, when highly lignified or high crystalline cellulose
substrates are used as feedstock in an AD, hydrolysis can underperform. 339 Microbial composition
in ADs is also known to be impacted by operational parameters like pH, temperature and the
presence of other substances like ammonium nitrogen.342,

343

Therefore, it is important to

understand what type of cellulose-degrading microorganisms survive in bioreactor environments
and what is known about their metabolism.336
Communities of microbes living in ADs have been studied with the application of -omics
measurements. Metagenomics studies have provided insights in community structure and
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metabolic potential,339,

341-344

while metatranscriptomics and metaproteomics investigations have

linked genetic information to function.345-348 Metagenomics studies have described the
predominance of the bacterial Firmicutes, Bacteroidetes and Proteobacteria phyla in biogas
communities and have highlighted their high polysaccharide hydrolytic potentials. 347-3 4 9
Importantly, these studies have also demonstrated that the relative abundance of bacterial and
archaeal phyla depends on process conditions.350

Likewise, metatranscriptomics and

metaproteomics data have helped put into perspective the metabolic capacity of microbial
communities. Specially, metaproteomics has been useful in observing protein patterns in ADs
communities in response to environmental and operational parameters. For example, glycoside
hydrolases with multiple enzymatic functions like endoglucanases, beta-galactosidases, alpha-Lfucosidases, alpha-amylases, xylanases and others have been characterized and their
expression assigned to specific bacterial genera and even species.347-349, 351, 352
There is no doubt that our molecular understanding of metabolic potential and function
within ADs for biogas production has been greatly improved due to the combined application of
omics approaches; however, they are time-consuming and labor-intensive to perform and it is
difficult to envision them as routine methods to monitor the molecular-level performance of an AD.
Data derived from omics techniques could be employed to develop faster and more convenient
assays to inform of the molecular changes occurring in a bioreactor.
Indeed, metagenome information has been used to develop RT-qPCR biomarker assays
targeting the V6-V8 regions of the 16S rRNA gene of specific bacterial taxa that can inform about
the potential of these microorganisms to contribute to hydrolytic and acidogenesis processes in
ADs.353 In this sense, metaproteomics has also the potential to help identify sets of proteins and
their shifts in expression patterns that could be used to monitor the metabolic performance of ADs
microbial communities or that could be employed as predictive indicators of process failure.354, 355
For example, variations in the abundance levels of methyl-coenzyme M reductase, which is a key
enzyme in all methanogenic pathways and is highly expressed in biogas reactor systems, 347, 355,
356

has been proposed as a predictive biomarker of acidification conditions.357
Hydrolysis of polysaccharides is an essential metabolic step in the production of biogas.

Several metaproteomic studies have identified and quantified abundance levels of GHs relative
to changes in the operational parameters of anaerobic digesters. In this sense, groups of GHs
can act as biomarkers of the ability of a system to degrade polysaccharides. Thus, it is plausible
to think that monitoring only the presence of these enzymes and their abundance changes in
anaerobic digesters could provide of faster decision-making capabilities to adjust operational
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parameters concerning the disposition of a digester or the microbial communities thriving within it
to degrade polysaccharides. Therefore, instead of investigating the expression of every protein in
an anaerobic digester, unique peptides representing groups of GHs could be detected by targeted
proteomics techniques faster and with more sensitivity than by executing complete
metaproteomics experiments.
A key element to any targeted proteomics study is the selection of a set of peptides that
can uniquely identify proteins of interest in a biological background without being redundant to
others. GHs are an extensive group of proteins classified into more than 100 families based on
amino acid similarities and 3D structure.358-360 Because of the diversity of families and number of
proteins belonging to them, in this project we specifically elaborate on the challenges associated
in selecting unique peptides in-silico not for individual GH enzymes but for selected families of
GHs. This process was demonstrated using two approaches.
The non-system specific approach involved the use of a curated database from
http://www.cazy.org/ which is the largest repository that comprises genomic, structural and
biochemical information on GHs found in all kingdoms of life, as well as of others CAZymes
involved in the biosynthesis and modification of carbohydrates and glycoconjugates. 360 In
contrast, a system-specific approach used a published dataset of 1401 high-quality and mediumhigh quality metagenome-assembled genomes (MAGs) published by Campanaro et al., 2019 as
part of the biogas microbiome project (https://biogasmicrobiome.env.dtu.dk/).361 This dataset is
the most complete repository of genomes in anaerobic digestors up to date and provides with a
realistic community of microorganisms (and their proteomes) living in these environments.

4.2 Materials & Methods.

4.2.3 CAZyDB.07312019 from dbCAN2 meta site.
For the non-system approach of peptide selection, the database CAZyDB.07312019.fa
stored in the automated Carbohydrate-active enzyme ANnottation (dbCAN2) meta server
(http://bcb.unl.edu/dbCAN2/)362 was used. This is a pre-computed file with GenBank proteins
annotated as CAZymes by the CAZy database. CAZyDB.07312019.fa has a total of 1,365,566
non-duplicate protein sequences including glycoside transferases (GTs), glycoside hydrolases
(GHs), polysaccharide lyases (PLs), carbohydrate esterases (CEs), auxiliary activities (AAs) and

91

carbohydrate-binding modules (CBMs). The same protein can have more than one annotation
(i.e., Protein X can have a GH 5 domain and contain several CBM modules).

4.2.4 Unique tryptic peptides from GH proteins compared to backgrounds of other
CAZymes.
Protein

sequences

belonging

to

distinct

GH

families

were

removed

from

CAZyDB.07312019.fa. The remaining sequences were used to create independent CAZy protein
backgrounds for each family. Databases of proteins in a GH family were clustered at 100%
sequence identity with USearch v10.0.240296 (command cluster_fast). Target sequences and
backgrounds were then loaded to the software Skyline260 to select unique tryptic peptides (6-25
amino acids in length, without Met or Cys residues, and excluding the first 24 N-terminal amino
acids of each protein) against the backgrounds.

4.2.5 Generation of a minimum list of unique tryptic peptides for GH families.
Lists of unique peptides against backgrounds and the proteins they mapped to were ran
through an in house developed Python 3 script to select the minimum number of peptides between
proteins in a GH family considering each protein is captured only once. Figure 4.1A shows an
example of how the script works starting with a list of seven proteins each containing different
proportions of six peptides which can be shared or unique. The script first assembles groups of
peptides and proteins like those shown in Figure 4.1B and then orders them based on groups
capturing the greatest number of proteins. In this example, peptide 1, which is the most shared
peptide amongst all considered proteins, is found in a total of four proteins. This group of 4
proteins that have peptide 1 is then compared to protein groups captured by other peptides. Based
on this comparison, if a protein that has peptide 1 is found in a group with fewer number of
proteins, the protein is removed from it. In this case, proteins are removed from peptides 2 and 3,
while peptide 4 loses all its proteins and is removed from further analysis. This cycle repeats but
now with the second largest group of proteins sharing a peptide which in this case is peptide 5.
Following this example, the final minimum list of peptides will have peptide 1 capturing four
proteins (A, D, E, F), peptide 5 capturing two proteins (C, G) and either peptides 3 or 6 capturing
one protein (B) as shown in Figure 4.1C.
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Figure 4.1 Example showing the process to select the minimum number of unique tryptic
peptides and their associated number of protein seeds in different GH families. Descriptions of
(A), (B) and (C) are presented in the text above this figure.

This bioinformatic approach ensures that proteins in a GH family are selected based on
shared peptides that meet the selection criteria and after they are compared to peptides
generated from background proteins. Even though this will not be ideal to target specific proteins
sequences within a family (i.e., a GH3 protein versus another GH3 protein) it ensures that the
final peptide list is not overwhelmingly large and impractical for targeted proteomics applications.

4.2.6 Super kingdom taxonomy of groups of proteins having unique peptides
selected from the CAZy database.
Taxonomical information at the superkingdom level of the protein sequences captured by
the minimal lists of peptides obtained for different GH families in CAZyDB.07312019.fa was
investigated. For this purpose, GH protein accessions and the taxa they belong to were extracted
from the CAZy database (http://www.cazy.org/) using the cazy-parser tool.363 Scientific names of
organisms were then used to retrieve taxa ID and lineage information from NCBI using the R
package taxonomizr (https://cran.r-project.org/web/packages/taxonomizr/index.html).
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4.2.7 Re-processing of 1401 MAGs in dbCAN2.
Predicted genes and coding sequences (CDS) data from 1401 bacterial and archaeal
high-quality (HQ) [Completeness > 90%, Contamination < 5%] and medium-high quality (MHQ)
[90% > Completeness ≥70%; 5% < Contamination < 10%] MAGs reported in Campanaro et al.,
2019361 were kindly provided by the first author of the study. The biogas microbiome project was
a collaborative effort in which 134 published datasets (~0.9 Tbp sequence data) derived from a
wide range of different biogas reactor systems (full scale biogas plants and laboratory -scale
bioreactors) fed with complex carbohydrates, proteins and lipids, were re-analyzed by means of
comprehensive metagenome-centric analyses. The provided CDS were annotated using Prodigal
v2.6.2 ran in normal mode. According to the Campanaro et al., 2019 study these predicted
proteins were used to predict CAZymes with the Carbohydrate-active enzyme ANnottation
(dbCAN2) meta server (http://bcb.unl.edu/dbCAN2/).362 Since the protein fasta files from Prodigal
lacked annotation information, CAZy annotation was performed again in order to identify individual
CAZymes in each MAG for further in-silico analyses of unique peptides. The dbCAN2 searches
in this chapter were performed using the HMMER 364, DIAMOND365 and Hotpep366 tools. Proteins
annotated by ≥ 2 tools were only considered to define CAZymes. HMMER annotations took
priority over DIAMOND and Hotpep tools. In case where no HMMER annotation was obtained,
common annotations between DIAMOND and Hotpep were only considered, otherwise, they were
discarded.

4.2.8 Selection of unique tryptic peptides from GH families in the biogas
microbiome MAGS and generation of a minimum list of peptides.
Protein sequences from GH families with the highest representation across all MAGs were
removed from their original proteome files. The remaining protein sequences in each MAG were
used to create independent protein backgrounds for selection of unique peptides. The first 24 Nterminal amino acids from the targeted GH sequences were removed using an in house
developed script. Targets and backgrounds were then tryptic digested in-silico using the prot2pept
command

of

the

Unipept367

command

line

interface

(CLI)

(https://unipept.ugent.be/clidocs/prot2pept). Tryptic peptides of 6-25 amino acids in length, and
without Met or Cys residues were filtered from the resultant target peptidomes. Peptidomes from
targets and backgrounds were then compared and unique peptides mapping only to targeted GH
sequences selected. Lists of unique peptides against backgrounds and the proteins they mapped
to were ran through the in house developed Python3 script to select the minimum number of
peptides representing all proteins in a GH family.
94

4.3 Results & Discussion.

4.3.1 A minimum set of unique peptides distinguishing between GH families using
sequence information from CAZyDB.
Due to the availability of online resources, and because our goal was to target families of
GHs and not individual proteins, we tested an approach of in-silico peptide selection that retained
the least number of peptides while capturing all the sequences contained in a given GH family
after peptide selection and peptidome comparisons (see Materials & Methods section). In this
sense, a reduced list of unique peptide sequences could, in a broad scale, differentiate between
GH family groups (i.e., GH family 3 vs GH family 10) in a targeted proteomics setup.
For this purpose, a curated protein fasta file from the CAZy database was downloaded.
This fasta file included a total of 1,365,566 non-duplicated protein sequences including all
annotated GH proteins to date as well as other groups of CAZymes. From this file, we first decided
to focus on members of GH families with known and diverse enzymatic activities and mechanisms
acting on the hydrolysis of celluloses and hemicelluloses (Table 4.1). These GH families also
covered a wide distribution of organisms in all super kingdoms of life (archaea, bacteria,
eukaryotes, and viruses). In addition, the number of protein sequences per GH families available
in the database varied widely giving us a chance to better explore the minimum peptide set list
approach. Apart from these reasons, these types of CAZy families have been commonly observed
in different metaproteomics experiments that have analyzed diverse fungal and bac terial
communities directly extracted from the environment or grown in laboratory settings. 368-376
After comparison of the set of peptides derived from clustered protein sequences (seeds)
of each GH family database versus those derived from the sequences of the remaining CAZymes
minus the subset of proteins under analysis, we found that > 700 peptides per family are able to
capture most of the protein seeds, while at the same time maintaining specificity to each family
(Figure 4.2A). This suggests that while there is some degree of tryptic peptide redundancy within
proteins in GH families, several protein seeds can be identified by single unique peptides. In fact,
26%, 27%, 37%, and 76% of the unique peptides in the GH1, GH3, GH9, and GH51, families
were peptides matching to unique proteins (i.e., one peptide → one protein), respectively,
whereas every protein in the GH10 family was represented by a single peptide.
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Table 4.1 GH families selected for testing the in-silico development of a minimum list of unique
peptides able to differentiate between groups of enzymes using sequence information from
CAZyDB.
GH family

Enzymatic activities

1

β-glucosidase, β-galactosidase, 6-phospho-β-glucosidase and 6phospho-β-galactosidase, β-mannosidase, β-D-f ucosidase and
β-glucuronidase
Exo-acting β-D-glucosidases, α-L-arabinof uranosidases, β-Dxylopyranosidases, N-acetyl-β-D-glucosaminidases and Nacetyl-β-D-glucosaminide phosphorylases
Primarily endo-glucanases and a f ew endo-xyloglucanases,
mixed-linkage endo-glucanases and exo-beta-glucosaminidases
Most of the enzymes are endo-beta-1,4-xylanases A f ew
show endo-beta-1,3-xylanase activity.
Most of the enzymes are L-arabinof uranosidase but f ew
members are also classif ied as
β-1,4-endoglucanases

3

9
10
51
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# of protein
seeds in
CAZyDB
14367

16148

2548
3195
2418

Figure 4.2 Minimum number of unique tryptic peptides and their associated number of protein
seeds in different GH families. (A) Total number of unique peptides selected for each GH family
after comparison to other proteins in CAZyDB and the protein seeds in which they are found. (B) Top
10 tryptic peptides (from blue bars in A) ranked by the highest number of protein seeds coverage in
each family. (C) Percentages of total proteins in GH families covered by top 10, 50 and 100 peptides
ranked by protein coverage.

The maximum number of total proteins that a peptide was able to capture in each of the
targeted GH families varied between 1682 peptides for the GH1 family to 1 peptide for the GH10
family (Figure 4.2B). When categorizing peptides by % of proteins covered, we found that 100
peptides in the GH1, 3 and 9 families, covered more than 50% of all protein seeds, whereas for
GH51 and 10 families, the lack of shared peptides meant than more than 100 peptides were
necessary to cover at least 50% of the proteins in these groups (Figure 4.2C).
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Unique peptides did not map to any conserved regions in GHs. For example, when GH1
proteins were analyzed with the ScanProSite tool,377 two conserved regions identified were an Nterminal signature and an active site motif (Figure 4.3). The in-silico approach to generate
peptides in this study did not consider any of the first 24 N-terminal amino acids in proteins due
to the potential presence of cleavable N-terminal signal peptides, so it was not unexpected that
none of the selected peptides mapped to these regions. However, the unique peptides selected
did not map to active sites either. For the cases shown in Figure 4.3, the active site of several of
these proteins was represented by the sequence LFIVENGFG which was not part of any of the
unique peptides identified. We believe that the variability of the adjacent amino acids next to active
sites in GHs, as well as the number and type of potential amino acids that can be part of their
active sites, may explain the lack of tryptic peptides covering this region in our approach. Besides,
tryptic peptides that could be produced near active site regions of GHs did not meet adequate
properties for their selection after in-silico digestion of proteins (i.e., lengths > 25 amino acids) or
even if they were present, they did not capture as many proteins as other peptides.

Figure 4.3 Examples of GH1 protein sequences analyzed with ProSite Scan . The unique tryptic
peptide TSIAWTR (in blue lined box) was amongst the 922 minimum unique peptides that covered
1682 GH1 proteins but did not map to any of the conserved sites on these sequences.
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4.3.2 Unique tryptic peptides selected for group of GHs in CAZyDB can separate
groups of proteins based on their superkingdom origins.
CAZyDB contains protein sequences from different domains of life including bacteria,
archaea, eukaryotes, and viruses. As there may be more sequence similarity between proteins
belonging to the same superkingdom, we decided to look at the number of unique peptides
selected for each GH family in CAZyDB under a taxonomical perspective. Interestingly, peptides
identified in each family provided a broad level of taxonomical resolution regarding groups of
proteins belonging to organisms in the same superkingdom. For example, 9 of the top 10 peptides
ranked by protein coverage for GH1 family were specific to bacterial GH proteins while the
remaining peptide FSISWSR covered a higher percentage of GH sequences of eukaryotic origin
(Figure 4.4A). A similar case was observed with protein sequences belonging to the GH51 family.
In contrast, 9 out of the top 10 tryptic peptides in the GH9 family covered on their majority
eukaryotic GH proteins, while peptide NNPDYLPQYGFFNAK was only part of bacterial GH
proteins.
Based on these observations we then investigated the total amount of peptides necessary
to cover proteins according to their taxonomical origins. As observed in Figure 4.4B, a smaller
number of peptides in each of the targeted GH families can indeed provide a level of taxonomical
resolution compared to the original numbers selected when broadly categorizing families of GHs.
For example, if considering only bacterial GH9 proteins, the total amount of peptides needed to
cover all of them is reduced to approximately half of the original number. Although the number of
peptides is still high to cover bacterial proteins in certain families like in GH10, GH3, and GH51,
this observation demonstrates how one can adapt the use of unique peptides for GH families to
provide different levels of information in a biological system.
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Figure 4.4 Peptide classification by taxonomy using sequence information from CAZyDB. (A)
Stacked bars showing the classification of groups of proteins captured by peptides based on their
taxonomical origins at the superkingdom level. (B) Number of peptides from the ones selected to cover
proteins by superkingdoms. NA, lacks annotation at the superkingdom level.
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4.3.3 Narrowing down the number of unique peptides by constraining the proteome
space.
The results and observations presented from the determination of a minimum set of
peptides from sequences extracted directly from CAZyDB taught us that even though protein
sequences belonging to these same family of GHs do not share higher amounts of tryptic peptides
between them (>700 in each case), it was encouraging to assess, that at least for some families
like GH1, GH3 and GH9, 50% or more of the proteins selected in each family after peptide
evaluation and comparison to background proteomes could still be covered with 100 peptides,
which is a more manageable number of analytes. It was also interesting to uncover that tryptic
peptides can provide some taxonomical resolution compared to others within same families which
could be useful to target proteins of specific origins.
Large-scale targeted proteomics studies have used between 300-600 peptides to identify
and quantify proteins of interest in a sample.378,

379

Although some of the numbers presented

before fall within this range, to increase the chances of developing a more manageable minimal
list of unique peptides for groups of GH families, the proteome space for consideration could be
reduced. Besides, all the selected peptides derived from the CAZyDB analysis still need to be
evaluated for uniqueness when put into a biological context. In other words, these peptides need
to be compared against the peptidome of other organisms found in a sample of interest. Thus,
instead of determining which other proteins in databases could also yield the tryptic peptides
selected here, we turned our attention to defined and realistic microbial communities like the ones
found in anaerobic digesters used for biogas production. For this purpose, data available from the
biogas microbiome project was considered by applying all the bioinformatic analysis conducted
so far.361

4.3.4 Taxonomic diversity of the 1401 high-quality (HQ) and medium-high-quality
(MHQ) MAGs in the biogas microbiome.
Hydrolysis of polysaccharides is an important step in the anaerobic digestion food chain
happening in anerobic digesters (ADs) using different lignocellulosic feedstock like animal manure
and crop silage.336, 380 In the original paper by Campanero et al., 2019, the coding sequences of
1401 HQ and MHQ MAGs were predicted with Prodigal v2.6.2 and then CAZymes annotated
using the dbCAN2 software. Although more in-depth functional analyses of CAZymes present in
the MAGs were conducted in the Campanero et al., 2019 publication, such as enrichment of
functional CAZyme classes to hypothesize relevant participation of microbial phyla in the
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degradation of complex carbohydrates; here, we decided to focus on all these MAGs to evaluate
the feasibility of selecting unique peptides for GH families in a comprehensive background of
microorganisms representative of communities thriving within a biogas reactor environment.
In total, 96.1% of the MAGs provided were of bacterial origin and the remaining 3.9% were
of archaeal origin (Figure 4.5). These percentages are common in microbial communities in
biogas production. The highest number of HQ and MHQ bacterial MAGs belonged to the
Firmicutes phylum. Amongst the bacterial phyla, several had been associated with the
degradation of polysaccharides in ADs fed with lignocellulosic biomass including for example,
members in the Firmicutes, Bacteroidetes, Fibrobacter, Spirochaetes and Thermotoga336,

381

.

Other phyla are less known to be involved in the hydrolysis of polysaccharides, but the study by
Campanero et al., 2019 hypothesized, based on functional enrichment, that MAGs belonging to
Candidatus Hydrogenedentes, the Armatimonadetes, Lentisphaerae and Planctomycetes are
also potentially involved in this process. In fact, one metaproteomics study that characterized the
microbial community of an industrial biogas reactor fed with food waste as dominant feedstock
operating at thermophilic temperatures (60°C) and elevated levels of free ammonia found that
Planctomycetes were metabolically active in the hydrolysis of carbohydrates. 352
The biogas microbiome also consists of other populations of satellite microorganisms that
act in concert with hydrolytic bacteria to produce methane as the end product in a digester 337 .
Groups of bacteria in the anaerobic digestion of lignocellulose material are linked to each other
as the products produced from one group serve as substrates for another. Besides hydrolysis,
other metabolic mechanisms include acidogenesis, acetogenesis and methanogenesis 335,

340

.

MAGs from these other satellite microbes were also identified in Campanero et al., 2019. For
example, several MAGs belonged to methanogenic Archaea. The HQ and MHQ Archaeal MAGs
found in Campanaro et al., 2019 were classified in five phyla, including the broad group of
Euryarchaeota,

which

contained

genera

like

Methanobacterium,

Methanosarcina,

Methanoculleus and Methanocorpusculum, from which several species have been isolated
before.382 Apart from methanogenesis, substrates like acetate, carbon dioxide and hydrogen can
be used by groups of bacteria to produce alternative products, and several MAGs from these
study also possessed the genetic potential to fix carbon in pathways including the phosphate
acetyltransferase-acetate kinase pathway, the reductive acetyl-CoA pathway and the reductive
pentose phosphate cycle.
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Figure 4.5 Number of HQ & MHQ MAGs identified in the biogas microbiome project. MAGs were
assigned to different phyla classifications based on tiered taxonomical assignment strategy described
in the original paper by Campanaro et al., 2019. The inset shows the total percentages of MAGs per
superkingdom. N/A- MAGs not assigned at the phylum level.

4.3.5 Distribution of GHs and other CAZymes in the proteomes of the 1401 MAGs.
The number of proteins predicted in each MAG varied considerably (Figure 4.6). For
bacterial sequences, the Planctomycetes phylum had the largest median number of 4061 proteins
and contained the largest bacterial proteome with 9288 predicted proteins assigned to a MAG
from the Rhodopirellula genus. The smallest bacterial proteomes were from four MAGs in the
Parcubacteria phylum with a median of 574 proteins. In terms of archaea the singly identified
Candidatus Lokiarchaeota MAG had the highest number of proteins (5276) while the singly
Candidatus Woesearchaeota (DHVEG-6) MAG had the least number of proteins (715).
Due to the distinct metabolic specialization of different microbes during the anaerobic
digestion of lignocellulose material, the numbers of CAZymes found in their proteomes were
expected to be variable. In total, 62,627 CAZymes were annotated across 1399 MAGs.
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Figure 4.6 Distribution of the sizes of the predicted proteomes from the HQ & MHQ quality
MAGs from the biogas microbiome project. The provided CDS were annotated using Prodigal
v2.6.2

CAZyme annotation included all the different categories of enzymes described in the CAZy
database apart from others like cohesin and S-layer homology domains which are structural
components of bacterial cellulosomes.383 The boxplots presented in Figure 4.7 show the % of
CAZymes in the different proteomes grouped at the phylum level. The median percentage of
CAZymes found per phylum was below 4%, which is consistent with the general abundance range
of 1-3% of these enzymes from the total gene content of all living organisms and with the >3% of
the gene content of organisms with specialized functions like the breakdown of complex
carbohydrates found in lignocellulose.384-386 The bacterial phylum having MAGs with highest
median percentages of CAZymes in their proteomes was that of Bacteroidetes, while Caldiserica
had the lowest median percentages.
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Figure 4.7 CAZymes annotated in the proteomes of different phyla. Box plots (left) show the
percentage of CAZymes annotated in the proteomes of different bacterial and archaeal phyla using
dbCAN2. The number of annotated MAGs per phylum are shown in parenthesis. Pie charts (right)
show the relative fraction of different CAZyme classes, which include AAs (enzymes of the auxiliary
activities), CBMs (carbohydrate binding modules), CEs (carbohydrate esterases), GHs (glycoside
hydrolases), GTs (glycosyltransferases), and PLs (polysaccharide lyases). Some proteins were also
annotated with cohesin and S-layer homology domains, which are involved in cellulosomes structure
and formation. MAGs lacking annotations at the phylum level are not shown.

105

Not surprisingly, MAGs from bacterial phyla like Bacteroidetes, Fibrobacteres,
Verrumicrobia, and Planctomycetes which are known to degrade various complex carbohydrates
from plant/algae material rich environments, were amongst the top phyla having the highest
percentages of CAZymes in their proteomes. However, other less studied taxa, like MAGs
assigned to Candidatus Hydrogenedentes, Candidatus Marinimicrobia, and candidate division
BRC1 also ranked high. The pie charts in Figure 4.7 show that all these phyla have higher
fractions of carbohydrate degrading CAZymes like glycoside hydrolases (GHs), carbohydrate
esterases (CEs), and polysaccharide lyases (PLs). More than 50% of the identified CAZy mes in
these phyla were GH proteins, although this situation was similar in other 11 bacterial phyla
proteomes including Fusobacteria, Thermotogae, and Firmicutes.
CAZymes were also annotated in the proteomes of archaeal MAGs with median
percentages by phylum below 2%. A large fraction of the annotated CAZymes in archaeal phyla
were glycosyl transferases (GTs), which are involved in the transfer of sugar moieties to specific
acceptor molecules. Archaea members are known to contain several genes expressing GTs in
part due to their intricate protein N-glycosylation mechanisms. In fact, GT2 and GT4 families
predominate in Archaea387 and this was observed in members of the Euryarchaeota phyla, in
which the 47 MAGs proteomes annotated with CAZymes contained on average 10 more times
GT2 and GT4 proteins compared to the numbers of other GT families. Members from the archaea
are known to use a wider variety of sugar subunits for N-glycosylation compared to eukaryotes
and bacteria. It is hypothesized that N-glycosylation in archaea may contribute to their ability to
survive or adapt to harsh environments, and some research has implicated it in cell structural
support and protein assembly and function.388
The only distinctive case of CAZymes found in archaeal phyla was that of the single MAG
assigned to Candidatus Lokiarchaeota, where 94% of identified CAZymes were GHs and the
remaining ones were annotated as CBM and CE modules. However, metatranscriptome analyses
have revealed the expression of ORFs with similarity to glycoside hydrolases in members of the
Candidatus Lokiarchaeota group, and anaerobic utilization of carbohydrates has been described
as one of their metabolic capacities.389
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4.3.6 A unique set of peptides for GH families in in the biogas microbiome.
Proteins from GH families with the highest numbers of representatives across every MAG
in the biogas microbiome were submitted to the bioinformatics pipeline of before to find the
minimum set of unique tryptic peptides on each of them (Table 4.2). Of note, we just wanted to
show examples of the selection of unique peptides in a realistic biological system, but one would
ideally select families of GH proteins that could act as indicators of the stable hydrolytic functioning
of a bioreactor or that can tell something of the underlying biology within it.
As observed in Figure 4.8A the number of peptides per each of the five selected families
were still above 700 but in this case we did not observe equal number of proteins to peptides as
was the case with GH family 10 when using the CAZyDB data. This information demonstrates
that the number of shared tryptic peptides amongst groups of GHs is still not as high as expected
even within more related organisms living in a specialized environment. The maximum numbers
of proteins covered by a peptide were 68, 47, 51, 29 and 13 in GH families 13, 3, 2, 43, and 23,
respectively (Figure 4.8B). The top 10 peptides ranked by coverage of proteins in each GH family
were able to cover between 7%-10% of the total proteins considered for analyses (Figure 4.8C).
Different than in the previous case of using all the information related to CAZyDB, 200 peptides
in GH families 1,3,and 9 are able to cover ~ 50% of all proteins in each of them while more than
200 peptides are necessary to cover 50% or more of the total proteins in GH families with more
specialized polysaccharides degrading functions such as GH51 and GH10.
Redundancy of tryptic peptides amongst families of GHs expressed by microorganisms
found in specialized systems have not been studied before; however, due to the number of
peptides we obtained for each family, we suspected that there is enough sequence variability
between different groups of microorganisms that peptides could again provide some level of
information regarding the taxonomical origins of the proteins they are derived from. By
determining which peptides are specific to certain phyla, reduced number of peptides could in
theory be used to target GH families from specific microbes.
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Table 4.2 GH families selected from the biogas microbiome data for testing the in-silico
development of a minimum list of unique peptides able to differentiate between groups of
enzymes.

GH family

13

2

3

43

23

Enzymatic activities
Some enzymatic activities include: α-amylase, oligo-1,6glucosidase, α-glucosidase, pullulanase, cyclomaltodextrinase,
maltotetraose-f orming α-amylase, isoamylase, dextran glucosidase,
trehalose-6-phosphate hydrolase, among others acting on complex
polysaccharides
Most common activities include β-galactosidases, βglucuronidases, β-mannosidases, exo-β-glucosaminidases and, in
plants, a mannosylglycoprotein endo-β-mannosidase

# of protein
seeds across
every MAG
4024

2182

Exo-acting β-D-glucosidases, α-L-arabinof uranosidases, β-Dxylopyranosidases, N-acetyl-β-D-glucosaminidases and N-acetyl-βD-glucosaminide phosphorylases

2134

The major activities reported are α-L-arabinof uranosidases, endoα-L-arabinanases (or endo-processive arabinanases) and β-Dxylosidases

1465

GHs in this f amily are lytic transglycosylases of both bacterial and
bacteriophage origin, and f amily G lysozymes of eukaryotic origin.
Both of these enzymes are active on peptidoglycan, but only the
lysozymes are active on chitin and chitooligosaccharides.
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Figure 4.8 Minimum number of unique tryptic peptides and their associated number of protein
seeds in different GH families. (A) Total number of unique peptides selected for each GH family
after comparison to other proteins in CAZyDB and the protein seeds in which t hey are found. (B) Top
10 tryptic peptides (from blue bars in A) ranked by the highest number of protein seeds coverage in
each family. (C) Percentages of total proteins in GH families covered by top 10, 50 and 100 peptides
ranked by protein coverage.
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4.3.7 Unique tryptic peptides selected for group of GHs in the gas microbiome can
separate groups of proteins based on their taxonomical origins.
In biogas reactors and plants, the hydrolytic ability of anaerobic bacteria of transforming
polysaccharides into low molecular weight intermediates that can be used by other microbes
during the anaerobic digestion food chain is a key element to the success to these types of
systems.336 The biogas microbiome data provided phylum-level information of all MAGs that were
re-annotated using dbCAN2. Hence, we decided to use this data to categorize the peptides we
selected and the proteins they mapped to based on their phylum-level origins.
Figure 4.9A shows the top 10 peptides ranked by coverage of number of proteins that
were specific to individual phyla contributing to proteins in each GH family. As a first observation,
we noticed that Firmicutes and Bacteroidetes proteins in families GH13, GH3, GH2, and GH43
were amongst the ones with most representation captured by the top 10 peptides in each dataset.
In terms of peptides found only in proteins of one phylum, in family GH43, for example, peptides
ITQDGR, VYVYGSHDR, WYALLFGDR were identified only in proteins from MAGs assigned to
the Firmicutes while peptide YLFWGSFR was specific to Bacteroidetes proteins. In family GH23,
many more peptides covered proteins from single phyla like was the case of five peptides mapping
exclusively to proteins from Bacteroidetes, three peptides found only in proteins originated from
Proteobacteria, and one peptide that mapped only to Firmicutes proteins.
From the total number of peptides selected for each GH family, we also calculated how
many of them were necessary to cover all proteins related to phyla with high hydrolytic potential
in anaerobic environments (Figure 4.9B). As observed, between 195-854 peptides are necessary
to cover all Firmicutes proteins in each of the analyzed GH families while the numbers were less
for other phyla. These numbers consider shared proteins amongst phyla so it is expected that the
numbers could be less if one is indeed only looking to target proteins from a specific phylum and
not any other one. These findings are important from a microbiological point of view, as members
of the hydrolytic Firmicutes and Bacteroidetes phyla are the most commonly found in biogas
plants,336 so it may be possible to target GH proteins that are only derived from these phyla.
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Figure 4.9 Peptide classification by taxonomy using sequence information from the biogas
microbiome MAGs. (A) Stacked bars showing the classification of groups of proteins captured by
peptides based on their taxonomical origins at the superkingdom level. (B) Number of peptides from
the ones selected to cover proteins by superkingdoms. NA, lacks annotation at the superkingdom
level.
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4.3.8 Unique tryptic peptides selected for group of GHs in the gas microbiome
can separate groups of proteins based on their enzymatic specificity .
Several GH families are populated with enzymes having different substrate specificities. 390
Such substrate specificity is expressed in the enzymatic commission numbers (EC) given to an
enzyme.391 For example, enzymes in family GH3 are known to have dual or broad substrate
specificities with respect to monosaccharide residues, linkage position and chain length of the
substrate.392 Depending on the type of lignocellulose material fed to an anaerobic digester, sets
of GHs with more or less specialized enzymatic activities and substrate affinities may become
more important for the successful degradation of complex polysaccharides. This reason led us to
explore the idea if peptides from selected families of GHs could also provide resolution of groups
of proteins within the same family with different enzymatic activities. To check whether this was
true, we employed the Ghost Koala annotation pipeline393 to retrieve EC numbers for all the GHs
captured by different peptides in the biogas microbiome.
Interestingly, we observed that the unique peptides we selected grouped proteins within
GH families based on different EC numbers. In Figure 4.10, we can observe, for example, that
out of the 1055 peptides originally selected for family GH2, 443 peptides are only found in GH2
proteins with beta-galactosidase activity (EC 3.2.1.23) while 196 are specific to GH2 proteins that
have beta-mannosidase activity (EC.3.2.1.31). Even in the GH13 family, which is known to
contain ~30 different enzymatic specificities394, discrete groupings of peptides and proteins
according to EC numbers were observed. For example, to target GH13 proteins with Amylo-(1,4
to 1,6)transglucosidase (EC 2.4.1.18) activity, 247 peptides are necessary, while proteins that
were annotated as Cyclomaltodextrinases (EC 3.2.1.54), Glucan 1,4-alpha-maltohydrolases
(3.2.1.133) and Neopullulanases (3.2.1.135) can be differentiated from other GH13 proteins by
189 peptides.
This differentiation given by the peptides selected here could be useful to target specific
groups of GH proteins by substrate affinity in a bioreactor and opens the possibility of monitoring
enzymes, independent of their families, but grouped under several EC numbers.
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Figure 4.10 Functional classification of groups of proteins captured by numbers of unique
peptides. Functional annotation of proteins captured by unique peptides was done with Ghost Koala.
N/A= lacks annotation.
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4.4 Conclusions.
In this project we have explored the in-silico selection of a minimum set of unique peptides
targeting groups of proteins in GH families. Contrary to most common targeted proteomics
workflows, we decided to make use of shared peptides within proteins in families of GHs to
capture all proteins that passed our peptide selection criteria as well as comparisons to
background peptidomes. During our analyses we found that the amount of tryptic peptides specific
to GH families either using sequence information derived from CAZyDB or the biogas microbiome
project were relatively high (>700 in each case); however, these peptides can be adapted to
provide different degrees of taxonomical information or even EC number distinction for the case
of peptides identified from the biogas data. The high number of tryptic peptides identified for GH
proteins was also useful to determine that it may be possible to find unique peptides for individual
GH proteins even within the same family (i.e., a GH3 protein versus another GH3).
As we mentioned before, large-scale targeted proteomics studies have employed between
300-600 peptides to target different proteins, however, in less biologically complex systems when
compared to biogas reactors or plants.378,
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Thus, reducing the number of peptides to more

manageable amounts (<100), if possible, will be a future goal of this work. Other in-silico
strategies to try out with the purpose of reducing the number of shared peptides amongst proteins
can include the digestion of protein targets and background databases with enzymes other than
trypsin that could for example, exploit the sequence similarities of active site regions found in
several GH families. Of note, after the initial in-silico determination of a set of peptides, these
analytes need to be tested experimentally to select the ones that can provide adequate signals in
a mass spectrometer. This process further reduces the list of initial peptide candidates albeit at
the expense of losing some of the proteins of interest.
Targeted proteomics promises a way to identify and quantify proteins in anaerobic
digesters that can serve as indicators of the hydrolytic capacity of the system. As of now, several
other techniques that measure biodegradable organics present in the sludge fraction of a
bioreactor (i.e., oxygen content, C/N ratios measurement) are employed to evaluate the
performance of the anaerobic digestion process in faster ways, but these metrics lack molecularlevel resolution. In terms of protein abundance, the hydrolytic capacity of anaerobic digesters has
been assessed by isolating active enzymes from different sample fractions and conducting invitro substrate-degradation assays to characterize their enzymatic activity, but these do not reveal
sequence-level identities of the CAZymes that are actively participating in the process and neither
of their microbial origins.332,

395

Thus, information derived from metaproteomics studies and
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adapted to develop targeted proteomics assays could get us closer to the high-throughput
identification of functional biomarkers for biogas reactors and plants.
The development of targeted proteomics assays relies on lists of protein targets that are often
selected based on experimental data obtained in global proteomics experiments. Common
workflows for designing targeted proteomics studies also use peptide information collected from
global approaches to choose those analytes that can provide not only analytical specificity to
proteins of interest, but that are also able to provide intense signals and adequate fragmentation
profiles by tandem mass spectrometry. These peptides then become protein surrogates and
primary carries of quantitative information. However, in typical global proteomics experiments
some of these peptides may be hidden in the spectral data that is collected. One reason of why
this happens is due to the prevalent occurrence of chimeric spectra in LC-MS/MS based global
proteomics runs, which causes peptide information to be lost during database searches. In the
next chapter the problem of chimeric spectra occurrence in LC-MS/MS global proteomics using
spectral data-dependent acquisition was explored under different experimental conditions to
evaluate the opportunity of recovering missing peptide identification data from these types of
experiments.
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CHAPTER 5
An updated perspective on deconvoluting chimeric MS/MS spectra by liquid
chromatography and precursor isolation and their subsequent assignment by a
multi-peptide-spectrum match algorithm
Text and figures were adapted from the following published journal article:
Villalobos Solis, M.I., Giannone, R.J., Hettich, R.L. and Abraham, P.E. (2019) Exploiting the
Dynamic Relationship between Peptide Separation Quality and Peptide Coisolation in a Multiple
Peptide Matches-per-Spectrum Approach Offers a Strategy To Optimize Bottom-Up Proteomics
Throughput and Depth. Analytical Chemistry, 91, 7273-7279.
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5.1 Introduction.
Despite advances in mass accuracy, resolving power, and scan speeds in mass
spectrometry instrumentation, one of the remaining challenges of any high-throughput bottom-up
proteomics experiment is that only a fraction of the collected tandem mass spectra (MS/MS) can
be assigned to peptide sequences with high confidence (usually ≤ 60%). 107 Although several
reasons contribute to this effect,109 one that has been under scrutiny by the proteomics community
is the occurrence of chimeric spectra (also known as mixture or co-fragmented spectra).
Chimeric spectra are the result of the co-isolation and co-fragmentation of two or more
peptide precursor ions with similar m/z and retention time. The complex nature of the samples
commonly analyzed in bottom-up proteomics (>100,000 detectable peptide species) and the m/z
isolation widths typically used in data-dependent acquisition (DDA) experiments (2-4 m/z)107, 109
can result in chimeric spectra representing 50% of the total MS/MS data collected. 109 Recent
investigations employing tryptic digests of Henrietta Lacks’ ‘Immortal’ Cell Lines (HeLa) cells
demonstrated that even in experiments with a narrow isolation width of 2 m/z, 39% of the total
MS/MS spectra collected is chimeric.118
The negative effects of chimeric spectra in proteomics studies have been well-studied.
For example, in database-driven peptide and protein identifications, the presence of chimeras
deteriorates the search scores of true peptide assignments given by algorithms such as MASCOT
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and SEQUEST.109 In addition, chimeric spectra reduces the accuracy of quantitative isobaric
tagging-based quantification methods such as iTRAQ or TMT, in which the contribution of reporter
ion intensities from co-fragmented peptides, causes the under-estimation of protein/peptide
abundance differences (a phenomenon termed as “ratio compression”). 110-112 Due to these issues,
experimental and computational approaches that minimize the negative impact of chimeric
spectra in bottom up experiments have been developed.
Reducing the complexity of samples prior to MS analysis has the advantage of minimizing
the chance of co-eluting peptides.396, 397 By exploiting independent physicochemical properties of
peptides, protocols coupling orthogonal chromatographic separations before MS detection have
shown improved separation resolutions and increased peptide and protein identifications, albeit
at the cost of increased analysis times.398-400 With the introduction of ultra-high-pressure
chromatography (UHPLC), a new era of high-quality one-dimensional separations has
resurfaced. The use of chromatographic pumps that can tolerate up to 10,000 psi and stationary
phases with particles sizes of < 2 µM diameter, 200, 205 not only has afforded narrower peptide
elution profiles and increased ion sensitivities, but the improved column capacities also reduces
co-elution of peptides and hence, the occurrence of chimeric spectra. 107 This mode of operation
has enabled “single-shot” proteomics studies, in which complex proteomes are analyzed in-depth
with the aid of 1D reverse phase chromatographic columns of 50 cm or more in length and
effective LC gradients times ranging from 300-500 mins.152,

200, 204, 401

Although 1D-UHPLC

(including “one-shot” separations) and 2D-HPLC based separations reduce the occurrence of
chimeric spectra, even under the best chromatographic separations, the co-elution of thousands
of peptides is still unavoidable.107
Computationally, database searching algorithms aiming to deconvolute chimeric spectra
collected in DDA experiments have been developed. 115, 402-405 These algorithms make use of the
multiple peptides-per-spectrum-match approach (mPSM) that, in comparison to most commonly
employed search strategies using a single-peptide match-per-spectrum approach (sPSM), try to
assign more than one peptide per MS/MS spectrum. A newly developed computational workflow
called CharmeRT demonstrated substantial improvement in peptide identifications when
compared to other methods.118 This was achieved by implementing a second search strategy
coupled with a highly accurate retention time prediction algorithm method. The second search
option of CharmeRT is integrated into the database search engine MSAmanda, with validation of
multiple peptide assignments to a given MS/MS spectrum performed by Elutator, a new tool built
upon the foundations of Percolator that incorporates retention time (RT) prediction in FDR
calculations. The impact of having RT prediction in FDR evaluations of first and second searches
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translated into 25%-62% more peptide identifications in runs of HeLa tryptic digests compared to
more frequently used database search workflows.
Further advancements in LC and MS technology will continue to improve the limit of
detection for peptide sequencing in complex mixtures; however, these alone are unlikely to solve
the problem with chimeric spectra. We contend that a concomitant evaluation of LC configurations
and mPSM search algorithms is required to further increase the number of detectable peptides.
Therefore, our study was designed to systematically evaluate several LC peptide separation
techniques, ranging from short HPLC gradients to UHPLC and orthogonal separations, as well as
precursor isolation m/z windows, to better understand the effects of each on the subsequent
assignment of MS/MS spectra by a traditional sPSM search strategy compared to a mPSM one,
specifically CharmeRT.

5.2 Experimental procedures.

5.2.1 Standard samples for LC-MS/MS analyses.
Commercial Pierce HeLa Protein Digest Standards were purchased from Thermo Fisher
Scientific (20 µg total amounts). The lyophilized peptides were resuspended in 40 µL of water
with 0.1% formic acid as per the manufacturer instructions. Stock solutions of ~0.5 µg/µL were
frozen at -80°C and used as needed. Volumes equivalent to 2 µg of HeLa protein digest were
analyzed each time using different LC setups and gradients as described below.

5.2.2 1D-LC-MS/MS runs of HeLa tryptic digest standards.
1D-LC-MS/MS runs were carried out using a Proxeon EASY-nLC 1200TM system (Thermo
Fisher Scientific) interfaced with a Q Exactive Plus (Thermo Fisher Scientific) mass spectrometer
equipped with a nano-electrospray source. For HPLC measurements, peptides were loaded in
mobile phase A (0.1% formic acid, 2% acetonitrile) each time onto a trap column (150 mm x 100
μm ID) packed in-house with ~10 cm of 5 μm Kinetex C 18 resin (Phenomenex). Peptide separation
was conducted on an analytical column (250 mm x 75 μm ID) packed in-house with 5 μm particle
size Kinetex C18 resin using a linear gradient from 2 to 22% of mobile phase B (0.1% formic acid,
80% acetonitrile) at a flow rate of 300 nL/min over 90, 210, or 240 min depending on the
experiment. Each gradient was followed by an increase to 35% B within 5 minutes, a 5 mins hold
in 35% B, and afterwards a decrease to 2% B in 5 minutes.
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To test the effects of smaller particle diameter size in number of identifications, the same
LC gradients were used in an UHPLC setup, where the trap and analytical front columns were
packed with 1.7 μm particle size Kinetex C 18 resin. In addition, HeLa peptides were separated with
an analytical 500 mm x 75 μm ID column packed with 1.7 μm Kinetex C 18 which was placed in a
column heater (Sonation GmbH) at a temperature of 60°C. The linear gradient for this
configuration was from 2 to 22% solvent B over 500 mins at a flow rate of 250 nL/min.
Optimization of relevant MS parameters in the Q Exactive instrument were performed and
were found to agree well with the Q Exactive benchmarking study.406 In brief, mass spectra were
acquired with the Q Exactive Plus instrument in a top 10 data-dependent acquisition setup.
Peptide precursor MS spectra was collected within 300 to 1500 m/z with automatic gain control
(AGC) target value of 3 × 106 at a resolution of 70,000 with a maximum injection time (IT) of 25
ms. Precursor ions with charge states ≥2 and ≤ 5 and intensity threshold of 1.6 × 10 5 were selected
for higher-energy C-trap collision dissociation (HCD) with a normalized collision energy of 27 eV.
Peptide precursor ions collected from the 1D HPLC and UHPLC gradient runs were isolated using
a 1.6 m/z isolation width; whereas for the best gradients under HPLC or UHPLC conditions (see
Results & Discussions), precursor m/z isolation widths of 0.8 and 3.0 m/z were additionally
employed in order to test the effects of co-isolation interference. Fragment ion spectra were
always acquired at a resolution of 17,500 at m/z 200 with an AGC target value of 1 × 105 and
maximum IT of 50 ms. Dynamic exclusion was set to 20 s to avoid repeated sequencing of
peptides. All runs were conducted in triplicate.

5.2.3 2D-LC-MS/MS runs of HeLa tryptic digest standards.
2D LC-MS/MS runs were performed using a Vanquish UHPLC interfaced with a Q
Exactive Plus mass spectrometer (Thermo Fisher Scientific) outfitted with a 100 µM ID triphasic
precolumn (RP-SCX-RP) coupled to a 250 mm x 75 µM ID nanospray emitter packed with 250
mm of 5 µm Kinetex C18 RP resin.407 For each sample, 2 µg of HeLa peptides were loaded to the
precolumn by direct flow (2 µL/min) then separated and analyzed across two successive salt cuts
of ammonium acetate (35 mM and 500 mM), with each cut followed by a 210 min, split-flow (300
nL/min) organic gradient, wash, and re-equilibration: 0% to 2% solvent B over 2 min; 2% to 22%
solvent B over 208 min; 22% to 50% solvent B over 10 min; 50% to 0% solvent B over 10 min,
hold at 0% solvent B for 15 min. Peptides were loaded with mobile phase A onto an in-house
assembled 100μm ID fritted precolumn packed with 10 cm of 5 μm particle size Luna strongcation exchange resin (SCX; Phenomenex). Mass spectra from the eluting peptides was collected
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using the same MS and MS/MS parameter settings on the Q Exactive Plus instrument as in the
1D-LC-MS/MS runs.

5.2.4 PSMs, peptide, and protein identifications by database search.
All MS/MS spectra collected were processed in Proteome Discoverer v.2.2. (PD) with
MSAmanda v.2.2 and Percolator. Spectral data were searched against the most up-to-date
human reference proteome database from UniProt (ID. UP000005640) to which common
laboratory contaminants were appended. The following parameters were set up in MSAmanda to
derive fully-tryptic peptides: MS1 tolerance = 5 ppm; MS2 tolerance = 0.02 Da; missed cleavages
= 2; Carbamidomethyl (C, +57.021 Da) as static modification; oxidation (M, +15.995 Da) and
carbamylation (n-terminus, +43.006 Da) as dynamic modifications. The percolator FDR threshold
was set to 1% at the PSM and peptide level. In addition, MS/MS spectral data were searched with
MSAmanda in which a second search option was enabled and Elutator v2.2 (the CharmeRT
workflow). Parameters applied for MSAmanda second search were as described in the original
CharmeRT publication, with the exception that a maximum of 3 additional precursors per PSMs
were searched (referred as second searches).118 The Elutator FDR threshold was set to 1% at
the PSM and peptide level.

5.2.5 Assessment of the performance of each 1D and 2D LC-MS/MS runs.
The following identification parameters were considered to assess the performance of
each 1D and 2D LC-MS/MS runs: number of protein groups, number of modification-specific
peptides with charge (referred to as peptide analytes), number of peptides without modification
and charge (referred to as peptide sequences) and number of peptide-spectrum matches (PSMs).
In addition, we considered the precursor isolation interference percentage calculated by Proteome
Discoverer, as a measure of chimerism in the spectra collected:

Eq.1 % 𝑖𝑠𝑜𝑙𝑎𝑡𝑖𝑜𝑛 𝑖𝑛𝑡𝑒𝑟𝑓𝑒𝑟𝑒𝑛𝑐𝑒 = 100 × [1 − (

𝑝𝑟𝑒𝑐𝑢𝑟𝑠𝑜𝑟 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑖𝑛 𝑖𝑠𝑜𝑙𝑎𝑡𝑖𝑜𝑛 𝑤𝑖𝑛𝑑𝑜𝑤
𝑡𝑜𝑡𝑎𝑙 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑖𝑛 𝑖𝑠𝑜𝑙𝑎𝑡𝑖𝑜𝑛 𝑤𝑖𝑛𝑑𝑜𝑤

)]

The full width at half-maximum (FWHM) region was calculated for each LC configuration
using the FeatureFinderMetabo node408 of OpenMS409 using default parameters except for the
expected chromatographic peak width (in seconds) setting, which was optimized for each
configuration. All spectral data collected in this study was deposited at the ProteomeXchange
Consortium via the MASSIVE repository. The project accession is PXD012635 and reviewers can
access the data under the username reviewer64304@ebi.ac.uk and password qd5l9bhm .
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5.3 Results & Discussions.

5.3.1 Performance metrics across a range of nanoLC peptide separation
techniques.
Two common LC peptide separation techniques are HPLC and UHPLC. The former
employs analytical columns packed with stationary phases having particle sizes > 2 µM and flow
rates that operate below 450 bar,410 while the latter uses stationary phases with particle sizes ≤ 2
µM that drive the backpressure of the LC system to 600-1300 bar.205 Our approach started with
investigation of the performance of 5 µM C18 packed HPLC and 1.7 µM C18 packed UHPLC
columns (250 mm x 75 μm ID) employing three different linear gradient lengths from 2 to 22%
solvent B over 90 min, 210 min and 240 min at a constant flow rate of 300 nL/min.
Not surprisingly, the 1D-UHPLC setups outperformed 1D-HPLC in average number of
identifications across the different gradients tested, with the best performance achieved in the
longer analysis time. For example, in the 240 min gradient, the average numbers of PSMs, peptide
sequences, peptide analytes and protein groups were 18%, 56%, 58% and 42% higher than the
values obtained for HPLC (Figures S-1A-D). These data are undoubtedly explained by UHPLC
providing narrower FWHM and boosting the sensitivity of the analysis with increased ion
intensities (Figure S-2).204 In addition, the overall improved chromatographic resolution provided
by UHPLC setups identified >90% of all the identified HPLC peptides and further yielded between
38-44% new peptide sequences and 25-32% new protein groups not found by their HPLC
counterparts (Figure S-1E).
The comparison across gradient time lengths on the same LC setups demonstrated that
the increase in linear gradient times was more beneficial for UHPLC. For both UHPLC and HPLC,
the change from 90 to 210 min increased the average number of PSMs by more than 90% per
platform, with at least 10% increases in the numbers of peptide analytes, peptide sequences and
protein groups. When the gradient lengths were adjusted from 210 min to 240 min, minor returns
in the number of identifications were still observed for the UHPLC setup, with a maximum gain of
12% in the number of PSMs and less than 5% for the remaining identifications. However, for
HPLC only an increase of 6% PSMs was observed at 240 min, but the numbers of the other
identifications were reduced between 2%-4%, thereby suggesting longer gradients for the HPLC
column results in diminishing returns. In general, the effect observed in the 240 min HPLC can be
explained by the peak dilution phenomena, in which the use of long gradients with large particle
sizes causes a decrease in peak heights which is accompanied by a loss of sensitivity and
resolution.411, 412
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One way to combat peak dilution is to use extra-long 1D UHPLC columns (> 30 mm) or to
fractionate the sample via 2D HPLC. While long 1D-UHPLC analytical columns have been shown
to offer in-depth proteome analyses with comparable identification metrics to 2D-HPLC
chromatography, these different modes of enhanced LC likely lead to differing degrees of coisolation. Therefore, both 2D-HPLC and long 1D-UHPLC configurations were employed to assess
their overall influence on chimeric MS/MS spectra. As such, a 2D-HPLC separation strategy was
evaluated where peptides were first loaded onto a triphasic precolumn and analyzed over two salt
cuts, each followed by a 210 min organic gradient, for a total measurement time of 420 minutes.
For the long 1D-UHPLC analytical column, a 500 mm long 1D-UHPLC column was evaluated in
which separation occurred over a 500 min organic gradient. As observed in Figures 5.1A-D, the
percentage increases in the average number of identifications were significant for both the 2DHPLC and the 1D-UHPLC 500 min runs when compared to the results from the 250 mm HPLC
and UHPLC configurations tested.

5.3.2 Comparison of precursor isolation interferences across a range of nanoLC
peptide separation techniques.
An obvious benefit provided by enhanced LC separation is a reduction in the number of
co-eluting peptides. As fewer peptides with similar m/z ratios co-elute, the amount and degree of
interfering precursor ions during isolation is expected to decrease. To evaluate this premise
across the tested LC configurations, the degree of isolation interference imparted by co-eluting
peptides was computed.
Given the already established relationship between precursor ion abundance and the
degree of isolation interference in MS/MS spectra, 109 the median isolation interference
percentages of identified PSMs in each LC-MS/MS run were plotted against different ranges of
precursor ion abundance (Figure 5.1E). As expected, higher precursor abundances have lower
median isolation interferences in each LC configuration. In general, the majority of PSM precursor
abundances ranged from 1e07-1e10. In this range, higher median isolation interference was
observed in the 1D-HPLC setups relative to the 1D-UHPLC setups, while the lowest isolation
interferences were found in the 500 min 1D-HPLC runs and 2D-HPLC. Between these more
specialized LC setups, precursors identified in the 2D-HPLC runs had a slightly lower median
isolation interference percentage. Plotting the 2D-HPLC values for the independent fractions of
peptides collected at each salt pulse revealed similar median isolation interference percentages
across both fractions, suggesting they have similar peptide complexity (Figure S-3).
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Figure 5.1 Results from the LC-MS/MS analyses of 2µg of HeLa digest using different LC
configurations. (A-D) Comparison of the average number of identifications between runs employing
different gradient times under HPLC (250 mm x 75 μm column ID, 5 μm C18 particle size) and UHPLC
setups (250 mm x 75 μm column ID, 1.7 μm C18 particle size). The alternative 1D-UHPLC 500min
(500 mm x 75 μm column ID, 1.7 μm C18 particle size) and 2D-HPLC (250 mm x 75 μm column ID, 5
μm C18 particle size) setups are also shown. Error bars are the standard error of the mean (n= 3
technical replicates). Percentage increase in the average number of identifications of 2D -HPLC and
UHPLC 500 min compared to 1D-UHPLC 240min runs are shown in each graph as examples (solid
and dashed lines, respectively). (E) Boxplots showing the median isolation interference of all identified
PSMs precursors across a range of abundances in all initial LC configurations tested. A distribution of
the total number of PSMs precursors per abundance ranges is also shown in blue bars. All spectral
data were searched with Amanda-Percolator.
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5.3.3 Evaluation of the CharmeRT mPSM search algorithm across different LC
peptide separation techniques.
Dorfer et al. (2018) benchmarked CharmeRT against other widely used search algorithms,
including MSAmanda, and demonstrated improved measurement depth. However, an in-depth
evaluation of the performance gains across a broad range of peptide separation techniques has
not been reported. Therefore, our objective was to compare the CharmeRT workflow (mPSM)
against its foundational algorithms, MS Amanda and Percolator (sPSM), across the various LC
configurations implemented. As expected, the application of CharmeRT increased the average
numbers of identified PSMs between 31%-63% for the HPLC runs, 56%-58% for the UHPLC runs,
and up to 64% and 26% for the more specialized 2D-HPLC and 500 min 1D-UHPLC runs,
respectively. These numbers translated to increases in the number of peptide sequences
identified overall with gains of 32%-55% per HPLC run, 45%-41% per UHPLC, 51% per 2D-HPLC
and 22% per 500 min 1D-UHPLC (Figure 5.2). The percentage gains in the average number of
peptide sequences did not translate into comparable percentage of increases in the average
number of protein groups; however, this observation is expected to vary across different peptide
mixtures. Nearly all peptides and protein groups identified with MSAmanda-Percolator were also
found with CharmeRT (Figure S-4). Moreover, most peptides identified from the second search
mapped to protein groups identified in the first search (Figure S-5). Overall, these observations
agreed well with results reported in the original CharmeRT publication.
A major goal of this study was to better understand how varying the quality of peptide
separation influences the performance of the CharmeRT search strategy and to determine
whether one could achieve similar depth using either a UHPLC with MSAmanda-Percolator or an
HPLC configuration with CharmeRT. A comparison of the average number of PSMs, peptide
analytes, and peptide sequences between these two approaches revealed that HPLC combined
with CharmeRT provided substantially more identifications than the conventional UHPLC
Amanda-Percolator search (Figure 5.2). More importantly, comparable performance was
observed between the HPLC 210 min CharmeRT and UHPLC 240 min Amanda-Percolator using
the shorter analytical column (250 mm x 75 μm ID). Intriguingly, this observation suggests that
peptide separation of a complex mixture on a HPLC column with shorter gradient times in
combination with a mPSM search workflow can achieve identification metrics comparable to
results given by a UHPLC column and a sPSM search strategy.
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Figure 5.2 Results from the LC-MS/MS analyses of 2µg of HeLa digest using different LC
configurations and MS/MS spectra search algorithms. (A-D) Bar charts depicting the average
numbers of identifications obtained from the spectral data collected for each LC setup tested (x-axis)
and searched with Amanda-Percolator or the CharmeRT workflow. Percentage increase or decrease
of the CharmeRT results compared to the ones obtained with Amanda-Percolator are shown above or
close to each pair of bars per LC setup. Error bars are the standard error of the mean (n= 3 technical
replicates).
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Next, the degree of overlap between the newly identified peptides provided by either
UHPLC or the application of CharmeRT was evaluated. More specifically, the newly identified
peptide sequences and protein groups identified from HPLC runs searched with CharmeRT were
compared to the results obtained from their UHPLC counterparts searched with MSAmandaPercolator (Figure S-6). These comparisons demonstrate that the newly identified peptides for
both approaches were mostly complementary, with only a small overlap (~10%).
When comparing the CharmeRT performance between 2D-HPLC and the 1D-UHPLC 500
min gradient runs (500 mm x 75 μm ID), the 2D-HPLC measurements had the highest percentage
gains in terms of average number of PSMs, peptide analytes, peptide sequences and protein
groups (64%, 63%, 51%, 13%, respectively) (Figure 5.2), despite 2D-HPLC having the least
interference (Figure 5.1E). To explore this further, the total number of PSMs derived from the 2DHPLC and 1D-UHPLC 500 min setups at different ranges of isolation interference were binned
and quantified based on their CharmeRT search depth (Figure 5.3, isolation width 1.6 m/z).
Interestingly, across every isolation interference bin, the 2D-HPLC configuration afforded 2-4x
more CharmeRT gains relative to the 1D-UHPLC 500 min configuration. Additionally, a greater
search depth (i.e., a higher percentage of scans having 2-3 additional precursors derived from
second searches) was observed at higher isolation interference ranges in 2D-HPLC. After
exploring accompanying data related to data quality and PSM scoring, it’s not immediately
obvious what metrics explain this phenomenon. However, a likely explanation is that the 2D
separation scheme, which reduces the complexity of the loaded peptide mixture for each salt
pulse, retains the CharmeRT performance gains like the 1D-HPLC 210 min separation scheme,
whereas the 1D-UHPLC 500 min CharmeRT performance gains suffers from dilution of lower
abundant secondary precursors.
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Figure 5.3 Search depth achieved by CharmeRT in the spectral data collected through
specialized LC modes of operation. Results from (A) 2D-HPLC and (B) 1D-UHPLC 500 mins runs
at different isolation windows. Histograms of the number of PSMs per isolation interferenc e range and
identified in the first search of CharmeRT are shown. The colored stacked bars below each histogram
represent the percentage (above each stacked bar) of PSMs identified in the first search of CharmeRT
from which no additional PSMs derived from second search were identified (green color, Depth 1);
from which just one additional PSM was identified (orange color, Depth 2, i); from which two additional
PSMs were identified (green color, Depth 2, ii); from which three additional PSMs were identified (pink
color, Depth 2, iii).
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5.3.4 Evaluation of spectra collected from LC peptide separation techniques with
different isolation widths and searched with CharmeRT.
Widely acknowledged, precursor isolation widths can impact the performance in LCMS/MS measurements: narrower isolation widths lead to loss in signal and wider isolation widths
results in more precursor co-isolation/co-fragmentation. As previously demonstrated by Dorfer et
al., (2018) applying wider isolation widths during data acquisition improves the performance gains
of the CharmeRT workflow. Therefore, our approach was to evaluate different isolation widths
across the different LC configurations applied in this study.
To this end, three isolation widths (0.8, 1.6 and 3.0 m/z) that encompass the range often
employed in LC-MS/MS measurements were applied and performance assessed across the 1DHPLC 210 min and 1D-UHPLC 240 min setups, which gave the highest numbers of average
identifications across each configuration either when the results were searched with AmandaPercolator or CharmeRT, as well as the 1D-UHPLC 500 min and 2D-HPLC setups.
At each isolation width, the 1D-HPLC 210 min runs had the highest precursor isolation
interference medians, followed by the 1D-UHPLC 240 min runs. The 1D-UHPLC 500 min and 2DHPLC setups presented similar isolation interference values (Figure 5.4A). Given the lower signal
and reduced potential for co-fragmentation, the narrower isolation width of 0.8 m/z had the fewest
identifications and lowest gains by the CharmeRT workflow (Figures 5.4B and S7). Similar to the
results observed above, CharmeRT gains in peptide and protein group identifications were higher
in the HPLC configurations relative the UHPLC setups, particularly the 2D-HPLC which
experienced the widest range in peptide identifications across the three different isolation widths.
In agreement with the original CharmeRT publication, our results revealed CharmeRT
improvements as isolation widths increased, except for the 1D-UHPLC 500 min configuration.
This is counterintuitive, as the increase in precursor isolation interference becomes seemingly
more favorable for the CharmeRT workflow (Figure 5.3, isolation width 3 m/z and Figure S-8).
This novel insight into mPSM expectations implies that long 1D-UHPLC gradient times do not
experience the same benefit in the CharmeRT workflow as observed for the 2D-HPLC and other
more common HPLC configurations tested in this study.
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Figure 5.4 Results from the spectral data collected with a range of isolation windows from the
best LC configurations. (A) Boxplots showing the median isolation interference of all identified PSMs
precursors from the spectral data of the optimized LC gradients collected under a range of isolation
windows. (B) Bar charts depicting the average numbers of peptide sequences and protein groups
obtained from the spectral data collected for each LC setup (x-axis) under a range of isolation
windows. Percentage increase or decrease afforded from the CharmeRT results compared to those
from Amanda-Percolator are shown above or close to each pair of bars per setup and isolation window.
Error bars are the standard error of the mean (n= 3 technical replicates). The average numbers of
PSMs and peptides analytes are presented in Figure S-8.
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5.4 Conclusions.
By using state-of-the-art LC-MS platforms, proteomes of simple organisms can now be
sequenced to near completion in just over an hour. 413 However, comparable coverage is still not
readily achieved in more complex peptide mixtures, like those derived from higher-order
eukaryotes or microbial communities. While steady advancements in MS technology and LC will
continue to transform the achievable throughput and depth of proteomic analyses, the results
presented herein suggest that a better understanding of the dynamic relationship between peptide
separation and co-fragmentation can be leveraged by mPSM approaches, such as CharmeRT,
to enhance saturation in peptide identifications with minimal measurement duration or without
advanced LC configurations, i.e., 500 mm long, heated, UHPLC-driven peptide separations.
Moreover, this approach coupled to more specialized LC configurations, like 2D-HPLC, offers
even greater depth when compared to more traditional single-PSM approaches.
While our results revealed an improvement in peptide separation leads to the expected
increases in the number of peptides identified, similar gains can be achieved using shorter
gradients coupled with a mPSM approach. This performance differential became less as the
peptide separation improved. This observation has substantial implications for LC-MS/MS
approaches that use HPLC columns, as it suggests that a new approach towards improving
peptide identification rates is to reduce peptide separation while employing a mPSM approach.
Moreover, for the 250 mm x 75 μm ID HPLC and UHPLC columns, a similar depth can be
achieved when HPLC measurements employ the CharmeRT workflow. Importantly, this suggests
that research laboratories separating complex mixtures on a HPLC column with shorter gradient
times can achieve comparable identification metrics as if the sample were separated on a UHPLC
column.
Many LC-MS proteome specialists view the use of longer columns packed with sub-2 μm
separation particles, as the most direct configuration toward improving peptide identifications.204
Yet, our results offer an alternative perspective, in which the application of CharmeRT performed
substantially better for a 2D-HPLC strategy when compared to a long 1D-UHPLC column.
Therefore, the 2D-HPLC strategy combined with mPSM represents the best path toward
improving the number of detectable peptides, enabling a more rapid and comprehensive
proteome analysis when compared to the longer UHPLC columns. Moreover, because the
demands of UHPLC configurations require LC platforms that withstand very high pressures, which
are often unavailable to non-specialists, MS/MS spectral data derived from HPLC separations
searched with a mPSM approach could become broadly adopted by the proteomics community.
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The occurrence of chimeric spectra in global proteomics experiments using datadependent acquisition are but one of the reasons behind missing peptide identifications. Other
causes are variable peptide ionization efficiencies and ion suppression effects. On the biological
side, peptides derived from naturally abundant proteins have better chances of being identified in
comparison to the ones produced from less abundant proteins. Related to this point, a vast
amount of research now agrees that amongst the molecules in a cell controlling important process
such as cell-to-cell signaling, differentiation, growth, and defense are endogenous or native
peptides of very low abundance that can be products of protein maturation, turnover or small open
reading frames. If global proteomics suffers from all these issues, how can we increase the
chances of identifying such part of the proteome that is subjected to dynamic range constrains?
This issue was explored in more detail in the following chapter.
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CHAPTER 6
LC-MS/MS based discovery and characterization of proteolytic cleavage products
(PCPs) produced during the mutualistic symbiotic interactions between the
perennial plant Populus X canescens and the ectomycorrhizal basidiomycete
Laccaria bicolor
Text and figures were adapted from the following manuscript submitted and under revision in the
Molecular Plant-Microbe Interactions Journal (Revised version submitted on April 3rd, 2020).
Manuel I. Villalobos Solis, Suresh Poudel, Clemence Bonnot, Him K. Shrestha, Robert L.
Hettich, Claire Fourrey, Francis Martin, and Paul E. Abraham. (2019) Regulation at the plantmicrobe interface: Discovery and characterization of signaling polypeptides using highperformance tandem mass spectrometry
Authors contributions: Manuel Ivan Villalobos Solis (M.I.V.S.) planned the study alongside
Suresh Poudel (S.P.) and Paul E. Abraham (P.E.A.). Clemence Bonnot (C.B.) and Claire Fourrey
(C.F.) growth and harvested biomass used for proteomics analyses. M.I.V.S. and P.E.A prepared
samples from proteomics analyses and collected spectral data. M.I.V.S., S.P. and Him K.
Shrestha (H.K.S.) analyzed the proteomics data. M.I.V.S. and P.E.A wrote the manuscript. Robert
L. Hettich, C.B, C.F and Francis Martin provided critical reviews and proof -read the manuscript.
Notes: Both M.I.V.S and S.P. are first authors of this study. Supplementary tables are included in
the online version of dissertation as downloadable files and their numbering reflect the one
followed in this chapter.

6.1 Introduction.
The plant peptidome encompasses a mixed array of low-molecular weight peptides (<10
kDa), or proteolytic cleavage products (PCPs), that are derived from endogenous cellular
mechanisms of proteolysis acting in protein turnover,414 or in the maturation of large protein
precursors.133, 415 PCPs from protein turnover processes may not have pronounced cellular effects
in plants but may act as sources/reservoirs of nitrogen.130-132,

416

By contrast, the group of PCPs

derived from protein maturation processes have key roles in plant growth and development,
reproduction, and stress responses.133,

135

These types of bioactive PCPs include well studied

families of plant peptide hormones that are classified according to primary sequence
characteristics.135
Plant PCPs also fulfill diverse roles in the different types of symbiotic interactions with
microorganisms in the environment.417 Although PCPs that are the products of protein turnover
events have not been directly implicated in biological functions during symbioses, it is interesting
to note that the machinery behind protein degradation appears to be affected in plants undergoing
symbiotic relationships with microbes, where the process is deemed essential for cellular
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maintenance.418-420 Regarding bioactive PCPs, several of them have been characterized as
molecular intermediaries in the responses that plants induce on associated microbiota.421-424
Amongst the different microbial signals that a plant perceives at any time are microbial bioactive
PCPs, which have been shown to alter their hosts cellular behavior in order to survive.425-428
The discovery and characterization of PCPs in plants and in plant-microbe interactions
have been expedited with the application of experimental mass spectrometry (MS) methodologies
that have used biomaterial known to be enriched in selective families of PCPs or genetically
altered to overexpress them, followed by purification or enrichment strategies, and in some cases
mapping of spectral data to custom-made databases containing known PCP precursors and/or
alternate sequence versions of bioactive PCPs.415, 429-439
All these studies have demonstrated the advantage of MS methodologies for the largescale identification of PCPs in plants and plant-microbial interactions; however, they have also
highlighted several technological challenges associated with their application including the
relatively natural low abundance of PCPs, as well as undefined proteolytic processing and
unusual post-translational

modifications that are normal sequence features on them.

Furthermore, several of these studies were also tailored specifically for the detection of known
PCPs families. Thus, alternative MS approaches that can provide a wider image of known or
unknown PCPs involved not only in plants but in plant-microbe interactions are needed.
One of such alternatives is to explore the capabilities of searching MS spectral data with
de novo database-assisted searches.440 In de novo database-assisted searches peptide
sequence tags derived directly from a MS/MS spectrum are used to better select candidate
peptides in a database.149, 441 In this way, de novo circumvents the low sensitivity and impractical
implementation of deriving in-silico spectra from database searches with nonspecific cleavage
rules;441,

442

or of narrowing the scope of identifications by searching spectral data against

databases that identify selected groups of PCPs.
Combined with experimental practices that enrich peptides < 10 kDa in samples from
tissues and cells,138, 139, 142, 144, 145, 429, 435 tandem mass spectral peptide sequencing via de novoassisted database searches could provide a feasible way to comprehensively detect endogenous
groups of PCPs produced in tissues of plants and in cells of microbes undergoing symbiosis. In
this study, we thus explored the feasibility of the application of 10 kDa MWCO filters to enrich
PCPs in biomaterial directly extracted from Populus X canescens plants grown in vitro with the
ectomycorrhizal basidiomycete Laccaria bicolor. Interestingly, recent publications on the
symbiosis between Populus trees and L. bicolor, have shown that the establishment and
regulation of this interaction is driven by effector-like PCPs derived from small protein
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precursors;443, 444 however, the comprehensive profiling of all types of PCPs expressed in active
ectomycorrhizal Populus roots is still missing in literature.
To benchmark the performance of our approach before its application to the Populus-L.
bicolor system, and evaluate the confidence levels of the de novo results, standardized samples
containing constant amounts of undigested Escherichia coli K12 proteome backgrounds as well
as digested Universal Proteome Standard (UPS1) tryptic digests and variable concentrations of
known absolute quantification (AQUA) heavy-labeled peptide standards were analyzed. After
peptide enrichment using 10 kDa MWCO filters, it was possible to reproducibly recover
quantifiable information from UPS1 peptides and AQUA peptide standards.
When applied to the Populus-L. bicolor system, our methodology was able to identify
PCPs involved in biological processes other than in the plant-fungi interaction, such as PCPs
representing the bioactive form of the Populus Photosystem II complex 5 kDa (PsbTn) protein in
plant leaves. A differential PCP abundance analysis determined a total of 157 PCPs that were
significantly more abundant in root tips with established ectomycorrhiza when compared to root
tips without established ectomycorrhiza and extramatrical mycelium of L. bicolor, thus suggesting
roles in the mutualistic interactions between both organisms. Of these, 96 PCPs mapped to 69 L.
bicolor proteins, 56 PCPs mapped to 64 Populus proteins and 5 PCPs were shared between 12
Populus and 6 L. bicolor proteins, respectively. These findings demonstrate that global profiling
of PCPs via LC-MS/MS with de novo-assisted database search could significantly advance the
comprehensive understanding of the role of these molecules in plant-microbe interactions, and
highlights the general applicability of this experimental strategy to acquire direct evidence of PCPs
from different plant tissues.

6.2 Experimental procedures.

6.2.1 E. coli background proteome sample preparation.
A crude E. coli K12 proteome was prepared to provide a sample matrix for known target
peptides for benchmarking. Briefly, an E. coli cell pellet (OD 0.4) was suspended in lysis buffer
(2% sodium deoxycholate (SDC) in 100 mM NH 4HCO3 (ABC)), disrupted by sonication (30%
amplitude, 10 s pulse with 10 s rest, 2 min total pulse time) and boiled for 5 min. Crude protein
extract was precleared via centrifugation for 15 min at 14,500 rpm and quantified with a
Nanodrops spectrophotometer (Thermo Scientific). The precleared protein extract was then
adjusted to 10 mM dithiothreitol (DTT) and incubated under constant shaking for 30 min at 37°C
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(600 rpm, Eppendorf Thermomixer) to avoid endogenous peptide cyclization or unwanted protein
interactions. Cysteines were then blocked with 30 mM iodoacetamide (IAA) to prevent reformation
of disulfide bonds. The E. coli proteome sample was stored at -20°C until further use.

6.2.2 Universal Proteomics Standard (UPS1) sample preparation.
One vial of UPS1 (Sigma) was solubilized in cell lysis buffer (2% SDC in 100 mM ABC).
Proteins were reduced with 10 mM DTT and incubated at 35°C under constant shaking for 30 min
(600 rpm, Eppendorf Thermomixer). Afterwards, proteins were alkylated with 30 mM IAA followed
by a 15 min incubation at room temperature in the dark. The UPS1 sample was submitted to a 3
hours trypsin digestion (1:20, enzyme to protein ratio) at room temperature under continuous
shaking followed by an overnight trypsin digestion using the same enzyme to protein ratio at 37°C
under continuous shaking. The UPS1 tryptic digest was stored at -20°C until further use.

6.2.3 Heavy-labeled peptide standards.
A total of 17 AQUA Ultimate (>97% purity) labeled peptide standards (Thermo Scientific)
were combined in a standard solution using 100 mM ABC as dilution buffer to individual
concentrations of 10 fmol/µL. The AQUA mix was stored at -20°C until further use.

6.2.4 Preparation of master mixes for benchmarking the performance of a 10 kDa
enrichment strategy of PCPs and their dentification/quantification via de novoassisted database search.
The master mix for benchmarking the identification of small peptides by the informatics
pipeline was prepared on top of Vivaspin 500 μL centrifugal filter units (MWCO 10kDa, Millipore
Sigma). To each filter, volumes equivalent to 100 µg of E. coli proteome and 0.24 µg of digested
UPS1, and volumes equivalent to 1000, 750, 500, 250 and 125 fmol of each standard in the AQUA
mix were pipetted (n=3 experimental replicate per standard concentration). Additionally, volumes
equivalent to 100 µg of E. coli proteome were also pipetted into three filters and used as
background controls.
All samples were then centrifuged for 30 min at 12,000 g to remove proteins from the E.
coli background proteome or undigested proteins from the UPS tryptic digest. The flow-through
was collected and acidified with 1% formic acid to precipitate SDC. Hydrated ethyl acetate was
added to each sample at a 1:1 (v/v) ratio three times to effectively remove SDC. Samples were
then placed in a SpeedVac Concentrator (Thermo Fischer Scientific) to remove ethyl acetate. The
peptide-enriched flow throughs were desalted on Pierce peptide desalting spin column (Thermo
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Scientific) as per the manufacturer instructions. After speed-vac concentration, dry peptide
samples were suspended in 10 µL of 0.1% formic acid solution and placed in autosampler vials.

6.2.5 1D-LC-MS/MS of master mixes samples.
A Proxeon EASY-nLC 1200TM system (Thermo Fisher Scientific) interfaced with a Q
Exactive Plus (Thermo Fisher Scientific) mass spectrometer equipped with a nano-electrospray
source were used to conduct 1D-LC-MS/MS analyses. Injection volumes of 2µL of each master
mix (n= 15) were loaded in mobile phase A (0.1% formic acid, 2% acetonitrile) onto a trap column
(150 mm x 100 μm ID) packed in-house with ~10 cm of 1.7 μm Kinetex C 18 resin (Phenomenex).
Peptide separation was performed on an analytical column (300 mm x 75 μm ID) packed in-house
with 1.7 μm particle size Kinetex C 18 resin using a linear gradient from 2 to 22% of mobile phase
B (0.1% formic acid, 80% acetonitrile) at a flow rate of 300 nL/min over 90 min.
Mass spectra were acquired with the Q Exactive Plus instrument in a top 10 datadependent acquisition setup. MS spectra were collected within 300 to 1500 m/z with automatic
gain control (AGC) target value of 3 × 106 at a resolution of 70,000 with a maximum injection time
(IT) of 25 ms. Precursor ions with charge states ≥2 and ≤ 5 and intensity threshold of 1.6 × 10 5
were isolated using a 1.6 m/z isolation width for higher-energy C-trap collision dissociation (HCD)
with a normalized collision energy of 27 eV. MS/MS spectra were acquired at a resolution of
17,500 at m/z 200 with an AGC target value of 1 × 105 and maximum IT of 50 ms. All spectral
data collected in this study was deposited at the ProteomeXchange Consortium via the MASSIVE
repository. The project identifier is MSV000084471 and the data can be reviewed under the
username “MSV000084471_ reviewer” and password “Martin”.

6.2.6 Preparation of Populus X canescens with or without Laccaria bicolor
ectomycorrhizae samples.
The hybrid Populus X canescens (Populus tremula x Populus alba line INRA 717-1-B4)
clones were micropropagated in vitro and grown in half -strength Murashige and Skoog (MS/2)
medium in a growth chamber at 24°C under a 16-h photoperiod. The dikaryotic vegetative mycelia
of strain S238N of the ectomycorrhizal fungus Laccaria bicolor were maintained on modified
Pachlewski agar medium P5 at 25°C in the dark.445
For in vitro coculture of poplar with L. bicolor, we used a sandwich system described
before.446 The Petri dishes were incubated for 2 weeks vertically in a growth chamber at 20°C
under a 16-h photoperiod. From these co-culture plates, we collected extramatrical mycelium,
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ectomycorrhizal lateral roots, non-mycorrhizal lateral roots and leaves. Leaves from control plants
(no ECM fungi) were harvested on plant grown separately but in the same in vitro conditions.
Cuttings of Populus X canescens (synonymous P. tremula x P. alba; INRA clone 717-1B4)
of 1 cm diameter and 15 cm were planted in pots containing 5 L of sterile sand and grown in a
greenhouse irrigated twice a day with 20 mL of nutrient solution (8 μM KNO 3, 8 μM
Ca(NO3)2.4H2O, 3 μM NaH2PO4, 3 μM MgSO 4.7H2O, 0.2 μL/L of Kanietra solution (COFAZ,
Paris). Xylem sap was extracted by natural root pressure after 7 weeks of growth. To ensure
xylem sap flow, poplars were watered with the nutrient solution two hours before sap collection.
Using a razor blade, poplars were then decapitated by transversal section of their stem 3cm above
its branching point from the cutting. To avoid contamination of the sap by other tissues of the
stem, the cell layers surrounding the stele were removed with care around the section site with a
scalpel on a surface of 1 cm length. After cleaning with deionized water and drying with tissues,
the exposed stele was attached tightly to 3 cm of Tygon ND 100-65 tubes (Saint-Gobain
Performance plastics, Courbevoie, France) of appropriate inner diameter with microporous tape
(Urgo, Chenove, France). Flowing xylem sap was collected regularly with a micropipette from the
Tygon tubes. Samples were stored on ice during sampling. 150 μL of sap per poplar was collected
over three hours from 16 poplars. The sap from four poplars was pooled to produce one sample
before flash freezing the samples in liquid nitrogen.

6.2.7 PCPs extraction from Populus X canescens and Laccaria bicolor samples.
All samples derived from the ectomycorrhizal and non-ectomycorrhizal interactions of
Populus X canescens with L. bicolor were processed to recover endogenous polypeptides for LCMS/MS analysis. Briefly, grounded samples were placed in 1ml lysis buffer (2% SDC in 100 mM
ABC), vortexed and then placed in a heat-block for 5 min at 90°C. Afterwards, samples were
disrupted by sonication (program: 30% amplitude, 10 s pulse with 10 s rest, 2 min total pulse time)
and boiled for an additional 5 min at 90°C. After recovering the supernatant via centrifugation, the
samples were adjusted to 10mM DTT and incubated under constant shaking for 30 min at 37°C
(600 rpm, Eppendorf Thermomixer). Cysteines were then blocked with 30 mM iodoacetamide
(IAA) to prevent reformation of disulfide bonds.
To separate the low molecular weight fraction of the proteome, samples were transferred
into 10kDa MW cutoff centrifugal filter units and then centrifuged for 30 min at 12,000 xg. The
peptide-enriched flow-throughs were collected into fresh Eppendorf tubes and acidified with 1%
formic acid to precipitate residual SDC. Samples were then placed in a SpeedVac Concentrator
(Thermo Fischer Scientific) to remove ethyl acetate. Peptide samples were desalted on Pierce
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peptide desalting spin column (Thermo Scientific) as per the manufacturer instructions. After
speed-vac concentration, dry samples were suspended in 10 µL of 0.1% formic acid solution and
placed in autosampler vials.

6.2.8 1D-LC-MS/MS of Populus X canescens with or without Laccaria bicolor
samples.
All samples were analyzed on a Q Exactive Plus mass spectrometer (Thermo Fischer
Scientific) coupled with a with a Proxeon EASY-nLC 1200 liquid chromatography (LC) pump
(Thermo Fisher Scientific). Peptides were separated on a 75 μm inner diameter microcapillary
column packed with 50 cm of Kinetex C18 resin (1.7 μm, 100 Å, Phenomenex) that was heated
to 60 °C in a Phoenix S&T NanoLC column heater. For each sample, a 2 μg aliquot was loaded
in buffer A (0.1% formic acid, 2% acetonitrile) and eluted with a linear 90 min gradient of 2 – 20%
of buffer B (0.1% formic acid, 80% acetonitrile), followed by an increase in buffer B to 30% for 10
min, another increase to 50% buffer for 10 min and concluding with a 10 min wash at 98% buffer
A. The flow rate was kept at 200 nL/min. MS data was acquired with the Thermo Xcalibur software
version 4.27.19 using the topN method where N could be up to 10. Target values for the full scan
MS spectra were 1 x 106 charges in the 300 – 1,500 m/z range with a maximum injection time of
25 ms. Transient times corresponding to a resolution of 70,000 at m/z 200 were chosen. A 1.6
m/z isolation window and fragmentation of precursor ions was performed by higher-energy C-trap
dissociation (HCD) with a normalized collision energy of 30. MS/MS scans were performed at a
resolution of 17,500 at m/z 200 with an ion target value of 1 x 106 and a maximum injection time
of 50 ms. Dynamic exclusion was set to 20 s to avoid repeated sequencing of peptides.

6.2.9 PSMs, peptide, and protein identifications by PEAKS.
The raw data were interrogated by de novo-assisted database searching against the
Populus trichocarpa v3 reference proteome coupled to the L. bicolor UniProt reference proteome
(UP000001194) accompanied with common contaminant proteins using PEAKS DB, PEAKS
PTM and PEAKS SPIDER in PEAKS X Studio (Bioinformatics Solutions, Waterloo, Canada). The
peptide and fragment ion mass tolerances were set to ±10 ppm and ±0.02 Da, respectively. The
enzyme parameter was set to “no enzyme”. Features associated with chimera scan were enabled.
De novo ALC score was set at >90%. A false discovery rate of 1% was applied to accept the
peptide sequences and a minimum of three peptides were required to identify a protein. For
PEAKS DB, carbamidomethylation (+57.02) of cysteine was set as fixed modification and
oxidation (+15.99) of methionine was set as a variable modification. PEAKS PTM algorithm was
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used to identify other common modifications in PCPs by allowing the search against all possible
modifications from the Unimod database. Similarly, PEAKS SPIDER algorithm was used to detect
any possible de novo sequencing errors and homology peptide mutations.
For differential abundance analysis of PCPs involved in ECM interactions between
Populus and L. bicolor, peptide data from the Populus roots with and without ECM, as well as L.
bicolor extramatrical mycelium sample sets, were filtered to remove all peptides, that were present
in only 1/3 replicates. All peptides present in 2/3 biological replicates were considered valid for
quantitative analysis. Missing data were imputed by random numbers drawn from a normal
distribution (width = 0.3 and downshift = 2.8 using Perseus software (http://www.perseusframework.org)262. The resulting matrix was subjected to ANOVA (p < 0.05) followed by post-hoc
Tukey test (Family-Wise Error Rate < 0.05) to assess peptide abundance differences between
the different experimental groups. The entire filtering and statistical analyses were done using an
in-house developed python script.

6.3 Results & Discussion.

6.3.1 Benchmarking the identification and quantitation of PCPs.
The low nanomolar to mid picomolar concentrations to which bioactive PCPs are thought
to be active, and which experimental measurements in plant tissue cultures have found,435, 447
prompted us to evaluate the quantitative accuracy and reproducibility of recovering peptides < 10
kDa from a molecular weight-spin column enrichment strategy. For this purpose, we created a
standard benchmarking sample that contained invariable amounts of proteolytically digested
universal proteomics standard (UPS1 – 48 proteins, 5 pmol each), combined with invariable
amounts of an E. coli crude protein extract to best mimic small endogenous peptides at relatively
low abundances within a complex proteome background. In addition, equimolar solutions of 17
heavy AQUA synthetic peptide (Table 6.1) standards in different molar amounts (injection
volumes equivalent to 12, 25, 50, 75 or 100 fmol of each standard) were also spiked into the mix
of E. coli proteins and UPS1 peptides (Figure 6.1) for quantitative benchmarking.
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Table 6.1 Heavy peptide standards (>97% purity) spiked into constant amounts of background
E. coli proteome and UPS tryptic digest used to benchmark the de novo peptide identification
and quantification pipeline. Peptide standards were derived from proteins of Sphingobium sp.
(Strain NBRC 103272/SYK-6). A 2 µL injection volume of each benchmark sample was analyzed by
LC-MS/MS. The injection volume is equivalent to 12.5, 25, 50, 75 and 100 fmol for each peptide
standard. Residues in red are heavy versions of amino acids containing 13C and 15N isotopes.

Heavy Peptide Sequence

Precursor m/z

Precursor Charge

IALAGAGAFGEK

556.8131

2

AEQAAEVAAK

498.2660

2

YDDLVTGK

459.7365

2

LVDDAPK

383.2152

2

SVAPLVADYADR

643.8343

2

GLVIDAGVR

455.2732

2

AIYAQGTVK

479.7760

2

VFTAQR

366.2073

2

ADESAYLDEWNLTPAAK

951.4539

2

LFSTDGK

388.2074

2

GGYFLAEDLPADTATR

853.9166

2

GLVAPTGDETR

563.2923

2

ETIEANQLR

542.2870

2

GIDPTTGHYFDDTK

525.5786

3

YIDALDISDQER

724.3505

2

EFDLNFIDK

574.7893

2

LISDPEELSK

569.8077

2
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Figure 6.1 Computational and experimental strategies followed for the identification and
quantification of small endogenous polypeptides. (A) Samples consisting of 0.24 µg of tryptic
digested UPS, 100 µg of E. coli protein and different fmol amounts of heavy labeled AQUA peptides
were prepared in triplicates on top of 10kDa spin filters. (B) After centrifugation, the flow-throughs were
collected and 2 μL of each sample were analyzed via LC-MS/MS using a Q Exactive Plus instrument
(n = 3 experimental replicates). (C) UPS1 and AQUA peptides were identified by PEAKS de-novo
sequencing of MS/MS spectral data. The number of UPS peptide -spectrum matches (PSMs) and
proteins were compared to values obtained by the de novo-assisted database search strategy
performed with PEAKS. In addition, MS1 peak areas of the spiked AQUA standards were compared
to values obtained with Skyline.
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The UPS1 peptides and AQUA standards were identified by de novo peptide sequencing
using PEAKS.448 The PEAKS software is recognized as a standard for automated peptide de novo
sequencing, which also introduced the capability of incorporating de novo results into its database
search algorithm to improve the sensitivity and accuracy of the identifications.149 In particular, de
novo-assisted database search is useful for novel PCP identification as the exact mechanisms of
how these molecules are originate is not well-understood and biasing the results towards the use
of an experimental protease and a database digested with specific in-silico rules would hinder the
characterization of PCP.
Overall, the de novo-assisted database peptide sequencing reliably identified a similar
number of peptide-spectral matches (PSMs) across the experimental benchmark dataset (Figure
6.2A) and identified over 55% of the UPS1 proteins in each sample (Figure 6.2B), despite the E.
coli crude lysate representing ~99% of the collected peptide biomass during enrichment (based
on BCA assay). In addition, all the 17 AQUA peptides spiked into samples were identified.
The calculated peak area for each AQUA peptide provided by PEAKS was also compared
to manually curated data obtained with Skyline, which is another popular software that provides
an alternative to extract MS1-level abundances of a relatively low number of peptides.449 In this
way, we evaluated PEAKS capabilities of providing quantitative values that could be used for
relative quantification of novel PCPs identified in complex biological matrices.
As observed in Figure 6.2C, for the spiked AQUA peptide standards, excellent agreement
between the Skyline MS1 extracted AUCs and PEAKS AUCs were observed (R 2 > 0.98). In terms
of individual peptide responses (Figure 6.2D), the lowest R2 value observed was for peptide
ADESAYLDEWNLTPAAK (R2 = 0.808) while the best linear response at increasing amounts of
injected standards was that from peptide EFDLNFIDK (R 2 = 0.936). Overall, the measured
changes in linear responses demonstrated the ability to accurately recover peptide quantitative
information from a complex proteome background after filtration through a 10 kDa membrane
filter, data acquisition via state-of-the-art tandem mass spectrometry, and post-processing using
PEAKS.
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Figure 6.2 Performance of 10 kDa membrane filtering and PEAKS software for peptide
identification. For this study we identified peptides from the UPS standards by de novo analysis and
extracted quantitative information from the AQUA peptide standards spiked into E. coli and UPS
backgrounds after 10kDa membrane filtering 15 samples x 17 peptides = 255 data points). ( A) The
number of total identified PSMs for the benchmarking samples and ( B) the total number of identified
UPS1 proteins are provided. (C) Scatter plot of peptide peak areas reported by PEAKS compared to
those identified by automatic and manual validation in Skyline. ( D) Linear fit regression analyses of
AQUA standards areas under the curve responses according to their molar amounts spiked into
benchmarking sample sets. Coefficient of determination values (R2) are shown in each graph.
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6.3.2 Identification metrics of PCPs from Populus and its ectomycorrhizal symbiont
L. bicolor.
The 10 kDa enrichment strategy with the de novo sequencing assisted MS/MS database
search was applied to Populus tissues (i.e., xylem sap, roots, leaves) with or without established
L. bicolor ectomycorrhizae (ECM) as well as extramatrical L. bicolor mycelium (Lb EXM) (Figure
6.3A). At a false-discovery rate (FDR) of < 1% at the peptide level, the sample types varied in the
total numbers of identified PCPs as well as their similarity to each other (Figure 6.3B, horizontal
bars in UpSet plot). Overall, the measured PCPs had similar peptide lengths (median length of
21 amino acids) and number of basic residues (average of 1) (Figure 6.4) as to what is generally
reported in conventional peptide sequencing studies.450
Across all datasets, 4564 PCPs were identified from which 1653 and 2859 mapped
exclusively and respectively to Populus and L. bicolor proteins, while 52 PCPs were shared
amongst a number of proteins highly conserved between both organisms such as elongation
factors and histones (Supplementary Table S6.1, see PCPs and Proteins information). Amongst
all sample types, the highest numbers of unique PCPs were detected in Lb EXM and mycorrhizal
roots (Figure 6.3B, vertical bars in UpSet plot). PCPs identifications detected across multiple
samples were also observed. The datasets with the greatest number of overlapping PCPs were
those of leaves with and without ECM, which is to be expected given the ECM interaction largely
affects roots tissues. Additionally, we noticed a significant number of PCPs in common between
the Lb EXM samples and the roots samples with and without ECM.
Bioactive PCPs can be occupied by post-translational chemical modifications that
influence structure and their biological activity.135 For example, the CLE and CEP families have
hydroxyprolines that are glycosylated with L-arabinose.

145, 431, 435, 451

Of the total number of PCPs

identified in each dataset, 19-33% contained post-translational modifications or amino acid
substitutions as found by the PEAKS PTM and PEAKS Spider modules of the de novo assisted
database searches, respectively. With the PEAKs software considering 313 natural modifications
reported in the Unimod database, we observed PTMs that are likely introduced during sample
preparation as well as those that are presumed to occur in vivo and have biological significance,
like methylation and phosphorylation (Figure 6.5).
In the context of sample sets, PCPs matched to a maximum number of 522 proteins (Lb
EXM samples) and a minimum number of 87 proteins (xylem sap samples) in the database
(Figure 6.3C, horizontal bars in UpSet plot). Like the peptide-level observation, we observed
substantial overlap in the proteins detected in the Lb EXM, poplar roots with established ECM
and roots without ECM (Figure 6.3C, vertical bars in UpSet plot).
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Figure 6.3 Proteomics metrics of the Populus X canescens and Laccaria bicolor PMI system.
(A) Illustration of the in-vitro sandwich type system used to harvest different P. X canescens extracts
and L. bicolor extramatrical mycelium. Xylem sap was obtained from plants growing in pots of sterile
sand and grown in a greenhouse and is not depicted in this figure. (B) The UpSetR plot depicts the
intersection between PCPs identified per experiment type. Horizontal bars indicate the total number
of PCPs detected in each experiment (unique + shared); vertical bars depict the number of jointly
identified PCPs. (C) The UpSetR plot depicts the intersection between proteins to which PCPs mapped
per experiment type. Horizontal bars indicate the total number of proteins detected in each experiment;
vertical bars depict the number of jointly identified proteins.
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Figure 6.4 Length and basic residue distribution of all identified PCPs (unique & shared) across
datasets. Colors overlaid on each histogram represent the number of basic amino acids (Lys, Arg or
His) found in each PCP. Lb EXM – L. bicolor extramatrical mycelium. ECM – Ectomycorrhiza.
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Figure 6.5 Counts of the top 10 most represented PTMs in PCPs identified in different sample
types. All PCPs identified by the PEAKS PTM module in each dataset were considered to plot the
counts of PTMs observed (Note: The same peptide can have more than one PTM).
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6.3.3 De novo database-assisted searches enable the identification of nonfunctional and functional PCPs in the peptidome of different sample types.
PCPs derived from the action of proteolytic mechanisms during protein turnover and
during protein maturation contribute to the total pool of native peptides in a cell. In plants, protein
turnover is a fundamental component in plant development. 133, 414, 452 As such, PCPs derived from
the degradation of functional proteins can represent a significant fraction of a cell peptidome, but
many of their functions are not well understood.415 On the contrary, several families of bioactive
PCPs in plants are derived from protein precursors during certain conditions, like in the presence
of microbial pathogens or of heavy metals, and many of their functions have been characterized.
Nevertheless, methodologies that can globally profile the expression of both types of PCPs
directly in plant tissues and in their microbial partners are still lacking, but our experimental
approach can potentially fill this void.
In our datasets, many PCPs mapped to housekeeping proteins like ribosomal subunits,
elongation factors and RuBisCO subunits (Supplementary Table S6.1). The role of these PCPs
in ECM samples or samples without ECM were not further investigated or directly compared, but
it is interesting to point that a recent study reported an increase of protein turnover in leaves of
Populus × canescens plants inoculated in vitro with the ECM forming fungi Paxillus involutus in
comparison to control plants.420 Similar observations have also been made for arbuscular
mycorrhizal symbiotic systems grown in lab.

418, 419

Hence, our MS methodology, in combination

with others like traditional proteomics, could be useful for more in-depth investigations on the
plant proteolytic “degradome” 133, 414 by directly analyzing PCPs abundance changes from plant
tissues experiencing plant-microbial interactions compared to controls.
Apart from detecting members of the degradome our approach was able to capture
previously reported endogenous mechanisms of protein maturation happening in different sample
types. For example, we were able to identify PCPs that mapped to the N- and C-terminus regions
of histone H2BK4 of L. bicolor, suggesting a histone clipping mechanism,453, 454 (Figure 6.6A) and
PCPs in Populus leaves that mapped to the proposed mature form of protein PsbTn (~ 3 kDa),
which is the smallest subunit of the Photosystem II complex (Figure 6.6B).455 In addition, we
observed several uncharacterized PCPs that may point to unknown mechanisms of protein
maturation; for example, N-terminus PCPs mapping specifically to the cysteine-rich domain
(CFEM) of a glycosylphosphatidylinisotol (GPI) anchored protein of L. bicolor, the former being a
domain that is common only to fungal extracellular membrane proteins (Figure 6.6C).456
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Figure 6.6 Visual representations of detected PCPs (highlighted in grey and in red letters)
produced as results of known and hypothesized protein maturation mechanisms in Populus
and L. bicolor samples. (A) PCPs mapped to the N-terminus and C-terminus regions of L bicolor
histone H2BK4 in L. bicolor extramatrical mycelium (Lb EXM) as well as root with and without
established ECM. (B) The mature form of protein PsbTn from the Photosystem II complex of Populus
was identified in leaves with and without ECM. (C) Identified PCPs from a CFEM-domain containing
protein with a predicted GPI-anchored site. PCPs spanned most of the CFEM domain. Peptide
mapping data is from Lb EXM.
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6.3.4 Comparative quantitative analysis of PCPs defines a set of significant
analytes in ectomycorrhiza symbiosis between Populus X canescens and L.
bicolor.
A differential expression analysis of PCPs and the proteins they mapped to in root samples
with or without ECM and Lb EXM was useful to narrow the dataset into groups of PCPs with
biological significance in the symbiotic associations between plant and fungus. Overall, 398 PCPs
were differentially abundant (ANOVA p-value < 0.05; Supplementary Table S6.2) between roots
with and without established ECM and Lb EXM. To further delineate the relevancy of PCPs to Lb
symbiosis with Populus roots, TukeyHSD post-hoc test was performed to quantify abundance
differences between relevant sample groups. Based on this analysis, a total of 157 PCPs were
determined to be significant in the mutualistic interactions between Populus and L. bicolor. Of the
157 PCPs, 96 mapped to 69 L. bicolor proteins, 56 mapped to 64 Populus proteins and 5 were
shared between 12 Populus and 6 L. bicolor proteins, respectively.
Like other large-scale ‘omic’ analyses, measured differences between relative
abundances of analytes can be explained by numerous phenomena. Regarding PCPs,
quantitative differences can arise from several levels of regulation (e.g. the amount of protein
expression, the rate of protein translation, protein and peptide turnover rates, post-translational
modifications, etc.) and therefore, while we highlight several intriguing observations below and
their likely implications, the mechanism(s) regulating these differences are largely unknown.

6.3.4.1 L. bicolor endogenous peptides associated with symbiosis with Populus.
Of the 157 PCPs determined to be significant in the mutualistic interactions between
Populus and L. bicolor 96 PCPs mapped to 69 L. bicolor proteins (Figure 6.7A). Amongst the
differentially abundant L. bicolor PCPs in root with established ECM compared to Lb EXM were
those belonging to a variant of the cysteine-rich C-terminus of the L. bicolor Mycorrhiza-Induced
Small Secreted protein MiSSP7.6, that in our database is annotated as MiSSP7.7 and has 97.3%
pairwise identity to MiSPP7.6 (Figure 6.7B). The SignalP-5.0457 and Phobius458 webservers
agreed on the presence of a signal peptide on the first 21 amino acid residues of MiSSP7.7. It
has been previously reported that MiSSP7.6 is secreted by L. bicolor and later imported into
Populus cells as a mature peptide of 54 amino acids. The matured MiSSP7.6 PCP localizes in
the nuclei of plant cells where it interacts with Zinc-Finger transcription factors belonging to the
Myb/SANT-like DNA-binding domain protein family.427 The C-terminal PCP detected in this study
may point to a plausible mechanism of protein maturation.
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(A)

(B)

Predicted signal peptide
Figure 6.7 L. bicolor proteins from significant upregulated peptides associated with ECM. (A)
A total of 96 PCPs mapped to 69 L. bicolor proteins, amongst them, a MiSSP7.7 protein (97.3% identity
to MiSSP7.6 reported in literature, highlighted in yellow). ( B) The region to which identified PCPs
mapped to MiSSP7.6 is highlighted in grey color. A predicted signal peptide in the protein is al so
shown.
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In addition, we identified 4 putative small secreted proteins of < 250 amino acids (B0FD3,
B0D9T2, B0DP29 and B0DXP4) 459 lacking functional annotation. As research on the symbiosis
between Populus and L. bicolor has been uncovering novel SSPs derived from both organisms
necessary for the establishment and regulation of the symbiotic association of L. bicolor and
Poplar,

427, 428, 443, 444

this dataset contributes additional novel protein candidates associated with

ectomycorrhizal symbiosis.
Another group of expressed PCPs in roots with ECM that mapped to several L. bicolor
proteins involved in the detoxification of reactive oxygen species (ROS). This observation is likely
related to the type of stress responses that mycorrhizal fungi can induce to plants which include
the generation of ROS species like hydrogen peroxide, superoxide anion, and hydroxyl radicals.
460

Amongst those proteins, we identified a tyrosinase (B0DMA1) that provides resistance against

reactive oxygen species and phenolic compounds during early symbiosis,461 a cysteine
peroxiredoxin (B0CY32) and a manganese peroxidase (B0DVT9).
Interestingly, amongst the differently expressed L. bicolor proteins we also identified PCPs
that mapped to a lectin-related tectonin 1 protein (B0D1K0). In general, fungal lectins are best
known to be part of the defense mechanisms against soil microbes and predators that act by
targeting glycoepitopes in the cells surfaces of the latter;462 however, fungal lectins that recognize
host cell glycans in ectomycorrhiza, albeit, not specifically in Populus – L. bicolor ECM, have also
been hypothesized to help mediate the adhesion of partners to hosts.463 Interestingly, a study
investigating the molecular mechanisms behind the physical interactions of Laccaria
bicolor S238N hyphae and its mycorrhiza-helper bacteria Pseudomonas fluorescens BBc6R,
found upregulation of the L. bicolor tectonin 2 gene, where it was suggested to have a role in cellto-cell recognition.464 Thus, it is plausible to hypothesize that the tectonin 1 found here has a
similar function to tectonin 2, but with Poplar root cells instead, and opens an interesting
experimental opportunity for its functional validation.

152

6.3.4.2 Populus X canescens endogenous peptides associated with symbiosis with
L. bicolor.
Overall, the majority of the 56 Populus PCPs found to be significant in ectomycorrhizal root
compared to Lb EXM mapped to proteins related to stress response mechanisms (Figure 6.8A),
with the metallothionein (MT) protein family being highly represented (Figure 6.8B). During
endomycorrhizal symbiosis, metallothionein proteins are generally hypothesized to provide
protection against oxidative stress including the one caused by heavy metals.465, 466 Interestingly,
the differentially abundant polypeptides map exclusively to the N-terminus and C-terminus of
these proteins, which are both cysteine-rich regions. An intriguing explanation for the specific
mapping to these regions is that Populus MTs experience post-translational cleavage, a largely
overlooked regulatory mechanism for this protein family. Cleavage of MT by proteases has been
shown to be largely dependent on the loading of the protein with heavy metals467 and occurs
among the large stretch of amino acid residues separating the cysteine-rich domains.468 A study
on a plant MT expressed in E. coli showed that the linker region was sensitive to the bacterial
proteolytic system; 469 however, whether this process occurs in nature or its functional importance
in symbiosis has not yet been shown.
Additionally, PCPs mapped to Populus house-keeping proteins involved in protein
expression machinery (i.e., subunits of ribosomal proteins) and/or components of active cell
signaling/communication systems (i.e., ADP/ATP carrier proteins and metal transport proteins).
Similar observations have been reported at the transcript level in active ECM symbiosis between
Pisolithus tinctorius and Eucalyptus globulus where the authors concluded that this was expected
due to intense bilateral metabolic transfers and high assimilative activity.470 Of note, although we
cannot accurately pinpoint to specific mechanisms of how the PCPs observed from these proteins
are being produced endogenously, there is no indication in literature that such molecules are
further processed to mature PCPs and thus, we can hypothesize that mechanisms of protein
turnover or degradation are the most plausible explanations behind their identification by our
experimental approach. Complementary proteomics analyses measuring the relative levels of
protein precursors from which these PCPs are derived from can confirm the natural degradation
of these proteins and/or provide a different functional perspective from pools of PCPs, similar to
what others have found before.415
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(A)

(B)

Figure 6.8 Populus X canescens proteins from significant upregulated PCPs associated with
ECM. (A) A total of 56 PCPs mapped to 64 Populus proteins, amongst them, proteins related to stress
protection like metallothioneins (highlighted in yellow). Other PCPs mapped to Populus house-keeping
proteins involved in protein expression machinery and/or signaling systems. ( B) Example of one of the
six metallothionein-like type 2 proteins identified (ID. Potri.001G041300.1). All identified PCPs from
this protein mapped to its N- and C-terminus regions (highlighted in grey).
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6.3.4.5 Differentially abundant PCPs shared between L. bicolor proteins and
Populus X canescens proteins.
The five differentially expressed and shared PCPs between Populus and L. bicolor
mapped mainly to functional domains of polyubiquitin and ubiquitin proteins which are well
conserved proteins across life.471 Ubiquitins can be found as monomers and polymers and have
distinct roles in intracellular protein degradation via the proteasome pathway.472,

473

Several

studies have demonstrated high and significant expression of ubiquitin genes in the establishment
of ectomycorrhizal symbiotic associations. For example, in the Eucalyptus globulus-Pisolithus
tinctorius ectomycorrhiza, upregulation of plant derived transcripts encoding components of the
ubiquitin pathway were reported, where it was hypothesized that these proteins help mediating
the downregulation of plant protein synthesis in colonizing roots.470 Another study analyzing the
transcriptional responses in the ECM interaction between the basidiomycete Paxillus involutus
and its host birch Betula pendula compared to extramatrical mycelium, shown a polyubiquitin that
was upregulated by 4.2-fold in ECM.471 In addition, the generation of reactive oxygen species like
hydrogen peroxide is known to induce the expression of polyubiquitin in cells as a mechanism of
detoxification 460 and in this study we saw significant expression of fungi ROS-related enzymes in
root with ECM.

6.4 Conclusions.
Over the last couple of years an increasing body of evidence at the transcript level has
demonstrated the expression of bioactive PCPs in biotrophic plant-fungal associations. However,
direct evidence of the products of genes and transcripts believe to be involved, or participating in
ECM establishment and/or regulation, is still lacking in literature, but can certainly provide a new
layer of evidence in the functional understanding of these molecules. As certain characteristics
typical of endogenous PCPs in any biological system can make their identification laborious and
difficult (i.e., unknown cleavage specificity, the presence of multiple PTMs, and relatively low
natural abundances), experimental approaches that can comprehensively identify them with
sensitivity and specificity are most welcome.
In this study, we systematically investigated the use of a 10 kDa membrane filtering
strategy to enrich and quantify Populus and L. bicolor PCPs expressed in active mycorrhizal
lateral root tips and identified novel peptide sequences using LC-MS/MS with de novo-assisted
database search strategy. Particularly, de novo-assisted database searches offer a way to detect

155

functional products of genes and transcripts without biasing the identification towards the use of
specific proteases or cleavage mechanisms like in traditional large-scale protein studies.
The differential expression analysis of PCPs conducted throughout this study enumerated
PCPs that have a role in the symbiotic interactions between both Populus and L. bicolor and
provide theories of their biosynthetic origins. For example, we found evidence of a L. bicolor PCPs
mapping to the C-terminal region of a MiSSP7.6 protein, or of PCPs that mapped to N-terminus
and C-terminus regions of Populus metallothionein proteins that are related to stress responses
happening during the formation of ECM. These cases highlighted the utility of the LC-MS/MS
methodology to capture potential mechanisms of endogenous protein maturation. Interestingly
several PCPs mapped to small L. bicolor proteins of unknown function from which four were
predicted to be secreted.
Housekeeping proteins supporting the crosstalk and metabolic adjustments between plant
and fungi such as transporters and ribosomal proteins, were also detected. It was hypothesized
that the identification of PCPs, and their PTMs, mapping to these types of proteins are related to
turnover/degradation proteolytic mechanisms which are supposed to be upregulated in AM and
ECM symbioses.418-420 Their detection may prove useful alongside relative measurements of
protein precursors to determine if such proteins are being subjected to natural turnover or if these
PCPs serve another role in the symbiotic system under study. Overall, this study provides
experimental support for a quantitative strategy to investigate the global expression of PCPs in
PMI systems allowing to identify those with potential roles in their associations.
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CHAPTER 7
Outlook, challenges, and conclusions
7.1 The potential of targeted proteomics to monitor environmentally relevant
microorganisms in bioremediation.
Anthropogenic pollutants are found worldwide. The expansion of human population and
its related activities such as industrial production processes and agriculture has led to an increase
in the amounts of toxic organic and inorganic compounds that are released in the environment.
To partially alleviate this global problem, active research on naturally occurring microorganisms
at contaminated sites that can degrade, transform, or accumulate a wide range of hazardous
compounds such as hydrocarbons, heavy metals, pesticides and chlorinated compounds 88 has
sparked interest into harnessing their intrinsic metabolic capabilities as a sustainable way to
degrade and detoxify contaminants in the environment. These strategies, known as monitored
natural attenuation (MNA) strategies,97 differ to others that employ genetically modified or nonnative species, and require a deep understanding on microbial physiology and the cellular
processes behind contaminant degradation.
As with other areas of microbiological research, the application of ‘omics’ technologies to
this field has not only greatly improved our fundamental understanding of the biology of these
microorganisms under controlled conditions; but they have also allowed their direct study in
contaminated environments, which has provided information on complex microbial dynamics
happening in situ.87 The latter has been particularly useful because unlike laboratory-scale
simulations, the application of MNA strategies takes place across environments with different
geochemical gradients, and diverse geophysical and hydrological complexities474 typically
involving the presence of more than one contaminant and of different strains of microbes with
specialized metabolic capacities.
In particular, the application of quantitative proteomics techniques for bacterial-mediated
bioremediation research provides critical insights into important cellular activities with temporal
and spatial resolution. Different than genes and/or transcripts, proteins are the direct catalysts
behind the variety of metabolic responses exerted by bacteria to contaminants in the environment.
Proteome analysis of these environmentally relevant group of microorganisms, either growing
under laboratory-controlled conditions or directly from environmental samples, can be used to
identify and compare the suite of expressed proteins from a particular sample in a particular state,
in order to elucidate metabolic pathways or identify group of proteins that can potentially be used
as biomarkers that register the desirable degradation response to a contaminant in the
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environment. Measuring proteins in bacteria provides direct and relevant information that can be
used to show that certain bioprocesses are occurring in situ and/or evaluate a certain set of
conditions that favor the degradation of a contaminant or class of contaminants.
As a case example, genomics, transcriptomics and proteomics research on the anaerobe
Dehalococcoides mccartyi (Dhc) bacteria has provided enough gene and protein level evidence
over the years to assess the metabolic capabilities of Dhc bacteria to transform chlorinated
ethenes to benign ethene via the expression of reductive dehalogenase enzymes (RDases). Early
proteomics studies, for example, focused on the identification of RDase enzymes on cultures of
Dhc bacteria amended with different organohalides as electron acceptors and in varying degrees
of concentrations, which allowed to gain a deeper understanding of the overall physiological
activity of the organism. Proteomics research on Dhc bacteria has also enabled a refined
validation of transcriptome results, as it has been observed in some cases that transcripts are not
always translated into functional proteins. Improvements in sample preparation and MS
technologies have enabled a deeper Dhc proteome coverage with percentages in different Dhc
strains ranging from 60-72% up to the ~ 9% that was reported in earlier studies.
The application of proteomics techniques to Dhc research has sparked the interest of the
research community of employing proteomics techniques for more specialized applications like in
situ monitoring of bacteria in contaminated groundwater as well as calculations of protein
activities. Indeed, directly applying proteomics to groundwater could provide information into the
actual functional activities of Dhc associated with each sample and complement state-of-the art
gene-targeted approaches that are commonly used to monitor Dhc cell abundances in situ. These
two goals are also appealing to site manager regulators that look to know if Dhc is present in a
site, at what levels, and if the bacteria are performing the desirable pollutant degrading activity.
One mode of MS data collection that can be used to answer these questions is targeted
proteomics via MRM-MS or PRM-MS. Monitoring specific Dhc RDases in groundwater with
sensitivity and in a faster way than with global proteome measurements, can in theory allow the
determination of Dhc bacteria in a contaminated site while at the same time providing relevant
information for the potential of enzymatically driven dechlorination. Furthermore, the shift from
relative to absolute quantitation can be used to calculate enzymatic degradation rates.
Few studies have explored the use of targeted proteomics for the organohalide respiration
capabilities of Dhc bacteria, but the systems under investigation have been restricted to anaerobic
mixed cultures grown in the laboratory. The results presented in those studies have provided
levels of targeted protein copy numbers per cell and even enzymatic kinetic rates. However,
transitioning this knowledge from simpler cultures to groundwater, where multiple metabolic
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processes mediated by taxonomically diverse bacteria are simultaneously happening is not trivial.
For instance, peptides selected in targeted studies that act as surrogates to monitor the
expression and calculate absolute abundance levels of a protein, can be not specific when
analyzing an environmental sample. Such a case was demonstrated with the study presented in
Chapter 3 of this dissertation, where the specificity of each selected peptides had to be compared
in-silico to the proteomes of other known type of bacteria living in groundwater or even on a
broader taxonomical context.
Importantly, the natural dynamic ranges of proteins expressed in an environmental sample
as well as other interferences can impact the detection of Dhc RDases in these types of samples,
and even when targeted proteomics provides sensitivities that are 1-2 orders of magnitude higher
than global measurements, targeted peptides and proteins may still not be detected. This
demonstrates the need of identifying peptides by this method as a first step to plan and execute
their absolute quantitation, which was the main goal of Chapter 3. It is expected that the list of
peptides selected in this study can then be useful for the development of a quantitative study, as
several of these peptides were detected in different groundwater matrices and their specificities
checked. Further studies could evaluate the dynamic ranges of these peptides and provide
estimates of the number of protein copies per volume of groundwater.
The application of targeted proteomics technology for protein analysis in the field of
environmental biotechnology is still in its infancy but when combined with adequate functional
genomic/proteomic analysis of degradative bacteria can potentially yield information of
genes/proteins acting as bioindicators of important metabolic process in the environment. A
recent example includes the quantitative measurement of nitrogen regulatory proteins, with
peptides capable of distinguishing

proteins derived from either Prochlorococcus and

Synechococcus cyanobacteria living in sea samples collected form the Central Pacific Ocean. 475
Interestingly, the applications of targeted proteomics are not only limited to bacteria, but recent
efforts have also been applied to higher organisms. For example, in the sentinel amphipod
Gammarus fossarum, a targeted proteomics method using MRM-MS was recently developed for
the simultaneous quantification of 38 peptides reporting for 25 proteins, whose changes in
abundance act as sensitive indicators for the presence of contaminants in river water.476
These are just some examples of studies demonstrating the use of targeted proteomics
strategies to monitor protein biomarkers in the environment, and the advantage that it provides
but many more are yet to come in the next years.
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7.2 Measurement of groups of proteins by targeted proteomics to monitor
metabolic processes in anaerobic bioreactors for biogas production.
Biogas is one of the products obtained from the microbial-mediated anaerobic degradation
of organic materials with high lignocellulose content like food, municipal, and agricultural wastes.
Production of biogas in anaerobic digesters holds great potential for the generation of electricity
and vehicle fuel. The application of molecular “omics” techniques to anaerobic digesters has now
enabled a more detailed understanding of the microbial metabolic processes occurring during the
production of biogas. Particularly, metaproteomics has linked genetic information to the functional
characterization of microbial communities thriving in anaerobic environments and has provided
information on regulatory processes necessary for enzyme production. Amongst other
advantages of metaproteomics is also the potential to identify proteins, and/or their temporal shifts
in abundances, in response to environmental and operational parameters which could be used to
monitor the performance of an anaerobic digestor, for example, of either of its stable or unstable
operation.
In fact, several publications in the field have mentioned an interest in the use of proteins
that are highly expressed during the process of biogas formation as functional biomarkers that
could act as predictive biomarkers of perturbations in a system.354, 355, 477 One of those examples
are variations in the abundance levels of the methyl-coenzyme M reductase, a key enzyme in all
methanogenic pathways from which decrease in abundance has been correlated to acidification
conditions in biogas plants.357 Besides proteins in methanogenesis, other proteins of potential
interest could be glycoside hydrolases (GHs) which are important for the deconstruction of
polysaccharides buried in lignocellulosic material. Hydrolysis of sugar polymers is considered a
bottleneck in the anaerobic digestion process because it can either underperform or outperform
other metabolic steps based on initial conditions, i.e., the use of highly lignified substrate sources.
Although metaproteomics approaches to reveal protein content and abundance in anaerobic
digesters can in theory improve process efficiency and stability, the amount of time and effort
required behind these types of experiments limits them to be performed routinely and in as many
samples as possible. However, targeted proteomics experiments present an interesting
alternative to discovery-based proteomics measurements of proteins as they allow for flexible,
quantitative, and relatively routine measurement of hundreds of peptides within a shorter time
frame.478 Compared to immunoassays, targeted proteomics also features faster assays
development and deployment and in principle can distinguish similar proteoforms such as
isoforms and post-translational modified proteins.479
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In Chapter 4, the initial steps in the development of a targeted proteomics assay to detect
GHs in anaerobic digesters that could provide information of the hydrolytic performance of the
latter, were presented. However, different than in the development of other targeted proteomics
assays, which are defined by the selectivity of peptides to specific proteins, it was decided to
show the selection of unique peptides capturing entire families of GHs. Some of these peptides,
although shared amongst individual members in a family, were specific to GH families meaning
that they cannot be produced from other proteins in the background nor found across different
families. Provided that sufficient data acquisition has suggested the expression of groups of GHs
at determined ratios to be indicative of the hydrolytic capacity of a digester, then monitoring groups
of proteins without necessarily knowing the signal contribution of specific proteins in a group could
provide of a faster assessment of the hydrolytic capacity of a reactor.
It was observed that several of the selected peptides mapped exclusively to GHs
belonging to different microbes but also to GHs with different enzymatic substrate affinities within
same families of enzymes. The latter characteristic may be even more important for anaerobic
digesters as the starting substrates can vary widely in their lignocellulosic content. Chapter 4 is
just the beginning of the development of a targeted proteomics assay and more work is required
to get a more manageable number of peptide candidates capturing groups of GHs to test
experimentally in a mass spectrometer. As proteins give the most direct evidence of the
functionality of active organisms within microbial communities, targeted proteomics is an
interesting alternative to metaproteomics and immunoassays towards the detection of proteins
biomarkers in selected metabolic routes in anaerobic digesters.
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7.3 Getting more out of DDA-collected spectra in bottom-up proteomics
experiments.
The interpretation of the thousands or hundreds of thousands of peptide sequences in a
protein database and their assignment to experimental spectra is a key challenge of MS-based
bottom-up proteomics experiments. After a peptide is fragmented in the mass spectrometer, a
series of characteristic set of ions, such as y- and b-ions, are used by a search engine to compute
the probability that an experimental spectrum represents an amino acid sequence in a database.
These peptide assignments are often achieved through scoring of the experimental spectrum
relative to a theoretical spectrum of a candidate peptide. 480 By setting up a score significance
threshold, peptides that are above the threshold are accepted, while peptides with a lower score
are rejected. Thus, the success that any given search engine has of finding and assigning the
correct peptide to a mass spectrum depends of how many fragment ions are characteristic for a
particular peptide sequence and how many other peptides are present in the database. 48 1
Therefore, when two or more different peptides of similar masses co-elute within the same time
window in a data-dependent acquisition procedure (see section 1.1.2), the fragment ions of these
“interfering” peptides, add to the uncertainty of peptide identification. 482
Chimeric spectra (see section 1.4.1) are unavoidable in LC-MS/MS bottom up proteomics
experiments that analyze complex biological mixtures. As mentioned before in Chapter 4, several
studies have reported that the percentage of chimeric spectra collected in bottom-up proteomics
experiments analyzing single cell isolates can be as high as 50% of the total data, 109 with newer
studies using state-of-the art mass spectrometer, putting this percentage close to 39%.118 Thus,
it is safe to assume that even greater percentages are expected in experiments analyzing
samples that are the target of metaproteome studies. Interestingly, one study reported that even
when every possible peptide precursor ion could be targeted for fragmentation in a LC-MS/MS
experiment via DDA, cofragmentation of precursor ions would be unavoidable as many peptides
coelute from the liquid chromatography part of the experiment.107 The same study also suggested
two ways of solving this issue: Computationally and/or by improving the capabilities of MS
technology by affording high resolution precursor selection.
Computationally, and in order to correctly assign multiple peptides to the concurrent
product ion spectra, conventional database algorithms have been improved over time and some
of them were already described in section 1.4.2. The project presented in Chapter 3, evaluated
the performance of the CharmeRT computational workflow to deconvolute chimeric spectra under
different LC setups and isolation windows commonly employed in bottom-up proteomics research
and proposed that when combined with database engines using the multiple peptides-per162

spectrum-match approach (mPSM), like CharmeRT, HPLC configurations can still provide
comparable identification metrics to UHPLC configurations that overall improve chromatographic
peptide resolution and lower peptide coisolation, but that are difficult and costly to implement.
However, besides specialized software that is tailored to deconvolute chimeric spectra in
proteomics data, other interesting alternatives are coming to light. For example, two research
groups483,
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have reported substantial improvements in the accurate prediction of theoretical

fragment ion spectra that is used in database search by using deep learning, a branch of machine
learning algorithms.485 In brief, these algorithms are trained on large dataset of experimental
fragment ion spectra, but different than other methods, they can more accurately predict fragment
ion intensities, by taking into consideration additional factors like collision energy and
fragmentation modes. These accurate reference spectra are then used for matching against
experimental spectra from either DDA or DIA experiments.480 These studies reported small
increases in the number of peptide identifications at 1% FDR, but both algorithms provided higher
identification gains when searching large databases, such as those that would be typical used for
metaproteomics.480 One of those studies483 concluded by stating that one potential use of deep
learning algorithms could be in deconvoluting chimeric spectra, perhaps by better differentiating
clusters of “contaminating” fragment spectra based on similarities to training datasets, or by
combining information from predicted retention time profiles of peptide sequences that can coelute under different chromatography conditions.
Besides the use of deep learning algorithms, developments in LC-MS/MS instrumentation
can also help in the task of increasing measurement depths to what has already been collected.
For example, newer types of mass spectrometers, like the Orbitrap Fusion Lumos Tribrid486
instrument provides resolving power up to 500,000 FWH at m/z 200 and scan rates up to 20 Hz,
and it would be interesting to compare how the improved mass resolution helps in the process of
selecting precursor ions that are targeted for MS/MS fragmentation. In the same way different
modes of LC operation are being explored to counter, in part, the effects of coelution in bottomup proteomics experiments. For example, one group explored a multiple solvent approach of
resolving peptides from a HeLa cell digest consisting of consecutive and separate gradient runs
using acetonitrile, methanol, and acetone, to reduce the effect of coelution and ion suppression.
Their strategy resulted in almost a 30% increase in the number of peptide identifications
compared to a simple technical triplicate of the same digest but using a typical single acetonitrile
solvent gradient.487 Another group explored temperature manipulation at different stages of a two
LC column setup and suggested that loading peptides at subambient temperature (0 °C) could
improve the characterization of hydrophilic peptides, which do not resolve quiet well in proteomics
163

experiments, by providing narrower peak shapes; but that also heating of the main analytical
column could help improving chromatographic resolution by reducing peak widths and facilitate
peptide elution.488
Due to the nature of the samples analyzed by bottom-up global LC-MS/MS proteomics
experiments, and of the data-dependent spectral acquisition mode used typically on them, some
level of peptide information often escapes these types of analyses in the form of chimeric spectra.
The occurrence of chimeric spectra lowers the rate of peptide spectral matches that are assigned
by common database search algorithms, but they also present an opportunity to increase
measurement depth. Although for low complexity samples, such as single cell isolates, the depth
of measurement achievable today be enough to answer the questions under investigation, studies
analyzing higher complexity samples, could benefit from the application of bioinformatic software
or experimental tools that can recover more information from chimeric spectra, or lower their
chances of occurrence, respectively. As database search algorithms get improved and LCMS/MS instrumentation cheaper, deconvoluting chimeric spectra from any given LC-MS/MS
bottom-up proteomics dataset could become a routinely step of any proteomics pipeline.
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7.4 Advantages of LC-MS/MS peptidomics to uncover bioactive peptides in
different systems.
The discovery of peptides of less than 100 amino acids that exist within cells and tissues
of different organisms across prokaryotes and eukaryotes have provided new insights into
diversity of molecules that govern the functionality of biological systems. These molecules are
involved in important biological roles including translational control, cell-to-cell communication,
development and protection mechanisms.489-492 While gene-based methods and targeted proteinbased methods like western blots have been the main tools used for the discovery and
characterization of endogenous peptides, the application of LC-MS/MS based methodologies has
provided comprehensive evidence of their expression and stability. LC-MS/MS peptidomics
workflows aim to detect and identify endogenous peptides in a biological system with molecular
weights ranging between 0.5-15 kDa.137 Although peptidomics has borrowed from analytical LCMS/MS proteomics strategies,493 there are fundamental differences and considerations that need
to be addressed when planning an experiment of the latter type.
One of those considerations is the distinct biosynthetic origins of endogenous peptides. In
diverse organisms, these origins may not only include protein maturation mechanisms or natural
turnover but also small, and in many cases, unannotated open reading frames. Each of these
origins reflect the acting of frequently unknown proteolytic mechanisms; post-translational
modifications, and the co-existence of different versions of peptides derived from the same gene
or precursor in a sample. Thus, to capture the biological origins of these peptides, LC-MS/MS
based peptidomics strategies may not necessarily require the enzymatic digestion of the
sample147 (i.e., the use of trypsin), and in some cases, this may be even detrimental for their
identifications, due to the limited number of cleavage sites available on them.
The issue gets further complicated when deciding how to search spectral data derived
from endogenous peptides. Typical LC-MS/MS based proteomics employ databases that are predigested in-silico to generate a list of theoretical peptides and spectra that is matched to
experimental data; however, without the constraints of sites for proteases in peptidomics data
analysis, database searches can become a real challenge. Using multiple proteases for in-silico
digestions not only increases the search space and computational resources needed to assign
peptide sequences to experimental spectra, but, false positive rates can also reach very high
levels compared to traditional proteomics.147 Other studies, especially in plants, have used
custom-made databases including known variants of families of endogenous peptides, but this
limits the scopes of identifications or works better with those analytes that have been studied with
more detail. In addition, peptidomics studies may also rely on single identifications, as peptides
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can originate from small protein precursors or, as mentioned before, be directly translated from
sORFs that, in addition, may not be represented in protein databases.494 Besides these issues,
others, like the relative natural abundance of peptides in a proteome (compared for example to
housekeeping proteins), their variable sizes (2-100 amino acids) and properties, can make their
identification by MS troublesome.
Several of these issues were taken into consideration in the development of the research
project presented in Chapter 6 of this proposal. Here, a method of identifying natural occurring
peptides or proteolytic cleavage products (PCPs) relevant in the establishment of ectomycorrhizal
symbiotic associations between the basidiomycete Laccaria bicolor and the perennial plant
Populus X canescens, through LC-MS/MS was developed. This dual system presents a good
opportunity to test the capabilities of a LC-MS/MS based peptidomics approach to provide
experimental evidence of the expression of native peptides at a global scale. An increasing body
of gene-based bioinformatic research has shown the presence of small secreted proteins (≤ 250
amino acids) in the genomes of Populus and L. bicolor,495,

496

and experimental data has

demonstrated different levels of gene/transcript-level upregulation during their mutualistic
interactions.497-501 Moreover, there is specific protein-level evidence of the mechanisms of some
small secreted proteins from L. bicolor, such as the mature form of the MiSSP7.2 protein (68
amino acids) that acts by stabilizing the Populus jasmonic acid signaling repressor PtJAZ6,497 or
more recently of four Populus secreted peptides and small proteins (ranging from 69 to 263 amino
acids) that localize to the nucleus of L. bicolor, with two of them impacting hyphal growth and
morphology.444
As many of these small secreted proteins in Populus and L. bicolor do not have
characterized mechanisms of expression, it was decided not to use any protease for their
identification via LC-MS/MS so not to bias the analysis towards specific groups of peptides or
hinder their identification due to limited cleavage sites. Furthermore, an enrichment protocol using
10 kDa filter membranes was used to deplete high abundant molecular weight proteins and/or
their proteolytic residues that could interfere with their identification due to electrospray signal
suppression, for example. The workaround to a regular database search was found in de novoassisted database searches, a capability implemented in the proteomics software PEAKS.149 As
the name implies, this mode of database search derives peptides sequence information from
experimental spectral data without relying on reference theoretical spectra generated from the insilico digestion of a proteome database. However, in contrast to stand-alone de novo sequencing,
the sequence tags identified de novo are used to identify proteins in a database.
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The application of this peptidomic approach to Populus tissues, including leaves and roots,
as well as roots with established L. bicolor ectomycorrhiza identified 1660 and 2870 Populus and
L. bicolor unique PCPs, respectively, having a median length of 21 amino acids. These PCPs
mapped to diverse proteins in the database and were able to capture previously reported
endogenous mechanisms of protein maturation. One example was the mature form of protein
PsbTn (~ 3 kDa) in Populus leaves, which is the smallest subunit of the Photosystem II complex.
Besides qualitative information, comparison of relative abundance values of PCPs demonstrated
upregulation of 157 analytes in root tips with established ectomycorrhiza when compared to root
tips without established ectomycorrhiza and free-living mycelium of L. bicolor. These PCPs
mapped to 64 Populus proteins and 69 L. bicolor proteins in our database, with several of them
previously implicated in biologically relevant associations between plant and fungus. L. bicolor,
for example, expressed proteins involved in the detoxification of reactive oxygen species which
are known to be induced during the formatting of mycorrhiza. Interestingly, the peptidome method
was also able to identify small secreted proteins, four of them without functional annotations and
another annotated as a MiSSP 7.6, from which it was plausible to hypothesize a knew mechanism
of protein maturation as the only peptides that mapped to it were exclusive to its C-terminus.
Although no predicted small secreted proteins from Poplar were identified in this study, the PCPs
identified mapped to stress related proteins like metallothioneins, an observation that has been
also captured in gene-based studies.
Endogenous peptides have been regarded as the “rising stars in the proteome”. 502 A
recent issue of the journal Proteomics highlighted the functional importance that these molecules
have in diverse organisms across different domains of life. With advances in RNA-seq and better
bioinformatic approaches for in-silico prediction, new regions in the genomes of even “well-known”
model organisms like E. coli and Arabidopsis thaliana with peptide encoding potential are being
discovered.59, 503 However, as the same Proteomics issue also mentioned, is the integration of
different sources of evidence that needs to become mainstream to detect and assess the coding
potential of such regions. Peptides derived from the maturation of annotated proteins, but with
unknown endogenous proteolytic mechanisms are also not exempt from this view. This is where
the power of LC-MS/MS peptidomics comes handy. The ability to detect and quantify the
expression of peptides under different conditions, not only can corroborate data derived from
gene-based techniques, but it can also, in a high-throughput fashion provide evidence of novel
molecules that can be candidates of further experimentation. With more technical advances in
LC-MS technology, but also in computational algorithms for peptide sequencing such as with
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better de novo spectra assignments,504 LC-MS/MS peptidomics will become a powerhouse for
the study of these “long overlooked, small… but mighty!”502 molecules.

7.5 Concluding perspective.
Liquid chromatography interfaced with tandem mass spectrometry has enabled and widen
the scope of protein-based knowledge to our understanding of the inner mechanisms of cells.
From the early discovery and characterization of a dozen-to-hundreds of proteins to current nearly
70-80% of complete proteome coverage on bacterial isolates, the in depth characterization of the
proteome has allowed researchers to understand that the array of proteins in an organism is a
dynamic and interconnected entity regulating multiple biological functions. However, as with every
other technique used in biology, proteomics by LC-MS/MS is not exempt of challenges. Some of
them include the lack of relatively streamlined experimental approaches for the recovery of
proteins from different sample types and the amount of initial material necessary to perform these
types of analyses when compared to genomics or transcriptomics. Likewise, there is no standard
sequencing platform and the high costs of state-of-the-art equipment, which keeps getting better
over time, has confined most of high-impact proteomic analyses to a small number of laboratories
around the world.
Despite these challenges, proteomics nowadays is sufficiently advanced to warrant the
characterization of a great variety of biological systems. Modern mass spectrometry techniques
have been deployed to analyze unique sample types with biological and clinical importance, from
bacterial communities thriving in acid mine drainage to cerebrospinal fluids. Although it may seem
with discomfort to more traditional researchers that proteomics enables the free conception of
hypotheses, this has facilitated a variety of follow-up experiments that have accelerated biological
research. It is the opinion of this author that the era of forming scientists specialized in the lifelong
learning of a few dozen of proteins will be even more challenged in the upcoming years as the
comprehensive characterization of the proteome becomes a routine and while proteomics
remains a rapidly developing and open-ended endeavor.
Besides the broader molecular understanding of organisms contributed by global LCMS/MS proteomics approaches, the adaptability of mass spectrometry has been demonstrated
with other more specialized techniques like targeted proteomics via multiple reaction monitoring
mass spectrometry. This technique has provided effective ways to address the identification and
absolute quantification of proteins of interest spanning wide dynamic ranges in cells. The non-
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scanning nature of MRM proteomics improves sensitivity relative to how data is collected in global
proteomics approaches like data-dependent acquisition. In addition, targeted proteomics provides
interesting advantages over techniques like Western Blot and ELISA assays including the ability
to analyze with specificity and sensitivity multiple protein targets at a time and not needing to use
antibodies. As technology gets more financially accessible, and software for data analysis more
user friendly, we may see targeted proteomics replace these traditional biomolecular techniques
at least in laboratories doing recurrent analyses of hundreds of samples like hospitals, clinics,
environmental monitoring labs, and others.
As the reader noticed throughout this dissertation, several challenges of LC-MS/MS
bottom up proteomics were tackled using different biological systems (i.e., groundwater, HeLA
cells, plant, and fungi extracts). This not only demonstrates the multifaceted characteristic of
proteomics but also its robustness as technology. Interestingly, these two attributes are also
shaping a new generation of researchers with all-around knowledge, those that can interpret and
condense enormous of data no matter of its origins to uncover the underlying biology within it.
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